Quantitative assessment of motor performance during robot-aided rehabilitation: preliminary results from NEUROPROBEs project by Débora Marisa Araújo da Silva Pereira
FACULDADE DE ENGENHARIA DA UNIVERSIDADE DO PORTO
Quantitative assessment of motor
performance during robot-aided
rehabilitation: preliminary results from
NEUROPROBEs project
Débora Marisa Araújo da Silva Pereira
DISSERTATION
MSC IN BIOENGINEERING - BIOMEDICAL ENGINEERING
Supervisor: Prof. Dr. Silvestro Micera, SSSA (Pisa, Italy)
Co-Supervisor: Prof. Dr. João Paulo Cunha, INESC TEC, FEUP (Porto, Portugal)
September, 2017
c© Débora Marisa Araújo da Silva Pereira, 2016/2017
Quantitative assessment of motor performance during
robot-aided rehabilitation: preliminary results from
NEUROPROBEs project
Débora Marisa Araújo da Silva Pereira
MSC IN BIOENGINEERING - BIOMEDICAL ENGINEERING
September, 2017

Abstract
Stroke refers to an episode of neurological dysfunction caused by a non-traumatic and permanent
vascular complication in the Central Nervous System. A typical consequence of such event, hemi-
paresis, is observed in abnormal patterns of movement coordination and task execution with the
impaired upper limb. As so, stroke survivors have a reduced quality of life, losing their indepen-
dence and ability to perform basic daily tasks.
Motor therapy, a component of neurorehabilitation, helps these patients to restore and main-
tain their motor ability. Recently, innovative technologies like robots have been adopted to assist
motor rehabilitation, inclusively for the upper limb. Among other existing techniques, robotic
therapy has become popular, because these devices provide movement assistance and controllabil-
ity, measurement reliability, and help physiotherapists to simultaneously supervise several patients
more easily. In addition, robotics has allowed rehabilitation to evolve towards the personalization
of the treatment for each patient, because movement execution can be quantified using robotics
kinematics and motor performance can be continuously estimated over the rehabilitation time.
However, treatment customization is emerging and needs yet to be validated concerning its effec-
tiveness over the standard therapy. Moreover, quantification of motor impairment is usually done
disregarding the neuromuscular state of the patient (the level of recovery of nondisabled neural
patterns), considering only the consequences of that state (movement execution skills).
This dissertation assessed the neurobiomechanical state of acute/sub-acute stroke patients dur-
ing robotic-assisted motor rehabilitation of the upper limb, using a novel exoskeleton (ALEx Re-
hab Station), in the scope of Neuroprobes project. To achieve this purpose, electromyographic
signals of 8 healthy subjects and 4 stroke patients were acquired while they executed 3D point-
to-point reaching movements wearing ALEx, as well as their arm trajectories. From this data,
muscle coordination and motoneural activity in the spinal cord were assessed and task execution
was quantified.
Patients who received the robotic treatment clearly improved their motor performance in terms
of accuracy, efficiency, smoothness, easiness and independence to accomplish a task. Neverthe-
less, their muscular organization and neural activity did not progress towards the one characteriz-
ing nondisabled persons.
In this regard, this work studied the possibility to include information about the patient’s mus-
cular organization in a recently developed algorithm for the personalization of the robotic treat-
ment with ALEx. Additionally, the present thesis proposes new kinematic parameters for the same
algorithm to improve the estimation of motor impairment: MDH (to measure accuracy), RMP (to
measure smoothness) and Assisted-distance (to measure robotic-assistance dependence). Finally,
recommendations are provided to improve the rehabilitation protocol with ALEx.
Keywords: Stroke, Robot-aided Motor Rehablitation, Arm exoskeleton, Quantitative assess-
ment, kinematics, Muscle Synergies, Spinal Maps
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Chapter 1
Introduction
1.1 Context and Motivation
Functional recovery from stroke demands a long period of physical rehabilitation. Investigating
the mechanisms of motor relearning and cortical reorganization supported the definition of suit-
able methods to restore the arm functional movements. Additionally, the development of new
technologies such as robotics has provided an opportunity to improve therapy delivery. In fact,
robot-aided neurorehabilitation can provide the intensive and repetitive training needed to relearn
upper-limb movements, by assisting the patient while performing motor tasks and by allowing the
therapist to supervise several patients at the same time. (Basteris et al., 2015; Panarese et al., 2012)
Above all, motor therapy must be challenging to effectively promote motor recovery and main-
tain patient’s attention and motivation, but, at the same time, it should be tailored on patient’s
residual abilities (Panarese et al., 2012). Given the fact that stroke population is highly heteroge-
neous (concerning, for example, the level of disability, the time course of recovery, the location,
extension and type of lesion, the patient’s age, and other reasons) (Basteris et al., 2015), an adap-
tive training, based on each individual needs and continuous progress, is believed to improve the
outcome of the rehabilitative treatment (Krebs et al., 2003; Novak et al., 2011; Panarese et al.,
2012; Papaleo et al., 2013; Metzger et al., 2014).
However, so far, tailoring exercises to the individual’s performance demands a physiotherapist
to evaluate the patient progress and adapt therapy accordingly, because customization capability of
current robotic systems is limited (Panarese et al., 2012; Guglielmelli et al., 2009; Wu et al., 2016).
With this concern, the present work is being developed within the NEUROPROBEs project -
Effect of an Automatic Personalized Robot-assisted Rehabilitation on Cortical Organization and
Clinical Recovery After Stroke.
The project aims to develop an automatic and personalized robot-based protocol of motor
rehabilitation for the upper limb. The personalization of the robot-aided treatment is expected
to better promote brain plasticity and, consequently, increase speed and quality of the patient’s
recovery, compared to a standard physiotherapist or robot-assisted training.
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In detail, the scope of the project is to continuously tailor the rehabilitative task assisted by a
robotic device on the residual abilities of the patient. The exercise proposed by the customization
algorithm is expected to contain only those movements that are useful for the patient’s training,
thus, focusing the treatment on meaningful exercises and continuously adapting it to the status of
the patient, increasing also his/her motivation to continue the training.
Following this, another goal is to assess the safety and clinical efficacy of a new upper limb
exoskeleton (ALEx RS) in assisting stroke patients during robotic-rehabilitation, compared to con-
ventional therapy. ALEx was selected among the available upper limb exoskeletons, because it is
the one presenting the highest "transparency" (Pirondini et al., 2016) and accessibility to the arm
of the patient. This last feature was essential, because it allows the recording of neurophysiolog-
ical measures, such as the electromyographic signals, which are necessary to characterize motor
recovery after stroke. However, ALEx is a research prototype and its use on patients has never
been tested before, requiring a further characterization and evaluation within the clinical environ-
ment of stroke patients rehabilitation.
For these purposes, a clinical trial is being conducted with 48 acute and subacute stroke pa-
tients at two hospitals - HUG (Hôpitaux Universitaires Genève) and Pisa University Hospital
(Azienda Ospedaliero Universitaria Pisana - Neurorehabilitation Unit). Additionally, 48 healthy
persons participate in the trial as part of a control group.
This trial is a collaboration between the Geneva-based Wyss Center, Wearable Robotics c©
(robot manufacturer and study sponsor), the group of the Bertarelli Foundation Chair in Trans-
lational NeuroEngineering at the École polytechnique fédérale de Lausanne (EPFL), the Swiss
National Centre of Competence in research Robotics (NCCR) and the two participating hospitals.
Results of a pilot study on healthy subjects demonstrate that, when wearing ALEx, the ex-
oskeleton allows arm movements similar to natural ones and, in an active mode (i.e. when ALEx
provides assistance), the exoskeleton moves the arm of the subject in such a way to emulate trajec-
tories and speed profiles similar to the natural arm movements, for a variety of tasks. This study
provided clues about the influence of different rehabilitative approaches on motion and muscle
coordination. (Pirondini et al., 2016)
An algorithm has already been develop, by Panarese et al. (2012), to track the motor improve-
ment of the patients and to adopt therapist-like decision rules for varying task difficulty based on
the patient’s performance at a sub-task level. This algorithm was re-adapted for 3D movements
and included in the online control system of ALEx, so that, for each treatment session with this
robot, the motor tasks are automatically selected according to the patient’s level of difficulty.
However, this implementation ought to be tested within the NEUROPROBEs trials and further
analyzed, to verify if it will be beneficial for stroke subjects and more effective than conventional
and standard robotic therapies in promoting arm motor recovery after stroke.
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Moreover, the current algorithm only estimates the motor performance based on the conse-
quences of the motor impairment, i.e., based on the kinematic performance of the patient. This
project intents to go further and look for metrics able to define the impairment. As so, during
the study, a multimodal neurophysiological assessment is carried out in order to evaluate the mo-
tor recovery not only in terms of kinematics, but also muscle and brain activity: kinematic data,
magnetic resonance imaging (MRI) data, electroencephalographic (EEG) and electromyographic
(EMG) signals are, thus, recorded. This extended evaluation will provide enough data to search
for biomarkers of motor recovery in the muscle and brain activity, which may be included as
parameters of an improved version of the personalization algorithm.
1.2 Thesis Goals
This thesis contributes to one of the main aims of NEUROPROBEs project, i.e. the definition of
the neurobiomechanical state of post-stroke patients during robot-aided motor rehabilitation of the
upper limb. With this purpose, the present work consisted in quantifying motor improvement of
acute/sub-acute stroke patients during the treatment, using kinematics and muscular activity.
To achieve this, it was necessary to:
1. Define the framework (a structured methodology) for the analysis of kinematic data and
muscle activity;
2. Identify meaningful indicators (quantitative metrics) of motor recovery and motor perfor-
mance in kinematic data and muscle activity of stroke patients.
Detailing the first point, the goal was to study the variability in movement execution and
muscle activity of healthy persons and, later, of stroke patients, while performing 3D point-to-point
reaching movements in different conditions (different directions, and targets). It was necessary to
explore this aspect since not enough information about 3D point-to-point reaching movements is
reported in the literature, and because data collected in the stroke population during the treatment
is constrained by the patients’ ability, so this data refers to different movement conditions, for each
subject and for each session of treatment.
Finally, the second goal of this work was to compare the two groups of subjects to identify
which metrics related to kinematics and muscle activity can be used to quantify motor impairment
and recovery.
It must be noted that the work developed was fully experimental and goes from data acquisi-
tion to data analysis, which provided an opportunity to practically learn how to perform recordings
of electromyographic signals in hospital environment, during robot-aided rehabilitation.
4 Introduction
This thesis was developed under the supervision of Prof. Dr. João Paulo Cunha 1, prof. Dr.
Silvestro Micera 2 and collaborators (Martina Coscia 3, Camilla Pierella 4, Peppino Tropea 5), at
the Biorobotics Institute of the Scuola Superiore Sant’Anna (in Pontedera - Pisa, Italy).
1.3 Dissertation Structure
This dissertation is organized in nine chapters, including the current contextualization chapter.
Chapter 2 describes theoretical concepts of anatomy and physiology in the context of Stroke,
and reviews the impact of this neural disorder in human society.
Chapter 3 introduces the main element of this work, Motor Rehabilitation of the Upper Limb
for post-stroke patients. This chapter goes from the concept of motor recovery to the personaliza-
tion of the treatment in Robotic-aided therapy. The necessary background theory is detailed for a
good comprehension of each section and a review of the state of the art is provided for the three
main branches of Motor Therapy addressed in this thesis.
Given that quantitative assessment are keywords of this work, two chapters (5 and 4) describe
the current methods of kinematic evaluation of arm movements and analysis of muscle activity of
the upper limb.
From Chapter 6 to Chapter 8, the work developed is reported: description of materials and
methods, report of results obtained with 8 healthy and 4 acute/sub-acute post-stroke patients, as
well as the respective discussion.
Chapter 9 presents the final conclusions of the thesis and future perspectives for Neuroprobes
project.
1PhD, INESC TEC, Faculty of Engineering of the University of Oporto
2PhD, Bertarelli Foundation Chair in Translational Neuroengineering, Center for Neuroprosthetics and Institute
of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland; Scuola Superiore
Sant’Anna, BioRobotics Institute, Pisa, Italy
3PhD, Wyss Center for Bio- and Neuro-Engineering, Geneva, Switzerland; Bertarelli Foundation Chair in Trans-
lational Neuroengineering, Center for Neuroprosthetics and Institute of Bioengineering, École Polytechnique Fédérale
de Lausanne (EPFL), Lausanne, Switzerland
4PhD, Wyss Center for Bio- and Neuro-Engineering, Geneva, Switzerland; Bertarelli Foundation Chair in Trans-
lational Neuroengineering, Center for Neuroprosthetics and Institute of Bioengineering, École Polytechnique Fédérale
de Lausanne (EPFL), Lausanne, Switzerland
5PhD, Scuola Superiore Sant’Anna, BioRobotics Institute, Pisa, Italy
Chapter 2
Stroke
This chapter provides background information about the pathological condition of the study (Stroke),
presenting a general overview of the anatomy and the pathophysiology relevant to this disorder, as
well as an analysis of its impact on today’s society.
2.1 Background concepts
Hemorrhage, ischemia and infarction of the central nervous system (CNS), as well as the relation
between these phenomena, are important in the context of stroke. Thanks to advances in neu-
roimaging, neuropathology and basic science, they are now better understood.
Ischemia is a restriction in blood flow to an organ, leading to oxygen and glucose insufficiency
(as well as inadequate removal of metabolites) and, consequently, causing the death of that tissue,
i.e. infarction (NIH, 2009; Steward, 2000).
Specifically, CNS infarction is defined as brain, spinal cord, or retinal cell death caused by
evident1 ischemia (Sacco et al., 2013).
An hemorrhage is a focal collection of blood within a tissue, resulting from rupture of an
hypertensive, weakened small-vessel and consequent bleeding (Donnan et al., 2008).
Specifically, CNS hemorrhage is defined as an hemorrhage within the brain, spinal cord or reti-
nal tissue. Ischemia may occur due to a focal CNS hemorrhage and, this way, a CNS hemorrhage
may lead to cell death - CNS hemorrhagic infarction (Sacco et al., 2013).
Additionally, an hemorrhage may also take place within the brain parenchyma or the ventric-
ular system - Intracerebral Hemorrhage (ICH) -, or into the subarachnoid space (i.e. the space
between the arachnoid membrane and the pia mater of the brain or spinal cord) - Subarachnoid
Hemorrhage (SAH).
1That is, ischemia diagnosed by an objective (imaging, pathological or other) evidence, or by a clinical evidence
(symptoms of neurological déficit present for 24h or more, or death).
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Ischemia may also occur due to occlusion or stenosis of CNS blood vessels caused by either
local embolism (that is, an atherosclerotic plaque which breaks away, travels with the blood flow
and blocks the blood stream) or thrombosis (formation of a blood clot which obstructs the blow
flow) (Dorland, 2011).
All of the mentioned conditions (ischemia, hemorrhage, infarction), and their anatomical vari-
ations in the CNS, lead to cell death, damaging the CNS and altering its normal function. This le-
sion may be symptomatic or not. When it is, the patient suffers from neurological deficit expressed
by the clinical evidences to be described in Section 2.2.2. When the lesion is assymptomatic, the
condition is called silent: silent CNS infarction; silent cerebral hemorrhage.
Stroke is a broad term referring to an episode of neurological dysfunction caused by a non-
traumatic vascular complication in the CNS (Figure 2.1 2), as those described above. According
to the Stroke Council of the American Heart Association (AHA)/American Stroke Association
(ASA) (Sacco et al., 2013), this complication identifies the type of stroke:
• a CNS infarction (being hemorrhagic or not) defines an Ischemic Stroke;
• an intracerebral hemorrhage defines a Stroke caused by ICH;
• a subarachnoid hemorrhage defines a Stroke caused by SAH;
• a cerebral venous thrombosis (CVT) defines a Stroke caused by CVT.
Figure 2.1: Possible vascular complications preceding stroke. (1) Subarachnoid hemorrhage takes
place when a weakened blood vessel of the brain ruptures, leaking blood into the subarachnoid
space and, consequently, narrowing adjacent blood vessels; (2) Intraparenchymal hemorrhage oc-
curs typically due to abnormal development of an important cerebral area in infants or high blood
pressure in adults - blood precipitates and breakdown products are deposited in the brain; (3) In-
traventricular hemorrhage, besides injuring the brain, results in hydrocephalus (increase of fluid in
the brain); (4) embolism - atherosclerotic clot blocks blood stream; (5) cerebral venous thrombosis
- blood clot interrupts blood flow.
2https://ncats.nih.gov/exrna/projects/biomarkers2015#brain;
https://www.verywell.com/lupus-as-a-cause-of-stroke-3146038
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Silent infarction and silent hemorrhage are also considered to be stroke, as well as events of
neurological deficit for which few information is available to further classify the stroke as one of
the above definitions.
A stroke caused by some hemorrhage in the CNS may generally be called an hemorrhagic
stroke. ICH or SAH can be considered subtypes of this definition.
It must also be noted that the definition of stroke assumes episodes of neurological deficit
persisting during 24h or more (that is, a permanent damage to the CNS), or until death (Sacco et al.,
2013). Temporary vascular-related episodes of neurological dysfunction (that is, a "transient"
expression of stroke symptoms) are, otherwise, termed “transient ischemic attacks” (TIA) (which
“may last from a few seconds up to several hours, the most common duration being a few seconds
up to 5 or 10 minutes”, as stated by C.M. Fisher during the Second Princeton Cerebrovascular
Disease Conference (Fisher, 1958)).
2.2 Stroke Anatomy and Pathophysiology
Different parts of the CNS have a critical role in the activation of muscles to produce voluntary
movement, such as the spinal cord, the cerebellum, the brain, and the brain stem. The resulting
motor behavior is affected by lesions in these regions, after ischemic or hemorrhagic events, as it
happens with stroke patients. (Cheung et al., 2009)
2.2.1 Relevant Anatomy of the Central Nervous System in Stroke
The cerebellum, the brain and the brain stem are components of the encephalon, the part of
the CNS contained in the skull.
Cerebellum is important in balance and muscle coordination, and is involved in motor control
learning. The brain stem, in turn, has an important role in controlling functions like breathing,
heart rate, and alertness/consciousness. The brain is the main center of processing of sensory
information. (Rod R. Seeley, 2003)
More specifically about the brain, the gray matter in its exterior surface is the cortex, and
deeper, are the basal nuclei.
Basal nuclei (which includes the caudate nucleus, putamen and globus pallidus) control auto-
matic motor functions like walking, running and swallowing.
Brain cortex is divided by the middle line in right and left hemispheres, each of which is
divided in lobes (see Figure 2.2 3). Frontal lobe has a crucial role in voluntary motor function,
motivation, sense of smell, mood/emotions/attention and speech production. Parietal lobe is re-
sponsible for processing most of the sensory stimuli concerning the sense of touch, pain and
temperature. Occipital lobe processes visual information and temporal lobe deals with hearing
information, speech comprehension and memory.
3https://inside-the-brain.com/2013/03/07/what-is-attention-and-where-is-it-in-the-brain/
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Figure 2.2: Brain lobes.
More specifically in the frontal lobe, the motor cortex is the region responsible for integrating
information about the body position and the surrounding environment, and for defining the best
plan to move the body for a given purpose. Thus, it controls voluntary movement. (Steward, 2000)
Figure 2.3: Cerebral motor cortex.
It is believed the motor cortex is divided in sub-regions (Figure 2.3) responsible for specific
features of motion (Binder et al., 2009c; Steward, 2000):
• The primary motor cortex (also called M1) has a key role in controlling fine movements
of the hand and fingers (manual dexterity), as well as face and tongue, which also demand
skilled movements;
• The premotor cortex plans the strategy of complex movement involving proximal muscles,
and has a key role in defining the orientation of the body to prepare some movement;
• The supplementary motor area has a similar role to the premotor cortex, for distal muscles;
• The posterior parietal cortex combines diverse sensory information to define the motor be-
havior relatively to the surrounding environment.
Sub-regions of the motor cortex are somatotopically organized, meaning that local stimulation
generates movement of a particular part of the body. The lower limb, the upper limb, trunk, face
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and tongue are represented in large areas of the primary motor cortex, situated in the precentral
gyrus of the cerebral motor cortex (see Figure 2.4).
Figure 2.4: A - The primary motor cortex is localized in the precentral gyrus. B - Somatotopically
organization of the primary motor cortex.
In what concerns the spinal cord, it is organized in different segments, each of which plays a
role in the control of and is linked to some part of the body by the sensory and motor nerves that
emerge from that segment. (Steward, 2000) For example, cervical segments of the spinal cord are
known to control arm movements. (Riehle and Vaadia, 2004)
There are 8 cervical segments, from C1 to C8, 12 thoracic segments, T1 to T12, 5 lumbar
segments, L1 to L5, and 5 sacral segments, S1 to S5. This division in segments is a mere termi-
nology used to define and discuss the location of lesions in the spinal cord, and there are no actual
boundaries limiting these spinal zones.
Neurons of the gray matter of the spinal cord are neither motor nor sensory but interneurons.
Thus, lesions in the spinal cord gray matter cause sensory/motor deficits in particular body seg-
ments, and lesions in its white matter break the communication between the brain and the body,
leading to sensory deficits and/or paralysis below the level of the lesion. (Steward, 2000)
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2.2.2 Pathophysiology of Stroke
During Ischemic Stroke, when blood flow reduces in the CNS, part of the tissue (called the
core of the infarct) is irreversibly damaged and dies within minutes, by experiencing mechanisms
like excitotoxicity 4, ionic imbalance (eg, increased intracellular calcium, following ischemia),
oxidative/nitrosative stress, inflammation, apoptosis and peri-infarct depolarization (Hakimelahi
and González, 2009; Sacco et al., 2013). The peripheral tissue, however, may be perfused by col-
lateral circulation and remain viable for some time. This region (called ischemic penumbra) must
be promptly treated, otherwise, it will infarct as well, rapidly increasing the core tissue volume.
(Hakimelahi and González, 2009)
In turn, when hemorrhage occurs, the leaked blood increases pressure in adjacent cells, in-
juring them and causing their death (hemorrhagic stroke). Alternatively, the excessive volume of
leaked blood surrounding cells may reduce the blood flow in nearby vessels feeding the tissue
(ischemia) and, this way, cause hemorrhagic infarction (ischemic stroke). (Steward, 2000)
Vessel breach may be caused, for example, by some vascular malformation, by high blood
pressure (chronic hypertension) or by the presence of aneurysms5 which eventually rupture. (NIH,
2009; Donnan et al., 2008)
Concerning hemorrhagic strokes as defined in the previous section, and, specifically, those
caused by ICH, the hematoma is located in the brain parenchyma or ventricules, but pressure re-
sulting from the mass effect of the hemorrhage may injure the neighbouring cerebral tissue and
the global intracranial pressure may also increase. Similarly, a SAH produces the same result and
debilitates cerebral autoregulation. (Sacco et al., 2013; Liebeskind, 2017)
The injury location in the CNS determines the type and level of neurological deficit. Typically,
damage in the right hemisphere leads to contralateral hemiparesis 6, left hemisensory loss, right
gaze preference and left visual field cut. Accordingly, the opposite side is similarly affected by
an injury in the left hemisphere. Nevertheless, symptoms resulting from damage in the right
hemisphere of the brain are not always detected by patient or medical doctor. (Liebeskind, 2017;
Sacco et al., 2013)
An injury in the internal capsule (or in the corticospinal tract) may lead to hemiparetic face,
arm and leg equally, whereas damage in the motor cortex leads to a more focal hemiparesis,
predominantly affecting the face and the arm (MCA cortical territory). However, stroke severity
does not necessarily determine the weakness severity.
4Excitotoxicity is a pathological mechanism of killing/damaging neurons by excessive excitation with neurotrans-
mitters like glutamate (endogenous excitotoxin). Glutamate accumulates in the extracellular liquid, after ischemia, in
stroke, and, along with the diminished nutrients and oxygen, leads nerve cells to die.
5Aneurym is a bulge developed in the wall of a blood vessel, due to its dilatation, which is filled with fluid or clotted
blood. - from Aneurysm at Dorland’s Medical Dictionary (2011)
6If the right hemisphere is damaged, the left side of the body is weakened, and the arm and leg movements are
debilitated.
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Specifically, hemiparesis is observed in abnormal patterns of movement coordination and un-
natural posture, as well as a reduced strength of the impaired limb (Lennon and Ashburn, 2000).
This is the main concern in physical therapy, during neurorehabilitation of the patient, to be dis-
cussed in Chapter 3.
2.3 Epidemiology and Economic Impact
Stroke is highly prevalent in the world, affecting 15 million people each year (WHO, 2002). Ac-
cording to the World Health Organization, in 2015, 6.24 million people suffered stroke worldwide
and died, being the Stroke the second most common cause of death (approx. 11% of all deaths)
after ischemic heart disease (WHO, 2017). The average age-adjusted stroke mortality for devel-
oped countries is about 50–100 per 100 000 persons per year (Donnan et al., 2008). However,
this is variable between countries, which may indicate that prevalence of risk and genetic factors,
as well as management of stroke, are geographically different (Donnan et al., 2008). In addition,
although the risk increases with age, a stroke may occur at any age. For example, in 2009, in the
United States of America, 34% of hospitalized stroke suffers were less than 65 years old (Hall
et al., 2012).
Nevertheless, thanks to improved living standards and an enhanced control of stroke risk fac-
tors (especially high blood pressure and cigarette smoking) in developed countries, stroke mortal-
ity has been constantly decreasing over last 50 years (mostly since late 1960s, about 5% per year).
Trends in developing countries are uncertain. (Donnan et al., 2008)
Additionally, stroke is the leading cause of impairment around the world: it is estimated that
by 2030 disabilities associated to stroke in western countries will be considered the fourth critical
cause of reduced disability-adjusted life-years (DALYs — “the sum of life-years lost as a result
of premature death and years lived with disability adjusted for severity”) (Donnan et al., 2008).
Stroke survivors have a reduced quality of life, and population follow-up studies have verified that
neurological impairment, dementia and recurrent stroke affect these patients after the first stroke
(Mendis, 2013). According to Carod-Artal et al. (2000), evaluation of stroke survivors’ life 1 year
after the incident, 2/3 of these patients present impaired reaching movements. 73-88% of first
time stroke survivors experience modifications in their upper limb function, as well as 55-77%
of chronic post-stroke patients (Donnan et al., 2008; Clarke et al., 2002) . Therefore, the vast
majority loses their independence in daily routines, being incapable to perform basic tasks with
their paretic limb (Pirondini et al., 2016).
In fact, it is estimated that about 500 per 100 000 persons live with such severe consequences
of stroke and, once stroke mortality seems to be falling faster than stroke incidence, this number
will probably raise together with health-care demands (Donnan et al., 2008).
Around the world, 2-4% of total costs in health-care are dedicated to stroke care. In industrial-
ized countries, direct costs of stroke care are higher than 4%: estimated at £7.6 billion in the UK,
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AUS$1.3 billion in Australia, and US$40.9 billion in the USA, which is equivalent to US$100 per
head of population per year (Donnan et al., 2008). Notwithstanding, World Health Organization
reports a need for improvements in stroke care and rehabilitation, even among developed countries
in favor of a reduction of post-stroke disability (Mendis, 2013).
Chapter 3
Upper Limb Motor Rehabilitation
following Stroke
This chapter introduces the main concepts and current strategies in motor therapy of the upper limb
and motor recovery of post-stroke patients. It goes from theory on motor control, neuroplasticity,
and motor learning, to a review of the state of the art in methods and tools (such as robotics) used
in motor therapy.
3.1 Motor Control, Motor Learning and Motor Recovery after Stroke
Motor control is the process by which the CNS (Central Nervous System) integrates sensory in-
formation in order to stimulate and coordinate the necessary set of muscles to execute some move-
ment (Reviews, 2016). In this context, motor skill can be understood as “the ability to plan and
execute a movement goal”, as defined by Krakauer (2006).
An action or movement has an associated geometry and speed (kinematics) and requires the
application of forces (dynamics). In this sense, motor skill is achieved (and improved by added
practice) by minimizing movement execution errors of kinematic and dynamic nature, using vi-
sual and proprioceptive1 senses, and, thus, minimizing energy and time spent. Motor learning
comprises this concept of skill learning, motor adaptation and decision making (to be able to
choose the appropriate movement for a specific situation) (Krakauer, 2006; Kitago and Krakauer,
2013).
One of the most currently accepted theories states that motor control is modular, which means
that any movement (such as a reaching movement) is controlled by a sequence of individual op-
erations (modules): an action trajectory may be previously planned disregarding the limb forces
(as it believed, for example with reaching tasks (Krakauer, 2005)); lately, the action is performed
by stimulating muscles to apply the adequate forces, according to the viscoelastic and inertial
properties of the limb (Krakauer, 2005).
1Proprioception is the perception of stimuli within the organism itself, especially regarding the position and move-
ment of the body and its elements.
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Each of those modules of motor control may be neglected by some injury, as it happens in
stroke. Following to such event, most patients experience spontaneous recovery to some extent
which is variable across patients (Kwakkel et al., 2006). Previous experiments and analysis of
recovery assessment indexes have shown that spontaneous recovery is maximized at early weeks
after stroke, but it also takes place during the subacute and chronic phases (Ganguly et al., 2013;
Krakauer, 2006; Di Pino et al., 2014).
This mechanism of natural neurological repair (as well as the one promoted by motor therapy)
is believed to occur due to a combination of processes like brain reorganization, restoration of
ischemic penumbra and recovery from diaschisis2 (Krakauer, 2006).
In particular, the motor cortex has redundant functional regions (and is also able to create new
functional regions), allowing a new brain area to get the responsibility to stimulate muscles pre-
viously recruited by the damaged brain area. This ability of the CNS to reorganize its functions
and structure (by activation of new neural pathways and neurogenesis) is frequently denominated
neuroplasticity (Krakauer, 2006; Di Pino et al., 2014; Ganguly et al., 2013; Hatem et al., 2016).
In fact, it has been previously observed that brain reorganization may involve intact, adjacent
or distant, brain regions to the injury (in the same and/or opposite hemispheres) (Feydy et al.,
2002; Erik Ween, 2008; Rehme et al., 2012). In the beginning (when only spontaneous recovery
occurs), functional reorganization may involve several parts of the brain, but, with increasing ther-
apy, reorganization tends to be more focal (near or distant from the original brain area responsible
for that function) (Krakauer, 2005).
Moreover, spontaneous recovery is commonly insufficient and, additionally, patients often
develop compensatory ways to execute some movements, using alternative muscles of the affected
limb or favoring the use of the unaffected limb, due to their inability to recruit the same muscles
as before stroke (Krakauer, 2006; Ganguly et al., 2013; Soekadar et al., 2014). For example, often
the shoulder is excessively elevated and retracted to lift the arm due to a decreased range of motion
of the shoulder flexion. Another example is the increased displacement of the trunk forward or its
rotation in reaching or pointing movements when the range of motion of the elbow extension is
limited (Levin et al., 2009).
Oppositely, true motor recovery presupposes the patient reacquires his ability to move the
affected limb in a natural way. Recovery is, therefore, characterized by the reappearance of sim-
ilar movement patterns to the ones of non-disabled subjects (the same end-effectors and joints,
comparable ranges of motion, similar muscle co-activation patterns and spatio-temporal interjoint
coordination, and normal muscle tone, i.e. reduced spasticity), as well as the ability to complete
different tasks (Levin et al., 2009). Notwithstanding, the promotion of fully motor recovery as de-
fined here is still an open question, because it is not certain that recovering all the patterns previous
2Diaschisis is “a temporary loss of function produced by acute focal brain damage in an adjacent region or in a region
connected through fiber tracts.” - from Diaschisis at INS Dictionary of Neuropsychology and Clinical Neurosciences
(2015)
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to injury result in a better performance of daily living activities.
In any case, these points explained in the two paragraphs above highlight the need for motor
therapy after stroke and, given that investigation with human and animal models suggests that
mechanisms involved in brain reorganization are similar to the ones in motor learning (Krakauer,
2005; Kitago and Krakauer, 2013; Di Pino et al., 2014), therapeutic methods which promote motor
re-learning are expected to achieve better outcomes.
In addition, as reviewed in Krakauer (2006), there are experimental evidences that, after prac-
tice (repeated execution of the same movement) and consequent learning of some type of move-
ment, the CNS has designed internal models which map the limb conditions (level of external
forces, initial position, and other) to the respective muscle forces to be commanded for the move-
ment execution. Moreover, experiments have also demonstrated that these internal models can
answer to different type of movements from those used to learn. This generalization capacity is
reflected in a consequent ability of the patient to perform not only the particular tasks trained dur-
ing rehabilitation, but also any activity of daily living (ADL), as reviewed by Krakauer (2006).
Finally, it is necessary to understand that motor recovery after stroke is heterogeneous in re-
spect to functional outcome. Individuals in acute phase affected by mild to moderate paresis of the
upper limb are expected to achieve a good level of motor recovery: around 71% of these patients
recover their dexterity to a considerable extent at 6 months after stroke (Nijland et al., 2010). On
the contrary, severely affected patients have a bad prognosis: about 60% of them fail to recover
their dexterity at 6 months after stroke (Kwakkel et al., 2003). In the worst scenario, patients with
paralysis are poorly expected to recover a functional use of their arm (Hatem et al., 2016).
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3.2 Physical Therapy of the Upper Limb
3.2.1 Background concepts
Neurorehabilitation is a complex medical process which applies basic and clinical neuro-
science research in helping patients who have suffered damage in the nervous system. Its main
purpose is to maximize functional recovery, and to minimize/compensate for any functional alter-
ations3 caused by the neurological injury (Ganguly et al., 2013). This is fundamental for a stroke
survivor to have back a self-sustainable life and to engage in society. (Mendis, 2013)
As emphasized by the World Health Organization (Mendis, 2013), the article 26 of the United
Nations Convention on the Rights of Persons with Disabilities appeals for “appropriate measures,
including through peer support, to enable persons with disabilities to attain and maintain maximum
independence, full physical, mental, social and vocational ability and full inclusion and participa-
tion in all aspects of life”. Therefore, neurorehabilitation considers the patient well-being in all
its aspects, being interdisciplinary: includes physical, occupational, psychological, vision, speech
and language therapies, and other. Therefore, several rehabilitative programs, whether conducted
in hospitals or specialized clinics, gather specialists of diverse fields in order to provide the best
treatment to the patient. (Veerbeek et al., 2014; Lipovsek et al., 2012)
A general timeline of neurorehabilitation is often considered as presented in Figure 3.1 (Proi-
etti et al., 2016). As the rehabilitative program evolves, the patient progresses and executes move-
ments more independently, becoming more active during physical training. More objectively,
three phases of stroke recovery may be considered in neurorehabilitation, according to Sullivan ’s
recommendation, and used in previous studies of stroke rehabilitation: the acute phase (0-7 days
from the stroke onset); the subacute phase (7 days to 6 months); chronic phase (6 months until
years post-stroke) (Sullivan, 2007). This distinction must be taken into account when develop-
ing rehabilitative treatments, specially in robotic-aided rehabilitation, where the control of robotic
devices must be adapted to each phase.
Figure 3.1: Global timeline of neurorehabilitation. The terms “Active” and “Passive” refer to the
patient (see Section 3.3.1, Table 3.3).
3In the context of injury-induced functional modifications, it is important to note that impairment and disability are
different concepts. Throughout this dissertation, these terms are used according to their definition by the WHO in The
International Classification of Impairments, Disabilities, and Handicaps (1980):
- Impairment: “any loss or abnormality of psychological, physiological or anatomical structure or function.”
- Disability: “any restriction or lack (resulting from an impairment) of ability to perform an activity in the manner or
within the range considered normal for a human being.”
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Physical therapy, one of the above-mentioned components of neurorehabilitation, focus on
restoring and maintaining the ADLs, commonly lasting from the early phase to the chronic phase
of post-stroke rehabilitation (Veerbeek et al., 2014). This is important since stroke survivors, be-
ing physically debilitated, have their quality of life considerably reduced. Impairment of the upper
limbs specifically limits their performance in basic activities like feeding and self-care, conse-
quently reducing the independence of these individuals. In detail, paresis of the upper extremity is
associated to weakness, loss of dexterity, spasticity, abnormal muscle synergies and, thus, abnor-
mal motor control (Krakauer, 2005; Kitago and Krakauer, 2013).
So far, only a modest advance has been reported in functional outcomes of stroke survivors
rehabilitation, despite the considerable improvements in stroke prevention, early diagnosis and
acute treatment (Ganguly et al., 2013). As so, a more comprehensive knowledge about recovery
from stroke is essential when studying any new technique to rehabilitate post-stroke patients.
3.2.2 State of the Art
Currently, it is generally accepted that a rehabilitative treatment must be adaptive to the pa-
tient’s progress, following four main steps cyclically (Ganguly et al., 2013):
1. Needs screening;
2. Definition of realistic objectives;
3. Plan therapy program according to patient capabilities;
4. Assessment of improvements.
Moreover, it has been demonstrated that an assisted training is more effective than just en-
couragement of the patient to execute tasks on his/her own based on the therapist advices (this
method may be, however, successful with patients with mild hemiparesis, being at least capable
to partially perform the tasks) (Lum et al., 2002). Nevertheless, only assisted training is not also
the best approach to induce motor relearning, so the modern therapists combines assistance with
coaching (Barnes and Good, 2013).
Oppositely to strategies based on intuition applied in the past, modern motor rehabilitation is
based on knowledge from experimental evidence or principles of evidence-based medicine (spe-
cially, conclusions from analysis of randomized controlled trials) (Barnes and Good, 2013).
A repetitive training is considered to have a major role in motor recovery. Thus, independently
of the physical therapy strategy being followed, treadmill training seems to be essential. (Ganguly
et al., 2013; Barnes and Good, 2013; Lum et al., 2002; Proietti et al., 2016; Maciejasz et al., 2014).
The following techniques are the state of the art of physical therapy of the upper limb after
stroke, referring to methods of motor training. Some of them (such as constraint-induced therapy,
EMG-triggered neuromuscular stimulation, or even interactive robotic-therapy) were developed
based on motor learning theory (see Section 3.1), other are based on clinical and empiric evidences.
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1. classical Bobath approach: The original concept proposes re-education over compensation
- therapists re-educate the patient to regain normal movements with the affected arm, instead
of teaching compensatory strategies with the unaffected arm (Graham et al., 2009);
2. evolved Bobath approach: Currently, knowledge on neuroplasticity, motor learning and
motor control is added to the classical Bobath concept, so therapists guide the patient to
develop optimal (not just "typical") movement patterns (Lennon and Ashburn, 2000);
3. practice of repetitive and stereotyped exercises: several studies have reported effective-
ness of implementing this type of training (as mentioned by Lum et al. (2002)), but several
more recent experiments have shown that the patient’s ability to execute the learned tasks,
retention of this ability, as well as capability of generalization to learn new actions are im-
proved by including variability of exercises (Krakauer, 2006). Even though, repetitive train-
ing has brought good results in recovering subacute stroke patients, patients with chronic
hemiparesis, and even patients with complete hemiplegia4 (Barnes and Good, 2013).
Additionally, it has been found that repetitions must be frequently interleaved by prolonged
rest, so that learning is optimized (Krakauer, 2006).
4. body weight support treadmill training (BWSTT): Practice of repetitive and stereotyped
exercises with body weight support, that is, with the effect of gravity (weight) being com-
pensated by some apparatus (the arm is suspended). BWS reduces the torque magnitude pro-
duced in the limb joints when some action is being performed (Coscia et al., 2014; Van Vliet
et al., 2005).
5. practice of repetitive and stereotyped exercises together with techniques to facilitate
movement execution: EMG-triggered neuromuscular stimulation5, supra-threshold electric
stimulation of hand and wrist muscles6, application of loads (external loads) are examples
of techniques combined with treadmill training. This approach is usually indicated for more
severely affected patients.
Past investigation has verified that repetitive movements (of hand and fingers) against loads
have lead to increased motor ability when compared to Bobath approach or electrical stim-
ulation treatments. (Lum et al., 2002) However, in more recent studies, EMG-triggered
neuromuscular stimulation has demonstrated effectiveness in the three phases of neuroreha-
bilitation mentioned in Figure 3.1. Oppositely, supra-threshold electric stimulation (being
independent of movement intention by the patient) results in little functional outcomes.
(Krakauer, 2006)
4Hemiplegia means “paralysis affecting only one side of the body”. (Steward, 2000)
5In EMG-triggered neuromuscular stimulation, EMG surface electrodes provide input to a microprocessor, which
outputs an electrical signal for neuromuscular stimulation when an intention to move the arm is detected. So, the patient
initiates a voluntary contraction to execute an action and, when the muscle activity crosses some pre-defined threshold,
the muscle is electrically stimulated to assist the movement.
6The electrical stimulation is provided independently from an intention of the patient to execute an action. Supra-
threshold simply means the electrical stimulus is a voltage sufficiently high to generate the action potential in muscle
fibers.
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6. Impairment-oriented training (IOT): This method includes two subtypes: arm ability
training and arm basis training. The first targets patients with mild hemiparesis, the latter
is adequate for patients with severe hemiparesis. (Barnes and Good, 2013) Training tasks
promote abilities like “hand grip, finger individuation, arm-hand steadiness, aimed reaching,
tracking, and wrist-finger speed”, as mentioned in Krakauer (2006).
7. task specific training: Normal human behaviour results form goal-oriented actions. This
fact and a concern on improvements in ability to perform activities of daily living (ADLs)
originated this approach. Tasks are intensively repeated but tasks’ difficulty may be var-
ied. Task-oriented repetitive movements have proved positive outcomes, such as improved
movement coordination and muscle strengthening. (Pirondini et al., 2016; Ganguly et al.,
2013; Van Vliet et al., 2005; Kitago and Krakauer, 2013)
8. constraint-induced therapy (CIT): Training of the impaired limb is stimulated by con-
straining the unaffected one (Maciejasz et al., 2014; Lum et al., 2002). This can induce an
increased use of the impaired limb in ADLs (Lum et al., 2002; Kitago and Krakauer, 2013),
but is still controversial, because the main improvement seems to be due to the intensity of
therapy (massive repetition of exercises) and not due to the constrain, and because eligible
patients for this therapy must have at least 10o of wrist and finger extension, excluding many
other patients Krakauer (2006); Barnes and Good (2013).
9. interactive robotic-therapy: Robots can be used to generate load against movement, to
assist the patient actions and trajectory, and to correct them, and allow the application and
combination of various techniques above enumerated (with improved intensity and repeat-
ibility, and with precise force patterns and accurate control of tasks execution (Pirondini
et al., 2016)).
For example, using force-fields produced by some robot, the patient’s ability to adjust to
disturbances to the movement is promoted7 (Krakauer, 2006; Maciejasz et al., 2014; Piron-
dini et al., 2016).
On the other hand, and with extreme importance for the work in the present thesis, robots
add precision to therapy evaluation (offering kinematic variables to quantitatively analyze
motor performance/improvement), and making possible to immobilize the patient trunk so
that compensation with trunk movements does not affect the evaluation (Krakauer, 2006).
It must be noted that other methods of physical therapy for the upper extremity are available
(like mental training or neuromodulation approaches). However, they are not so relevant to intro-
duce robotic-aided rehabilitation and its assessment (the main context of this dissertation), since
they are not usually applied in combination with robotic devices in post-stroke motor recovery.
For a larger review on this matter, further reading of Barnes and Good (2013) is advised.
7The same theory of assistance-when-needed, as with EMG-triggered neuromuscular stimulation, but muscles in-
volving movement of more than one joint are assisted at the same time.
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Other important aspects are dose (amount of practice) and timing of physical therapy, which is
yet a concern, nowadays. For example, it has been demonstrated that starting rehabilitation 5 days
after injury is considerably more effective than after 1 month (Krakauer, 2005), and more stud-
ies provided similar evidences that early and intensive rehabilitation is more beneficial (Kwakkel
et al., 1999; Kitago and Krakauer, 2013). However, other studies have proved the opposite, show-
ing, for example, that an intensive therapy in the first hours and days after stroke does not achieve a
good outcome (Nijland et al., 2011; Dromerick et al., 2009). As so, this topic is still under debate,
being unknown the correct dose-timing relation, specially considering that each patient is different
from another one (Lang et al., 2015).
As stated in Lang et al. (2015), it is urgently necessary to perform preclinical and clinical
investigation in order to design an effective prescription system of physical training. Currently,
according to the data analysis conducted by Lang et al. (2015) from various studies, one can say
that:
• each patient requires a different optimal dose according to his/her clinical presentation;
• there is a limited relation between dose and positive functional outcomes, suggesting that
usually larger amounts of physical training incomes better recovery;
• dose and timing may be connected - individuals at 2 to 3 months after stroke may benefit
from large doses, but it might not be recommended for patients at the acute and sub-acute
phase (days, weeks after stroke).
All of the above-mentioned characteristics in physical therapy must be considered to accu-
rately assess any rehabilitative method (with any device, just like with the exoskeleton of the
present work).
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3.3 Robot-aided Motor Therapy of the Upper Limb
3.3.1 Background concepts
Recently, innovative technologies have been adopted to support the motor rehabilitation of the
upper limb after stroke. They include, for example, robotics, brain computer interfaces, virtual
reality games, functional electrical stimulation and brain stimulation (Maciejasz et al., 2014).
In particular, robotic technology has advanced towards faster and more powerful computers,
novel approaches in computation, as well as more sophisticated electro-mechanical components,
facilitating the integration of robotics into rehabilitation treatments. (Esquenazi and Packel, 2012;
Chang and Kim, 2013)
Robot-aided rehabilitation is a physical therapeutic method supported by robotic devices hav-
ing sensors, actuators and control units. Among many existing techniques of physical therapy for
the upper limb (see Section 3.2.2), rehabilitation supported by robotics has attracted attention of
researchers and therapists, because robots can provide an intensive (longer and independent of
the physiotherapist’s level of fatigue) and reproducible therapy, movement assistance and control-
lability, and measurement reliability. In addition, they allow physiotherapists to simultaneously
supervise several patients more easily (Maciejasz et al., 2014; Huang and Krakauer, 2009; Lo and
Xie, 2012).
Regarding the mechanical structure of robotic devices, there are two main classes, according
to the mode of movement transfer from the robot to the patient (see Figure 3.2 8 and Table 3.1):
end-effector-based and exoskeleton-based devices. There are combinations of these two designs in
more-than-one-robot systems: some parts of the robots are attached to and independently control
the joints, and other parts are controlled simultaneously. Specifically, two-robots systems make it
possible to mimic the usual assistance of a therapist with two hands (Maciejasz et al., 2014) - see
Figure 3.3.
Figure 3.2: Examples of the two main classes of robotic devices: at left, an end-effector-based
(named MIT-MANUS), and at right, an exoskeleton-based robot (named ArmeoPower).
8Source of the left image: https://www.strokengine.ca/intervention/robotics-introduction/;
Source of the right image: http://products.iisartonline.org/productinfo.php?go=22
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Table 3.1: Mechanical design of robotic devices in rehabilitation. (Huang and Krakauer, 2009;
Maciejasz et al., 2014)
End-effector-based device
It is usually only a robotic arm (a “manipulandum”) or a joystick.
Patient and robot only have contact at the most distal component
of the device. Being so simple, it is easy to fabricate and easy to
fit the arm of any patient.
Exoskeleton-based device
It is similar to a suit, having several limb-mirroring components
that wrap the segments of the human arm like an exoskeleton.
Each component of the device is attached to the respective limb
segment. This design has more degrees of freedom (DOF) and,
thus, provides precise and independent control of each limb joint
movement.
a
Robotic devices like exoskeletons demand more complex control algorithms and also more
setup time before using the device, because each component has to be adjusted to fit the patient
limb segments. Besides that, an added care must be taken in respect to the position of the joints’
center of rotation (especially the shoulder), which may vary while moving the arm. Oppositely,
end-effector-based robots are simpler, requiring simpler control algorithms and a shorter setup
time (Maciejasz et al., 2014; Lo and Xie, 2012).
Figure 3.3: Analogy between the main types of control strategies for robotic-aided rehabilitation
and a physical therapist work. (Proietti et al., 2016)
On the other hand, given that end-effector-based devices only interface with one joint (at the
patient’s hand), they make it difficult to control the position and torques on the other joints, allow-
ing multiple combinations of movements at the wrist, elbow and shoulder (inclusively possible in-
correct and injury-inducing positions, and uncontrolled load transfer between the joints) to achieve
a desired position of the end-effector. On the contrary, exoskeletons can assist each joint of the
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limb and allow the control of the position and orientation of their several segments. (Maciejasz
et al., 2014; Lo and Xie, 2012)
a
Table 3.2: Types of assistance provided by robotic devices in rehabilitation.
Active Device capable of producing movement (of the upper limb) through ac-
tive actuators (that is, actuators driven by electric motors).
Passive
Device unable to generate movement, having only passive actuators
(that is, actuators like brakes or springs, which can only provide resistive
force against movements performed in the incorrect direction).
a
Concerning the most relevant type of assistance provided by robotic devices, these may be
classified as active or passive, according to definitions in Table 3.2. In order to move the patient’s
arm, active devices have one or more actuators, and are appropriate to rehabilitate patients with
severe difficulties in exerting force or unable to move the limb. Passive devices have lower-cost,
lower-energy consumption, and lighter actuators, and are more suitable for a training dedicated to
optimize the patient’s strength, or to guide the movement in the correct trajectory (by resisting the
patient’s movements, when they are not correctly directed) (Maciejasz et al., 2014).
By using one or another type of devices, rehabilitative exercises may also be classified as
active or passive - see Table 3.3 (Maciejasz et al., 2014). This distinction between devices and
exercises terminology is important to avoid confusion in further reading about the state of the art
in robotic-aided rehabilitation.
Table 3.3: Types of rehabilitative exercises.
Active Exercise during which the patient uses his/her own strength to move the
limb, wearing (or not) an active or passive device.
Passive Exercise during which the patient does not put much effort, since the
limb is moved by an active device.
a
Research to apply robotics in rehabilitation has started many years ago and a lot of novel
devices have been invented and foresee promising results. Diverse clinical trials have shown that
robotics provides an intense and safe motor rehabilitation (Kwakkel et al., 2008; Lo et al., 2010; Lo
and Xie, 2012; Mehrholz et al., 2012; Norouzi-Gheidari et al., 2012; Klamroth-Marganska et al.,
2014; Veerbeek et al., 2017). Task-oriented training with robotic devices enhances improvement
of motor functions in chronically impaired, especially severe (Klamroth-Marganska et al., 2014),
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stroke patients more effectively than conventional therapy. However, this difference in respect to
conventional hand-assisted therapy is about 0.78 (Klamroth-Marganska et al., 2014) to 2.17 (Lo
et al., 2010) Fugl-Meyer (FM) points, a magnitude not satisfying towards recovering dexterity in
daily life activities (Maciejasz et al., 2014).
Aso so, further investigation, development and implementation (in clinical practice) of new
technologies for physical therapy of the upper extremity require objective methods to accurately
evaluate outcomes of functional recovery and systematically demonstrate advantages of robot-
aided treatments (Mazzoleni et al., 2014).
3.3.2 State of the Art
Research into robotics rehabilitation, particularly for post-stroke patients, has been grow-
ing rapidly, and the number of therapeutic robots has increased dramatically during the last two
decades (Mazzoleni et al., 2014; Proietti et al., 2016).
These robotic devices may be designed for home-based conditions, however, they are mainly
used at rehabilitation centers and hospitals due to their unaffordable price and the requirement
for supervision/assistance from qualified professionals. Being so, therapists demand for intuitive,
easy and fast to setup devices, besides having a reasonable price. (Maciejasz et al., 2014)
In fact, robotic therapy for the upper extremity has begun with end-effector-based devices (Lo
and Xie, 2012). Some examples of this type are the MIT-MANUS (Hogan et al., 1992; Krebs
et al., 2003), the MIME (Burgar et al., 2000) and the GENTLE/s (Loureiro et al., 2003), which
have been extensively tested in clinical environment and contributed to improve the motor ability
of robotically-treated patients (Krebs et al., 1999; Lum et al., 2002, 2004, 2006; Coote et al., 2008).
Nowadays, research evolved towards the development of more sophisticated exoskeletons for
the upper limb, because they enable the control of multiple joints and offer a larger range of motion
to practice rehabilitation exercises when compared to end-effectors (Lo and Xie, 2012). Currently,
there are a lot of new devices of such type, but there is a lack of detailed information about their
effects in rehabilitation and few have been tested clinically (Proietti et al., 2016). Some examples
are detailed in Table 3.4, but more exoskeletons exist and are reviewed in Maciejasz et al. (2014),
Proietti et al. (2016), or Lo and Xie (2012). Interestingly, some of these robots, like ARAMIS
or EXO-UL7, have two arms, allowing bilateral schemes of rehabilitation training (like mirror
therapy) (Kim et al., 2013).
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Table 3.4: Examples of exoskeletons used in upper limb rehabilitation. Act./Pass. DoF - Number of active/passive Degrees of Freedom.
Exoskeleton name Act.DoF
Pass.
DoF Elements Nationality year Other information
ARAMIS (Pignolo et al., 2012,
2016)
6 0
two-arms exoskeleton with fixation
in shoulder, forearm and handle
Italy 2009
Clinical testing:
Pignolo et al. (2012)
ArmeoPower c© (by Hocoma)
(Riener et al., 2011)
6 0 fixation in arm, forearm and handle Switzerland 2011
The first commercialized exoskele-
ton for rehabilitation of the arm;
based on ARMinIII robot
IntelliArm (Park et al., 2008;
Ren et al., 2013)
8 2 fixation in arm, forearm and handle USA 2007
EXO-UL7 (Simkins et al.,
2013)
7 0
two-arms exoskeleton with fixation
in arm, forearm and handle
USA 2011
based on CADEN-7
(Perry and Rosen, 2006)
MEDARM (Ball et al., 2007) 6 0 fixation in arm and forearm Canada 2007
MGA (Carignan et al., 2009) 5 1 fixation in arm and handle USA 2005
ABLE (Garrec et al., 2008) 4 0 fixation in arm and handle France 2008 Clinical testing:
Crocher et al. (2012)
RehabExos (Vertechy et al.,
2009)
4 1 fixation in arm, forearm and handle Italy 2009
RUPERT IV (Balasubramanian
et al., 2008)
5 0
fixation in shoulder, arm, forearm
and handle
USA 2005
ALEx (Pirondini et al., 2014,
2016)
4 2 fixation in arm, forearm and handle Italy 2013
Clinical testing: ongoing;
ClinicalTrials.gov identifier:
NCT02770300
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Different strategies are known to control movements of the joints of robots. According to Ma-
ciejasz et al. (2014) and Proietti et al. (2016), terminology associated to the main types of control
strategies is presented in Table 3.5. These approaches are usually combined in physical therapy
exercises, similarly to the work which is performed by a patient-assisting therapist (Figure 3.3).
More specific, “low-level” 9 (Maciejasz et al., 2014) strategies are considered by each robot de-
veloper. See the typical subtypes of assistive control strategies in Table 3.6.
Table 3.5: Types of control strategies for robotic devices in rehabilitation.
Assistance
The limb weight (gravity and friction) is supported by the device, and
the robot also helps the patient to complete the desired movement, by
providing forces if necessary.
Correction
The device only forces the arm to have a defined interjoint coordination,
whenever the patient executes the movement incorrectly. This means the
device does not act if the limb stops moving (the robot doesn’t complete
the task for the patient).
Resistance
The device offers opposite forces to motion. This strategy may also
be called “challenge-based control” (Maciejasz et al., 2014), since the
patient is challenged by the robot to perform some movement with more
difficulty, requiring more attention and effort, and promoting the patient
capacity to react to perturbations correcting the movement.
Note that, while assistive control acts on both tangential and orthogonal directions respective to
the trajectory of the patient’s limb movement, corrective control only acts on orthogonal direction.
This is the reason why corrective control, in opposition to assistive control, is not able to guide the
arm to the target in order to complete the task. (Proietti et al., 2016)
In resistive control, the challenge offered to the patient is often an increased force induced
by the robot over the patient limb trajectory (to cause him/her to make larger errors and adapt)
and/or a constrain of the unaffected limb (constraint-induced robotic rehabilitation). The challenge
may include, in some devices, the presentation to the patient of an amplified value of his/her real
performance error. This methods are implemented to promote a faster improvement. (Maciejasz
et al., 2014; Krakauer, 2006; Proietti et al., 2016)
Most exoskeletons have a combination of assistance and correction control strategies (Proietti
et al., 2016; Maciejasz et al., 2014). ALEx, for example, has a partially-assistive control, also
know as "assistance-as-needed (see details in Section 3.3.2.1).
At the acute and early phases of physical therapy, the patient’s movements need to be assisted
so that mistakes are minimal and the patient feels motivated to continue training (passive or trig-
gered passive control). It is, nevertheless, crucial to progress in the treatment and, thus, the robot
9A "sub-strategy" to control specific parameters, like force, position, impedance or admitance, developed when
implementing one of the main global types of control strategies.
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must be able to adapt its behaviour. When the patient starts recovering his/her motor ability, the
control of the movement must be shared between robot and patient, as necessary (partially assistive
control). (Proietti et al., 2016)
Table 3.6: “Low-level” subtypes of assistive control strategies. Some devices include a combina-
tion of these types.
Passive10 Control
Deviations of the trajectory followed by the limb, in relation to
a reference trajectory11, are corrected by position control (classi-
cally, using a proportional-integral-derivative, PID, feedback con-
troller, or with more complex algorithms, like the recent sliding
mode control with exponential reaching law, SMERL (Rahman
et al., 2010)), with high controller gains. This method is com-
monly applied at early phase of rehabilitation, because usually
the patient weakly moves the injured limb, so the robot performs
most of the movement along the desired trajectory.
Triggered Passive Control
The exoskeleton assists the patient when he/she triggers its help
(by choosing one target to reach) through a brain-machine inter-
face (BMI). This BMI estimates the patient intention to move the
limb towards the target, modulates the due speed, acceleration
and jerk, and triggers the exoskeleton to move - then, it is con-
trolled passively along the determined trajectory. This control is
adequate to patients with hemiplegia.
Partially Assistive Control
Also called “assistance-as-needed”, this strategy provides partial
assistance: the patient is allowed to control the movement, be-
ing only supported by the exoskeleton when the performance is
weak. So, in these cases, the controller gains are lower than in
passive control, and usually are based on impedance or admit-
tance control approaches: in impedance control, the limb posi-
tion is measured (position feedback) and the controller defines
the robot force to be provided (force controller); in admittance
control, the controller defines the displacement to be performed
(position controller), from the force exerted by the patient (force
feedback).
10Note that "passive", here, has the same meaning as “Passive exercise”, defined in Table 3.3. So, a patient wearing
a passively controlled exoskeleton does not put much effort to perform the task - the exoskeleton does that for him/her.
11The reference trajectory may be recorded during a teaching phase, where the therapist guides the patient to perform
a desired trajectory with his/her paretic arm, or where the patient uses the unaffected limb to perform the desired
movement, wearing, in both cases, the exoskeleton in a transparent mode (in which the robot only compensates for
gravity, friction and inertia).
sEMG has already been used, too, firstly to detect the patient intention to move the limb and, then, to obtain the
desired reference position determined from a muscle activity model.
Alternatively, optimization algorithms are used to minimize costs (for eg. minimize jerk) in order to define the best
trajectory to reach the desired target.
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The input signal for the control algorithm of the robotic device is usually one (or a combination
of signals) of three types (Maciejasz et al., 2014):
1. kinematic: Position, angular/linear velocity and acceleration of the robot joints and/or seg-
ments;
2. dynamic (kinetic): Torque or force generated on the robot joints and end-effector (only the
latter, in an end-effector-based device) as a function of time;
3. trigger: Signal, triggered by a switch/button or, for example, by a threshold value relative
to a surface EMG signal (sEMG), used to initiate some operation.
The implemented “low-level” control strategy dictates, in part, the type of signal required, or
vice-versa.
The latter type of input signal when used with sEMG allows to identify a contraction of the
patient’s arm as an intention to execute some movement and, thus, the robot can be controlled to
support the action. sEMG signals from the unaffected extremity have already been used in some
devices to control actions of the paretic limb.
Interestingly, some robots have also implemented contactless methods (with motion capture
systems) for detecting movement.
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3.3.2.1 ALEx RS - Arm Light Exoskeleton Rehab Station
One element of this thesis is the Arm Light Exoskeleton (ALEx), a robotic device to support
rehabilitation of the upper limb (see Figure 3.4).
Figure 3.4: The Arm Light Exoskeleton Rehab Station - ALEx RS.
ALEx is mechanically compliant to the human upper extremity. The center of rotation of its
shoulder is dislocated from a normal position so that the human limb can perfectly align with the
robotic arm, and the limb joints’ axes overlap the exoskeleton joints’ axes. 12
This exoskeleton can cover 90% of the human arm natural workspace, without singularities,
and has six DoF (range of motion for each DoF is provided in Table 3.7.):
- shoulder abduction/adduction (SH-Abd-Ad), rotation (SH-Rot) and flexion/extension (SH-
Flx-Ext), as well as elbow flexion/extension (EL-Flx-Ext) are sensorized and actuated;
- forearm prono-supination (FO-Pro-Sup) and wrist flexion/extension (WR-Flx-Ext) are sen-
sorized and passive.
At the EE (end-effector), it is possible to generate, at maximum:
- a continuous interaction force of 50N;
- a peak force of 100N;
- a continuous torque of 40Nm;
- a peak torque of 80Nm;
- a joint speed of 500o/s.
12Kinetek, Wearable Robotics
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Table 3.7: Range of motion for each degree of freedom (in o). SH-Abd = shoulder abduction;
SH-Rot = shoulder rotation SH-Flx = shoulder flexion; EL-Flx = elbow flexion; FO-Pro = fore-
arm prono-supination; WR-Flx = wrist flexion. For each DoF, 0o corresponds to a configuration
where the upper arm and trunk are parallel, while the elbow joint is perpendicular, i.e, 90o flexed
relatively to the upper arm.
SH-Abd-Ad [0,100]
SH-Rot [-40,60]
SH-Flx-Ext [10,155]
EL-Flx-Ext [0,160]
FO-Pro-Sup [-90,90]
WR-Flx-Ext [-50,50]
The robot can be used in three modalities (terminology used by Pirondini et al. (2016)):
• Passive13: the robot only performs measurements of the subject arm movements;
• Assistive14: the subject arm is guided by the robot while he/she performs a movement;
• “Assisted-when-needed”15: the subject arm is guided by the robot to a defined position if
he/she takes 3 seconds or more to initiate the movement.
In the three modalities, ALEx control algorithm generates the necessary compensation for:
gravity (weight of the exoskeleton segments); friction between the robot components; masses and
inertia of its moving parts (exoskeleton segments and motors).
ALEx can be operated in two modes:
• Force mode16: forces are provided to the EE, or joint torques to each joint;
• Position mode17: trajectories are provided to the EE (EE control) or to the joints (joints
control) with the respective stiffness.
13Passive, here, means ALEx behaves like a “passive device”, as defined in Table 3.2, and does not interferes in the
movement, besides compensating for dynamics.
14ALEx behaves like an “active device”, with assistive control - more specifically, the “low-level” strategy of passive
control mentioned in Table 3.6.
15Partially Assistive Control - Table 3.6
16Equivalent to impedance control “low-level” approach - see Table 3.6
17Equivalent to admittance control “low-level” approach - see Table 3.6
3.4 Personalization of Robot-aided Motor Therapy 31
3.4 Personalization of Robot-aided Motor Therapy
Improved outcomes of robot-aided motor therapy have been envisioned if the therapeutic train-
ing would be tailored to each patient. (Fuhrer and Keith, 1998; Krakauer, 2006) Nevertheless,
designing the appropriate customized exercises and the respective robotic assistance is still chal-
lenging and how to do it is an open debate. Therefore, currently, the evaluation of the patients’
progress and decision to adjust therapy accordingly is done by a physiotherapist (Panarese et al.,
2012). However, this assessment is usually done just before and after sessions of treatment, using
scores of clinical scales, like Fugl-Meyer, for example. On the other hand, measures continuously
recorded by robotic devices can be used as immediate feedback on the patients’ progress (Panarese
et al., 2012).
In fact, apart from reliable measurement, robotic devices of today allow the patients to re-
peatedly train general or task-oriented movements or sub-movements (like planar or 3D reaching
movements in one or more directions) (Marchal-Crespo and Reinkensmeyer, 2009), and provide
variable assistance or resistance (as detailed in Section 3.3.2). When this training is centered in
exercising specifically the impaired movements of each patient, the treatment is expected to be
more effective and efficient, given that motor learning is optimized if the difficulty of the exer-
cises matches the degree of motor ability (Guadagnoli and Lee, 2004). Additionally, this type of
training is more intense (because the therapy is focused on a set of movements and the patient
can practice them several times), which increases the level of motor improvement (Kwakkel et al.,
1997, 1999; Krebs et al., 2003).
3.4.1 State of the Art
Following the explained perspective, various researchers have been working in designing
methods to personalize both the robotic assistance and the rehabilitation training protocol (Krebs
et al., 2003; Koenig et al., 2011; Novak et al., 2011; Panarese et al., 2012; Papaleo et al., 2013;
Metzger et al., 2014).
Particularly, Panarese et al. (2012) developed a statistical algorithm which estimates motor
improvement of stroke patients during upper limb robotic-assisted therapy based on kinematic
measures of easiness (average speed), accuracy (distance to a straight path) and smoothness (num-
ber of peaks in the speed profile).
In turn, Krebs et al. (2003) proposed an adaptive algorithm to control the robotic-assistance
(during training of upper limb movements) using kinematic (speed, or time) or muscle activity
(EMG signals) thresholds.
Papaleo et al. (2013) also designed an approach to modulate the level of robotic-assistance
(in 3D rehabilitative movements with the upper extremity) in accordance to the patient’s perfor-
mance. However, these investigators evaluated performance using kinematic (measures of accu-
racy, smoothness and inter-joint coordination) and kinetic (forces exerted by the patient) param-
eters of the patient’s behaviour. Similarly, Metzger et al. (2014) adapted the task difficulty of
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robotic hand rehabilitation of post-stroke patients, based on the assessment of the ROM (range of
motion) of 2 DoFs of the hand and on the assessment of grasping stiffness.
Other groups of research combined kinematic metrics with psychophysiological measure-
ments. For example, Koenig et al. (2011) studied control methods in robotic-aided gait therapy for
post-stroke patients. These authors proposed a metric combining the patient heart rate (to quantify
physical effort) and the weighted sum of the interaction torques between the robot and the patient,
to select one of two strategies of the gait therapy: voluntary or forced, the last one with speed
adaptation. On the other hand, Novak et al. (2011) investigated the usefulness of psychophysio-
logical measurements like heart rate, skin conductance, respiration, and skin temperature, solely or
in combination with task performance metrics and biomechanics, to adapt the level of difficulty of
upper limb motor tasks during rehabilitation. They have demonstrated that a combination of both
types of measurements provides more accurate results in selecting the correct level of difficulty,
than using solely psychophysiological or only kinematic measurements.
Despite the good results obtained in the above-mentioned studies, customization of rehabilita-
tion is yet an emerging field and lacks validation concerning its effectiveness over the conventional
treatment.
3.4.1.1 The NEUROPROBEs project - pilot study
The Neuroprobes’ project is in the framework of robotic-treatment customization. In fact, the
first goal of the project is to test safeness and clinical effectiveness of ALEx in assisting post-
stroke patients during robotic-rehabilitation. Second, this project aims at designing a personalized
robot-based protocol of motor therapy for the upper limb based on the statistical model proposed
by Panarese et al. (2012). Finally, the third main aim is to characterize the neurobiomechanical
state of stroke patients and its progress during the treatment, and use such information to improve
the personalization protocol.
In the context of NeuroPRoBES project and, more specifically, its first goal, a pilot study was
already conducted in healthy subjects which evaluated the effects of wearing ALEx while per-
forming point-to-point reaching movements. These evaluation included the analysis of joint and
end-effector kinematics, muscle synergies and motoneural activity in the spinal cord of healthy
subjects, during active and passive exercises (Pirondini et al., 2016). Different tests were per-
formed during 3 days:
• 1st day: free reaching movements and movements with the exoskeleton in passive modal-
ity - allowed the investigators to compare the subjects behaviour with and without the ex-
oskeleton, i.e, to determine if the exoskeleton influenced the subjects muscle activity and
coordination;
• 2nd day: reaching movements with the exoskeleton in passive and assistive (position mode
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at the EE18) modalities - allowed to evaluate if the assistive modality of the robot influenced
the subjects behaviour (once again, their muscle activity and coordination);
• 3rd day: reaching movements wearing the exoskeleton in passive modality and, then, in
the assistive modality19 with two control sub-strategies (joint control and EE control - sub-
strategies of position mode - see Section 3.3.2.1) - allowed the investigators to compare the
two methods of control.
The main results obtained with this pilot evaluation were the following:
• Normal movements are not modifyed by wearing ALEx (based on analysis of end-effector
kinematics), although muscle activation patterns and movement coordination are changed
to some extent (Pirondini et al., 2014);
• Reaching movements have similar dynamics, similar patterns of muscles recruitment (al-
though with weaker activity in assistive modality) and similar joints’ angular excursions
both in passive and assistive modalities, when wearing ALEx. However, free movements
and movements wearing the exoskeleton differ a little, to be highlighted that wearing ALEx
improves the movement accuracy.
• Analysis of muscle synergies allowed to verify that synergies activation over the move-
ment time was different while executing free movements or performing movements wear-
ing ALEx in passive or active modalities, showing that using the exoskeleton influences the
muscle coordination in a positive way (the use of the exoskeleton lead to an enhanced dis-
tribution of contributions of different muscle groups to perform the reaching movements).
• Both joint and EE control strategies induced similar motor activity and, thus, preserved
motor coordination of the passive modality, specially the joint control.
This preliminary results of NeuroPRoBES project endorse the application of ALEx in rehabil-
itation of post-stroke patients to support physical therapy of the upper extremity.
Regarding the second main aim of Neuroprobes project, an adapted version of Panarese et al.
(2012) algorithm was developed and implemented in ALEx to personalize the rehabilitation train-
ing of each patient. Indeed, the model proposed by Panarese et al. (2012) was developed for
planar movements and tests were performed offline (i.e. after the training session that was part
of the experiments). Then, this model was adapted for 3D movements and for execution in real-
time, so that motor improvement of patients receiving the robotic treatment could be continuously
estimated.
18Reference trajectories were defined as straight lines between the initial and final points of the reaching movements.
19The natural trajectories performed in the passive modality were recorded and used as the reference trajectories in
assistive modality.
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This estimation is performed for every task (a reaching movement towards one target) pre-
sented during the training session. From the progress (over repetitions of the same movement) of
motor improvement for all tasks, the algorithm replaces one task by a more difficult one, when a
performance plateau is reached (i.e. the algorithm determines the movements that the patient has
to train - the ones that the patient shows more difficulty).
Chapter 4
Kinematic assessment of the Upper
Limb
Early investigation on robotic-aided motor therapy has made an extensive use of clinical scales
to assess motor performance of stroke patients during rehabilitation, and to infer on the contri-
bution of robotic assistance to that motor ability. Nevertheless, over the years, an increased use
of kinematic metrics has been registered (Santisteban et al., 2016), mainly because some studies
(Alt Murphy et al., 2013; Bensmail et al., 2010) have shown that sensibility of these metrics is
enhanced when compared to clinical scales and, this way, allow more fine-grained measurements
of changes in motor ability of patients. In addition, kinematics is often used in combination with
the FMUE (Fugl-Meyer scale for the Upper Extremity) (Santisteban et al., 2016).
Therefore, background concepts about kinematics is provided in this chapter, as well as a
review of kinematic metrics reported in the literature to assess movement execution in robot-
assisted rehabilitation of the upper limb following stroke.
4.1 Background concepts
Kinematics, a component of Biomechanics, describes the movements of bodies using graphical
or numeric representations of position, velocity, acceleration, disregarding the applied forces on
those bodies. (Binder et al., 2009b)
Specifically, the study of geometrical and temporal features (kinematics) of movements of the
human body segments provides important information on the individual motor control, movement
smoothness and accuracy, and other.
The human upper extremity, in particular, is a multi-joint, multi-DoF system, as represented
in Figures 4.1 and 4.2. The arm is able to execute a broad range of goal-directed actions. For each
of these actions, several paths may be taken and different velocity profiles are possible for each
path, with more or less expenditure of energy and time, resulting in numerous possible trajectories.
Nevertheless, real arm movement trajectories in healthy persons seem to be stereotypical, having
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invariant kinematic features: for example, it has been suggested that point-to-point reaching tasks1
follow approximately straight paths with bell-shaped tangential velocity profiles (Binder et al.,
2009a). Notwithstanding, care must be taken with the approximation to straightness, according to
results of Wisneski and Johnson (2007) work, which demonstrate that arm trajectories of healthy
subjects are more curvilinear than theoretically suggested. This detail must also be considered
when assessing modifications in movement execution induced by stroke.
Figure 4.1: Some of the the upper limb degrees of freedom (DoF). 1: arm flexion/extension; 2:
arm adduction/abduction; 3: arm internal (medial) / external (lateral) rotation; 4: elbow flex-
ion/extension; 5: forearm pronation/supination; 6: wrist flexion/extension; 7: wrist adduction
(ulnar deviation) / abduction (radial deviation); 8: hand grasp/release. (Maciejasz et al., 2014)
Figure 4.2: Additional degrees of freedom (DoF) of the upper limb, associated to the shoulder
(more specifically, the sternoclavicular joint). A - shoulder protraction; B - shoulder retraction; C
- shoulder elevation; D - shoulder depression (Kingston, 2005)
Even though, given the stereotypical behavior of nondisabled persons, abnormalities in pat-
terns of kinematic parameters can be monitored in post-stroke patients and used for recovery
evaluation (Binder et al., 2009a; Krakauer, 2005).
1Reaching movement between two points in the space.
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In fact, reduced motor ability following stroke is identified in several features of movement,
mainly related to paresis of the arm, increased muscle tone and absence of somatosensation (Lang
et al., 2013). Due to paresis, patients move the arm more slowly, less accurately and less effi-
ciently. An abnormal muscle tone is reflected in jagged movements: an increased tonicity causes
resistive forces against the movement direction, making the movement less smooth. In addition,
loss of somatosensation interferes with the ability to correct movements. (Nordin et al., 2014)
4.2 Review of Kinematic metrics to assess Motor Performance in Up-
per Limb Robotic-aided Rehabilitation
As mentioned in the beginning of this chapter, most of past investigation assessing motor per-
formance during rehabilitative programs typically use nominal or ordinal scales Krakauer (2005).
For example, most of the studies reviewed in Hesse et al. (2003) used only the Fugl–Meyer motor
score (which measures the DoFs that a patient is able to control - van Kordelaar et al. (2013)) to
evaluate the motor function of the impaired upper extremity at the end of the robotic treatment.
Other similar scales are also used, like the Wolf Motor Test, the Motor Activity Log or the
Chedoke-McMaster Stroke Assessment Measure, as mentioned by Krakauer (2005) and Roh et al.
(2013), for instance.
Even more recent studies make extensive use of these scales, such as the assessment of the
exoskeleton ARAMIS (Pignolo et al., 2012), or the evaluation of the robot ARMin Klamroth-
Marganska et al. (2014), and others (Milot et al., 2013).
However, Kinematics has gained importance as a reliable method to assess effectiveness of
rehabilitation therapies, mainly because previous studies (Alt Murphy et al., 2013; Bensmail et al.,
2010) have shown that sensibility of these metrics is enhanced when compared to clinical scales
and, this way, allow more fine-grained measurements of changes in motor ability of stroke patients.
In addition, other studies (Sivan et al., 2011) suggest that kinematic measurements are suitable for
all phases of stroke rehabilitation.
Specially in the context of robotic-aided rehabilitation, kinematic measurements are facili-
tated, because robots typically include movement sensors to acquire position, velocity and orien-
tation of the end-effector and/or joints, in a reliable way (Huang and Krakauer, 2009).
As so, more recently, an immense variety of kinematic metrics is used in robot-based rehabili-
tation studies. Particularly for point-to-point reaching movements, different authors have proposed
distinct metrics to quantify movement execution features like efficiency, efficacy, accuracy, easi-
ness and smoothness - see the most used ones in Table 4.1. (Nordin et al., 2014)
Movement accuracy is usually measured in respect to a straight path, that is, the straight line
between the initial point of the movement and the reaching point. Metrics of accuracy include: the
mean distance to the theoretical path (straigh line), which is computed by averaging the distance
between each point of the path and the respective point of the theoretical path (Panarese et al.,
38 Kinematic assessment of the Upper Limb
Table 4.1: Example of kinematic metrics to assess different features of movement execution.
Movement features Kinematic metrics
Accuracy
Mean distance from theoretical path,
Euclidean distance between target and end-point
Temporal efficiency Task completion time (movement duration)
Spatial efficiency
Path legth,
Ratio of affected path length and unaffected path length
Efficacy
Percentage of successful tasks,
Target unreached
Easiness
Mean velocity,
Peak velocity
Smothness
Increase in mean acceleration,
Ratio of mean acceleration with peak acceleration,
Number of peaks in the speed profile,
Spectral Arc-Length
2012; Coscia et al., 2014; Colombo et al., 2005); or the euclidean distance between the target
location and the point at which the patient stops moving (Daly et al., 2005).
For any of those metrics, a low value corresponds to a good accuracy. This feature has been
significantly correlated with severity of impairment following stroke (Cirstea and Levin, 2000)
and, thus, it is expected to improve with motor recovery (Panarese et al., 2012).
Temporal efficiency is measured in respect to the optimal time taken to complete some move-
ment/task, being defined as the elapsed time from the beginning to the end of that movement
(Zollo et al., 2011). As the patient recovers his/her motor abilities, this time is expected to become
shorter (Frisoli et al., 2012; Lum et al., 2004).
Spatial efficiency, in turn, is measured relatively to the optimal path to reach the target. Inves-
tigators suggested that an optimal path is the shortest one, and longer paths presuppose a greater
energy expenditure (Colombo et al., 2008). Therefore, spatial efficiency is commonly measured
with the path length, which has been shown to decrease in chronic stroke patients receiving uni-
manual rehabilitation (Colombo et al., 2008; Coderre et al., 2010; Beer et al., 2008). In bimanual
studies, like Semrau et al. (2013), the ratio between the path length where the patient actively
moved and the path length guided by the robot was used.
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Efficacy in movement execution is defined as the ability to accomplish a task. For example, in
robotic-assisted training of reaching movements, this feature can be measured with the percentage
of completed tasks (Panarese et al., 2012) or, inversely, the number of targets which the patients
was not able to reach (Coderre et al., 2010). Although this feature is expected to improve with
motor ability, solely it is not able to evidence if such improvement occurs as a result of true recov-
ery or compensation (Nordin et al., 2014).
Easiness is defined as the ability to execute the movement using the least effort possible
(Nordin et al., 2014). This feature is typically associated to the movement velocity. Colombo
et al. (2005), for example, reported that mean velocity significantly increases in chronic patients
receiving a robotic-treatment, and also in subacute patients (Colombo et al., 2008). Similarly,
other studies with different protocols of rehabilitation also found a significant improvement in
mean velocity (Mazzoleni et al., 2013; Panarese et al., 2012).
In turn, an increase in peak velocity with rehabilitation is reported in Zollo et al. (2011) and,
moreover, this metric has been correlated with scores of clinical scales like FMUE (Bosecker et al.,
2010).
Finally, lack of smoothness is characterized by the occurrence of short sub-movements, due
to sudden, increased acceleration and deceleration (Rohrer et al., 2002). Consequently, the speed
profile includes several positive and negative peaks and, thus, the number of peaks has been used
before to measure this movement feature (Panarese et al., 2012). Differently, Mazzoleni et al.
(2011) verified that mean acceleration increases for smoother, planar reaching movements, in
chronic patients. Later, they reported significant increase in the ratio between mean acceleration
and peak acceleration for subacute stroke patients, but not significant for chronic patients (Maz-
zoleni et al., 2013).
More recently, a new metric has been developed to quantify smoothness: the Spectral Arc-
Length. This metric corresponds to the negative arc length of the Fourier spectrum magnitude of
the speed profile (Balasubramanian et al., 2012) - see Equation 4.1.
ηsal ,−
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Vˆ (ω), V (ω)
V (0)
where V (ω) is the Fourier magnitude spectrum of the movement velocity, and [0,ωc] is the
frequency band occupied by the given movement. ωc = 40pirad/s (which corresponds to 20Hz)
covers the normal and abnormal aspects of human movements such as tremor (Balasubramanian
et al., 2012).
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Chapter 5
Muscle Activity of the Upper Limb
Motor recovery following stroke must be assessed beyond its final result (task accomplishment
and kinematic performance). According to the definition of true recovery provided in section 3.1
of the Motor Rehabilitation Chapter, a kinematic description of movement must be completed
with an analysis of neuromuscular activity, because it provides additional information on the neu-
rophysiological state of the patient, allowing to infer about the restitution, or not, of movement
patterns previous to lesion (healthy patterns).
Thus, features of single muscle activity (following electromyography), muscle coordination
(muscle synergies analysis) and estimated motoneural activity of the spinal cord (spinal maps) can
be investigated to search for biomarkers of true motor recovery. Thus, theoretical concepts and
previous work reported in the literature concerning these analyses are presented in this chapter.
5.1 Electromyographic Analysis
The electromyographic signal (EMG) measures the electric potential generated by muscle cells
when these cells are electrically or neurologically activated (Reaz et al., 2006). It represents the
local electric current which results from ions crossing the membranes of muscle fibers and which
diffuses to surrounding tissues (Wang et al., 2013). Electromyography is the technique used for
detecting and analyzing this electrical signals measured from skeletal muscles. (Jamal, 2012)
Each neuron innervates a group of muscle fibers, constituting a “Motor Unit”, the functional
unit of muscles (Wang et al., 2013). When a stimulus is sent to a motor unit, a “Motor Unit
Action Potential” (MUAP) is generated. Until the muscle force is no longer needed, the CNS
continues to send the stimulus, originating a train of MUAPs. At the measurement place, the
EMG signal results from the superposition of MUAPs trains of nearby motor units which were
activated. (Jamal, 2012)
This bioelectrical signal has become an important tool for diagnosing neuromuscular diseases
and disorders of the CNS, specially concerning the motor control and movement coordination (Ja-
mal, 2012), providing useful data for quantitatively evaluate outcomes of rehabilitation programs.
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EMGs are pre-processed before being further analyzed:
1. to retain only the movement informative content (remove frequency components originated
by muscle fibers firing rate, electric/thermal noise, etc.), being filtered,
2. to make the range of amplitudes comparable between muscles, being each signal indepen-
dently normalized,
3. to extract the envelope of the signal, being rectified or integrated over a time interval.
Filters with different characteristics have been used by distinct scientist, such as filters with
FIR (finite-impulse response) and Butterworth response, of 3th, 4th, 7th order, and filtering fre-
quencies of 15/20/50 Hz for the lower cut-off frequency, and 400/450/500 Hz for the upper cut-off
frequency. (Grasso et al., 2004; Cheung et al., 2009; Tropea et al., 2013; Pirondini et al., 2016)
The normalization procedure is also variable across studies: EMG signals may be normalized to
have unit variance (Tropea et al., 2013), normalized by the MVC (maximum voluntary contrac-
tion) (Pirondini et al., 2016), or by the maximum of the muscle recordings (d’Avella and Bizzi,
2005; Frère and Hug, 2012). The signal envelope may be obtained by half-wave rectification, full-
wave rectification, half/full-wave rectification followed by integration over 25ms, 100ms, 200ms,
or other time interval. (Ivanenko et al., 2006; Tropea et al., 2013; Pirondini et al., 2016)
Details of filtering and normalization procedures, as those explained above, must be adapted to
the experiment, being this the main reason for the variability of methods used in previous studies.
The pre-processed EMG amplitude is usually analyzed preliminarily using simple measures
as the mean activity or the RMS (root-mean square) value (Equation 5.1), to quickly detect trends
of muscle activation, compare levels of weakness/strength, and compare muscle activity across
conditions (eg. Pirondini et al. (2016)).
RMS=
√
1
N
N
∑
n=1
EMG(n)2 (5.1)
In the context of stroke and motor rehabilitation of the upper limb, several muscles of the arm,
shoulder and trunk are important. Muscles that were analyzed to develop this thesis are presented
in Figure 5.1 and their function is described in Table 5.1.
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Figure 5.1: Location of muscles of the arm, shoulder and trunk that were analyzed to develop this
thesis.
5.2 Analysis of Muscle Synergies
Motor coordination is the result of combining different muscles to perform a goal-oriented action
in a smooth and efficient way. The kinematic (like direction and speed) and dynamic (forces)
variables of the intended task are achieved with the muscle selection and control performed by
the CNS. (Fetz, 1993) Muscles are recruited with specific electric patterns (neural commands sent
from the CNS to the muscles), which are hypothetically identifiable in the EMG signals (Kamen
and Gabriel, 2010). For each activated muscle, the stimulus intensity varies along time, increasing
when the movement direction (as well as the speed and force) is required in the direction of the
muscle contraction. (Thach, 1978; Binder et al., 2009d)
Although it seems that muscle patterns are dependent on the above-mentioned kinematic and
kinetic variables, their origin in the CNS is believed to follow simplifying rules which define
stereotypical profiles of muscle co-activation: the muscle synergies (Tresch et al., 1999; Torres-
Oviedo and Ting, 2007; Kargo and Giszter, 2008).
In summary, a muscle synergy is a standardized recruitment of a group of muscles to perform
part of some movement, during a time window, therefore, having a structure (a set of weighting
coefficients) and being activated by the CNS in different instants (time activation coefficients).
(Binder et al., 2009d)
In detail, the synergy structure indicates which muscles are co-activated and the proportion
of activation intensity between them (muscle weights profile). While executing some movement,
different synergies are combined by modulation of the structure of each synergy in intensity along
the movement time (time activation profile of the synergy) (Binder et al., 2009d) - see Figure 5.2.
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Table 5.1: Function of relevant muscles in the context of stroke, considered for the present thesis
(Kingston, 2005).
Muscle Function
Trapezius
upper fibers - shoulder elevation and forward rotation; middle/lower
fibers - shoulder retraction.
Deltoid
middle fibers and whole muscle - shoulder abduction; anterior fibers -
flexion and medial rotation of the shoulder; posterior fibers - extension
and lateral rotation of the shoulder.
Pectoralis major adduction, medial rotation and flexion of the shoulder.
Latissimus dorsi extension, adduction and medial rotation of the shoulder.
Infraspinatus lateral rotation of the shoulder.
Rhomboid major Retraction, with slightly elevation, and backward rotation of the shoulder.
Biceps brachii
(long and short heads) elbow flexion, supination of the forearm and hand,
and assistance in shoulder flexion
Brachioradialis elbow flexion, and assistance in pronation, supination of the forearm.
Triceps brachii (long, lateral and medial heads) elbow extension.
Pronator teres pronation of the forearm, and assistance in elbow flexion.
In fact, the upper limb musculoskeletal system has redundant ways to generate an action be-
cause of its large number of DoFs and, thus, large number of possibilities for muscles combina-
tions. So, synergies are thought to be a simplifying mechanism of:
- first, mapping movement parameters into muscle patterns, just like an implementation of
inverse kinematics and inverse dynamics (Binder et al., 2009d).
- and, second, reducing the number of DoFs to be controled, i.e., instead of controlling a big
number of muscles separate and independently, the CNS only controls (selects and modulates) a
lower number of synergies and linearly combines them to achieve the movement goal. (Cheung
et al., 2009)
The muscles synergies real existence is yet in debate (Tresch and Jarc, 2009; de Rugy et al.,
2013) but, since Bernstein (1967) proposed this hypothesis, it has been supported by empirical ev-
idences on the past years experiments (d’Avella et al., 2003; Ivanenko et al., 2004; Torres-Oviedo
and Ting, 2007; Ting and Macpherson, 2005; Overduin et al., 2012): similar patterns in the muscle
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Figure 5.2: Schematic representation of the synergies theory (example with 2 synergies, one green
and another red, to command 3 muscles, M1 to M3): recorded EMGs result from the linear com-
bination (thick blue lines) of time-invariant synergies (set of muscles’ weighting coefficients -
horizontal bars), each being activated by a different time-dependent coefficient (waveforms in the
bottom). (Adapted from Cheung et al. (2009).)
activity across individuals, motor activities, and species have lead scientists to propose that muscle
synergies reflect a modular organization of movement production by the CNS. As so, it is one of
the most adopted theories to study the motor limitations and the motor recovery following stroke,
and the effects of rehabilitation. (Cheung et al., 2009; Clark et al., 2010; Salman et al., 2010;
Safavynia et al., 2011; Cheung et al., 2012; Tropea et al., 2013; Roh et al., 2013)
After stroke, impaired movements of the upper limb are often expressed in generally increased
weakness and atypical patterns of shoulder, elbow and trunk muscles (Krakauer, 2005; Levin et al.,
2009; Roh et al., 2013). As mentioned in section 3.1 of the Motor Rehabilitation chapter, hemi-
paretic patients frequently use less elbow extension and compensate this with the trunk rotation or
bending in reaching movements, and/or present difficulties in shoulder flexion/abduction, increas-
ing the shoulder elevation and the elbow flexion to lift the arm (movements in opposite direction
to gravity). (Levin et al., 2009; Roh et al., 2013; Coscia et al., 2014). This abnormal coupling
between muscles is typically reflected in a reduced number of synergies (Roh et al., 2013). Nev-
ertheless, other types of alterations on muscle synergies (compared to healthy subjects) have been
found before, and it must be noted that more than one type of alteration may be present (Roh et al.,
2013).
Cheung et al. (2009) concluded that synergies’ structure was preserved, but not their activation
(time coefficients) in mildly impaired post-stroke patients. However, from a more diverse group
of subjects (concerning the level of impairment and age of lesion) (Cheung et al., 2012), they were
able to quantitatively demonstrate that synergies structure is preserved, modified by a merging of
synergies, or modified by fractionation of synergies, as a function of both severity of functional
impairment and time from stroke onset (see Figure 5.3): severely affected patients (regardless of
the temporal distance to stroke onset) presented a reduced number of synergies due to synergies
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Figure 5.3: Example of correlations found between the synergies structure as result of synergies
merging and level of impairment (A), and between the synergies structure as result of synergies
fractionation and temporal distance from stroke onset (B), by Cheung et al. (2012).
merging; subjects with mild-to-moderate impairment preserved the number of synergies but pre-
sented modifications in the weight coefficients; some synergies of chronic survivors result from
the fractionation of healthy synergies.
Additionally, Roh et al. (2013) have observed completely altered synergies’ structure, like new
synergies, and not a result from merging or fractionation of normal synergies, in chronic survivors.
These conclusions provide clues on muscle coordination of post-stroke patients, but cannot be
assumed disregarding the type of movements. Thus, they need to be verified for 3D point-to-point
reaching movements as those concerning this work, having been a starting point of this thesis to:
- first, use muscle synergies to characterize the neural state of post-stroke patients along the
treatment course with ALEx;
- second, search for features of such muscle synergies that could be correlated with motor per-
formance and, in the future, could be included in the motor improvement algorithm for treatment
personalization.
Typically, muscle synergies are obtained from EMG signals using matrix factorization algo-
rithms, like NNMF (non-negative matrix factorization), FA (factor analysis), ICA (independent
component analysis), PCA (principal component analysis), and variations of these methods. Fac-
torization algorithms model the observed data (in this case, recorded EMGs) as a linear combina-
tion of a small set of basis vectors (synergies). (Tresch et al., 2006) Despite being similar, these
algorithms rely on particular assumptions, which are, then, reflected in some differences in the
results. However, such differences have been demonstrated not to be significant in several studies
with muscle synergies extracted by different algorithms (Tresch et al., 2006; Steele et al., 2015b;
Lambert-Shirzad and Van der Loos, 2017). As it will be explained in Chapter 6, an adaptation of
the NNMF algorithm was selected to extract the muscle synergies in this work. Therefore, theory
on this method is provided in Appendix A.
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In fact, matrix factorization methods are dimensionality-reduction algorithms: taking as input
a high-dimension dataset, they output a lower-dimension dataset which best approximates the in-
put one, by finding common patterns in the input variables able to algebraically relate one variable
to another. This is the reasoning for applying them to EMG data in order to discover the most
probable set of muscle synergies used by the CNS. (Tresch et al., 2006)
Notwithstanding, the dimension of the output is not known from the start and it is not deter-
mined by the algorithm itself. This number must be provided to the algorithm. As so, the number
of muscle synergies needs to be estimated or known from previous studies of the same muscle
activity (eg. regarding movements in the same dimensions of space, executed by similar subjects
in age and health condition). Although there is an interval of the number of muscle synergies com-
monly found in healthy subjects to perform point-to-point reaching movements, 4 to 7 synergies
(d’Avella et al., 2006; Cheung et al., 2009; Coscia et al., 2014), the exact number may differ for
different tasks in a 3D space. Moreover, this number is modified in stroke survivors and differs
for each patient, due to the heterogeneity of post-stroke impairments across patients. In spite of
several studies on this matter (Roh et al., 2013; Cheung et al., 2012; Clark et al., 2010), the re-
lation between these impairments, as well as the age of the lesion, and the number of synergies
is uncertain. (Roh et al., 2013) Therefore, an estimation of the number of synergies is required.
Generally, this value is selected as the minimum able to capture the structural variation of the input
dataset, so that, by adding one more synergy, it will only add noise to the reconstructed dataset.
(d’Avella et al., 2006) However, more specific approaches are followed in different studies, not
only to estimate the number of synergies, but also in the other steps of this analysis, as explained
next.
A set of steps is commonly found in the literature to analyze muscle synergies. They are
enumerated here and adopted variations by different scientists are mentioned:
1. Synergies Extraction and Determination of the Number of Synergies:
Independently of the extraction method (matrix factorization algorithm), different authors
have tried distinct approaches to select the correct number of synergies. For example:
- A searching procedure is frequently followed, where k synergies are repeatedly extracted
for several times (for ex., 50 times, like in Pirondini et al. (2016)) using the dimensionality-
reduction algorithm and, each time, the set of k synergies found by the algorithm is used
to reconstruct the EMGs; an accuracy measure is calculated to evaluate this reconstruction
in comparison to the original EMG; the best result of those times is associated to the k
value; k is varied from 1 (or other low number) to the number of muscles, repeating the
previous steps for each k; finally, the best estimate of the number of synergies is assumed to
be the k value for which the best reconstruction accuracy was obtained. Using this method,
a threshold may be defined for deciding which is a good value of accuracy (for ex., 95%),
or the variation of the slope of the accuracy measure may be analyzed and the number
of synergies estimated for the lower variation. This measure of accuracy is frequently the
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VAF, variance accounted for (the amount of explained variance retained by the reconstructed
dataset) (Frère and Hug, 2012; Pirondini et al., 2016).
- Alternative to the repetition for k synergies and choice for the best result, cross-validation
can be performed using datasets of different individuals to obtain the synergies and to assess
them (Cheung et al., 2005);
- Another alternative is to determine the eigenvalues of the dataset and use the criterion of
eigenvalue > 1 to decide if an additional synergy explains significant variance of one initial
variable (one EMG signal) (Tropea et al., 2013);
- Alternatively, the number of synergies may be considered the one at which the cumulative
variance drops below the 75% of a randomly shuffled dataset (see details in Cheung et al.
(2009) or Tropea et al. (2013)).
2. Matching Synergies:
After extraction, muscle synergies are not equally ordered for all datasets, which requires a
categorization of each synergy as S1,..., Sn, for each subject, and matching pairs of synergies
among different subjects. This procedure may be accomplished using the weight coefficients
or the time coefficients.
Typical methods for this step include a clustering process or the maximization of the dot
product between pairs of synergies. The clustering may be achieved, for example, by the
minimization of the Minkowski distance. (Cheung et al., 2009)
When only two sets of synergies are being matched, the dot product maximization is easy
to compute. However, when comparing a higher number of set of synergies, the clustering
process may be more adequate, although both methods may and, actually, have been applied
before (Tropea et al., 2013; Cheung et al., 2009).
3. Similarity Assessment of Synergies’ Structure:
The similarity between synergies of the matched pairs can be assessed to evaluate the syner-
gies’ structure modifications between groups of comparison (healthy vs. patient, or patient
in different moments of the treatment).
Typical measures of similarity are: the normalized dot product between the synergies’ vector
of weight coefficients (Pirondini et al., 2016; Tropea et al., 2013), the correlation coefficient
between the matched pair (Tresch et al., 2006), and others.
4. Similarity Assessment of Time Coefficients:
Some studies also compare the time activation profiles of muscle synergies. For example,
the root mean squared value of the time coefficients (Pirondini et al., 2016) and also the
Pearson’s correlation coefficient (Tropea et al., 2013) have been used to assess the similar-
ity between synergies activation of the same pairs.
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5.3 Analysis of the Motoneural Activity in the Spinal Cord
Muscles are, in general, innervated by more than one segment of the spinal cord. In fact, several
myotomal maps (localizing the motoneural pools in the human spinal cord which innervate the
body muscles) have been published in the past, based on evidences from different sources: clin-
ical, neuroimaging, autopsy, and electrophysical studies (read Wilbourn and Aminoff (1998) for
a review). However, the root innervation of some muscles is not a certainty, being any myotomal
chart usually considered a significant approximation of the reality, given that abnormal innervation
may occur. (Phillips and Park, 1991; Stewart, 1992)
Notwithstanding, functional MRI of the human spinal cord has been confirming the statements
of published charts (Kornelsen and Stroman, 2004; Stroman and Ryner, 2001), so that scientists
have been using the muscle activity to estimate the spinal cord activity in cats (Yakovenko et al.,
2002), healthy subjects during locomotion with different gaits (Cappellini et al., 2006; Ivanenko
et al., 2008), healthy subjects assisted by robots in reaching movements (Pirondini et al., 2016),
spinal cord-injured patients (Grasso et al., 2004), among others, based upon such charts.
These authors propose to map recorded EMG activity onto the ipsilateral motoneurons (MN) in
the human spinal cord (considering only the approximate location of such MN in the anatomical
rostrocaudal axis). In practical, the MN activity of each spinal segment is estimated from the
weighted summation of the EMGs of all muscles innervated by that segment (see Equation 5.2).
The weight coefficients are usually in accordance with Kendall’s chart (Kendall et al., 1993),
which indicates the number of sources confirming the connection between the spinal segment and
the muscle and, given that number, muscles are weighted: when there is an agreement of five or
more sources, the coefficient is 1, and it is 0.5, in case of agreement of three or four sources; the
muscles with lower number of sources are neglected. The frequent choice for the Kendall’s chart
is due to the simplicity of using it as guide and for the comparable results with other charts, at
least demonstrated for the lower limb (Ivanenko et al., 2006). For the upper limb, the analysis of
the spinal cord activity is yet a novelty and the Kendall’s chart was considered in published work
(MacLellan et al., 2012; Pirondini et al., 2016).
S j =
∑n jj=1 ki j ·EMGi
n j
(5.2)
where S j is the estimated activity of the jth spinal segment during the execution of some
movement, n j is the number of EMGi signals corresponding to that segment, recorded during
such movement, and ki j is the weighting coefficient for the ith muscle.
Each signal, S j, reflects the relative magnitude of each spinal segment’s activity, during that
time interval. It does not provide, however, the absolute amount of activity, since the EMG signals
are previously normalized. (Grasso et al., 2004)
Basically, this analysis assumes that, first, rectified-EMGs allow the indirect quantification of
the net firing rate of MNs and, second, the total output of the spinal segments is well represented by
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the activity of the recorded muscles. The first assumption is based on earlier investigation demon-
strating that increases of EMG amplitude are significantly linear with the net firing rate of the
motor unit, both in young and elderly subjects. (Day and Hulliger, 2001; Masakado et al., 1994;
Zhou and Rymer, 2004) The second assumption has been recently tested with the lumbosacral
spinal segments, for movements with the lower limb, and results showed that spinal activity is
relatively insensitive to the subset of muscles analyzed. (La Scaleia et al., 2014) Unfortunately,
the same has not been validated for the upper limb. Nevertheless, La Scaleia et al. (2014) study
was conducted for diverse movements (different types of human gait) and a considerable number
of spinal segments. Therefore, until further validation for the arm, the second assumption of this
analysis seems quite reasonable to be considered for upper limb studies, as in the present thesis.
For a visual representation of the spinal cord activity along the rostrocaudal axis, the signals
S j, for all j segments, are pooled together and the resulting matrix is represented in a colored map,
as in the examples of Figure 5.4. Spinal maps are, therefore, representations of the spatiotemporal
distribution of the activity in the spinal cord while executing some movement.
Figure 5.4: Examples of spinal maps extracted (A) for the upper limb, in healthy subjects wear-
ing the exoskeleton in passive mode (i.e. without providing robotic assistance) while executing
reaching movements, specifically for targets in the North (targets 1, 2, 11, 12, in the down figure)
(Pirondini et al., 2016), and (B) for the lower limb, while walking (Ivanenko et al., 2008). Notice
also the representation of the CoA superimposed in the spinal map of (A), in black. The x-axis of
the spinal maps correspond to the time interval of the movement (the map results from resampled
data of several subjects to have the same lenght, so the axis represents the relative time, from the
beggining, 0%, to the end of the movement, 100%). In (A), C2-T1, and in (B), C3-S2 are the
considered spinal segments. The color of the map indicates the activity intensity for each instant
and spinal zone, provide by each author.
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Spinal maps provide a synthetic and simple-to-compute representation of the activity in one
upper element of the neuromuscular system, the spinal cord, which is likely to be modified after a
stroke given that input for such activity comes from an injured brain cortex. As so, and recalling
that spinal cord activity related to upper limb movements is poorly exploited in the literature
(although promising results have been obtained in studies with the lower limb), this analysis was
considered important for the present thesis.
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Chapter 6
Materials and Methods
6.1 Participants
The present work was developed within Neuroprobes project. Accordingly, post-stroke patients
are enrolled in the study if they fulfill the following inclusion criteria:
• age more than 18 years old;
• right/left hand dominant;
• cerebral lesion onset between 2-8 weeks (i.e. subacute and acute patients);
• ability to participate to a rehabilitative session of about 30-60 minutes;
• right-hemiplegic with at least 10deg of motion in the treated joints (shoulder and elbow).
On the contrary, patients are excluded if they:
• have participated in another therapy or study including the use of a robotic device within the
30 days preceding and during this study;
• have previously been enrolled into the study;
• have an active implantable device or wear an active device (e.g., pacemakers, metallic ob-
jects in the brain, infusion pumps, etc.);
• have persistent delirium or disturbed vigilance, moderate or severe language comprehension
deficits (i.e., incapability of discernment), or a skull breach;
• have a new stroke lesion during the study;
• have reduced mobility due to previous injuries or abnormalities unrelated with the cerebral
accident.
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Experimental data from four post-stroke patients, that were enrolled in the study and com-
pleted the treatment before the end of this work, was used in this work. Clinical data of these
patients is reported in Table 6.1.
Table 6.1: Clinical data of the 4 post-stroke patients whose experimental data was used in this
thesis.
Subject
Age
(years
old)
Gender Weight(Kg) Height
Time
after
Injury
Hand
Domi-
nancy
Treatment
Group
ALEX-HUG-
001
69 Female 80 155 4 weeks Right Group 2
ALEX-HUG-
003
34 Female 82 165 2 weeks Right Group 2
ALEX-HUG-
004
86 Male 66 165 3 weeks Right Group 3
ALEX-HUG-
006
79 Female 66 160 3 weeks Right Group 1
In addition, recordings from eight right-handed healthy persons (7 females and 1 male, age
54.8±13.8, weight 61.6±11.6 kg, and height 167.0±8.5 cm) were used for the control group 1.
The healthy subjects did not present any evidence or known history of skeletal or neurological
diseases, and they exhibited intact joint range of motion and muscle strength. Healthy subjects
were enrolled in the same age range of the stroke group.
1In the following sections of this dissertation, healthy subjects may be referred to as H01, . . . , H08, meaning healthy
subject 1, . . . , 8.
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6.2 Experimental Setup
In the trial, the patients undergo motor rehabilitation training consisting in four weeks of treatment
and four sessions of assessment. In particular, two assessment sessions were administered before
the beginning of the treatment (A1 and A2, respectively two weeks and one week before) and two
sessions after the end of the treatment (A3 after the last week of treatment, and A4, one-month
after, as follow-up) – see Figure 6.1. Each week of treatment includes 3 sessions of arm training
that lasts, approximately, 30 minutes of effective training with the robot.
Figure 6.1: Experimental protocol for the post-stroke patients. During each session of treatment
(from T1 to T12), stroke patients of group 1, 2 and 3 train the upper limb movements whether being
assisted by a physiotherapist, or by the exoskeleton (ALEx) with a conventional robotic treatment,
or with a personalized robotic treatment, respectively. During each session of assessment (A1 to
A4), a robotic evaluation is done, where the patient (of any group) wears ALEx and performs as
many movements with the upper limb as he/she can.
a
The experimental treatment is proposed in addition to the habitual physical rehabilitative treat-
ment of the patient. Post-stroke patients are enrolled in one of 3 groups of treatment:
1. Group 1 – Standard physiotherapist-assisted therapy: during all the sessions of treat-
ment, the patients perform the traditional motor rehabilitation provided by a therapist, where
the training exercises are decided and assisted by the clinician;
2. Robotic-assisted therapy: the patients train the upper limb movements with the assistance
of the exoskeleton (ALEx). In each session of rehabilitation, they execute point-to-point
reaching movements towards (and backwards) 8 of 18 possible targets 2 in a 3D space de-
fined by a sphere of 19cm of radius (see Figure 6.2). The movement towards one target starts
in the center of the sphere and finishes in that target (forward movement), the opposite move-
ment starts in that target and finishes in the center of the sphere (backward movement). The
2A “target” refers to a “reaching point” of the training task of the robotic treatment, located in one of the 18 positions
in the sphere of Figure 6.2 and, in this text, it will be numerically identified accordingly (eg. T1 refers to the reaching
point 1).
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patients perform as many movements as they can, wearing the robot in assisted-as-needed
mode, i.e. when the subject is not able to reach the target, the robot moves the arm of the
patient towards it. The subject visualizes the task (a red ball signals the target that they must
reach) on a monitor placed in front of him/her.
2.1 Group 2 – Conventional treatment: the 8 targets are selected by the therapist for
each session; the selection is based on the clinician analysis of the patient status and
his/her conclusion about the patient (in)ability to reach those targets;
2.2 Group 3 – Personalized treatment: the 8 targets are selected automatically by the
customization algorithm in the control system of the exoskeleton.3
During each session of assessment, a robotic evaluation is done, in which the patient (of any
group of treatment) executes point-to-point reaching movements towards (and backwards) all the
18 targets of the sphere, repeating them as many times as possible, wearing the robot in assisted-
as-needed mode.
Figure 6.2: 18 targets equally distributed on a sphere with 19 cm radius constituting the reaching
points of the tasks of the robotic treatment.
Healthy participants execute at least 3 repetitions of the same 3D point-to-point-reaching
movements as the post-stroke group, towards (and backwards) the 18 targets in passive mode,
i.e. they wear the exoskeleton only to record their kinematics.
The study was approved by the Commission cantonale d’ethique de la recherché (CCER)
de Geneve, Switzerland and by the Comitato Etico Area Vasta Nord Ovest in Pisa, Italy, and
the recordings were carried out in agreement with the Declaration of Helsinki and Good Clinical
Practice norms. The participants were informed of the procedure and they signed an informed
consent, which included the consent to the use of all data collected during the experiment in
scientific publications.
3The personalization algorithm is an adapted version for 3D movements of the model proposed by Panarese et al.
(2012), which takes as parameters the mean tangential velocity of the handle, the spectral arc-length of the handle
velocity, and the frequency of the robotic assistance. By monitoring these metrics in real-time during the rehabilitation
training, the algorithm assesses the level of motor improvement of the patient for all movements performed towards
the different targets presented during the training session, and replaces some target by a more difficult one once a
performance plateau is detected. Inclusion/exclusion of some target (in the set of 8 targets) is done within the same
session, and from one session to the other.
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6.3 Movement Kinematics and Muscular Activity Recording
Kinematic data and muscular activity were recorded during the execution of the movements by
subjects of both control and stroke groups.
The position and velocity of the end-effector (held by the subject’s hand) were acquired by
the exoskeleton at a sampling rate of 1000Hz. The state (on/off) of the robotic assistance was also
recorded in a binary signal (time points for which the signal is 1 correspond to instants when the
movement is being assisted by the robot, i.e. robotic assistance is on, and vice-versa).
As represented in Figure 6.2, for the stroke group, kinematic data is recorded by ALEx during
every assessment and treatment sessions of the experimental protocol. Muscular activity (elec-
tromyographic signals) is recorded in every session of assessment, and in one day of every week
of treatment. The work developed in this thesis was focused on the analysis of recorded data
during the assessment sessions.
In particular, it was not possible to record data of patient ALEx-HUG-004 during the As-
sessment 2, and of patient ALEx-HUG-006 during the Assessment 4. In addition, during the
Assessment 3 of ALEx-HUG-003, the patient was not feeling so well and the recordings were
interrupted several times.
Each healthy subject participates in a single day of data recording (kinematics and EMG).
The EMGs (electromyographic signals) of 15 muscles of the upper limb (upper trapezius,
TRAPS, trapezius medialis, TRAPM, anterior deltoid, DANT, medial deltoid, DMED, posterior
deltoid, DPOS, pectoralis major, PECM, latissimus dorsi, LAT, infraspinatus, INFRA, rhomboid
major, RHO, biceps brachii long head, BICL, biceps brachii short head, BICS, brachioradialis,
BRAD, triceps brachii lateral, TRILA, triceps brachii long head, TRILONG, pronator, PRO) were
acquired, for both control and stroke groups, by using superficial Ag-AgCl electrodes (Kendall
H124SG, ECG electrodes 30x24 mm) with a Noraxon Desktop DTS wireless system at a sampling
rate of 1500Hz, after appropriate skin preparation.
Electrodes were placed according to guidelines of the Surface Electromyography for the Non-
Invasive Assessment of Muscles European Community project (SENIAM) (Hermens et al., 2000)
and Anatomical guideline (Perotto and Delagi 2005).
The exoskeleton automatically segments the kinematics data by movement and identifies each
movement (i.e., indicates the reaching target and the repetition number of that movement 4).
4Forward and backward movements towards/from one target are considered two repetitions of one movement re-
garding the same target, being a forward movement always followed by a backward movement.
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6.4 Data pre-processing
6.4.1 Synchronization of EMG signals with Movement trajectory
15 channels were used in Noraxon to record the EMG signals. An additional channel was used
to synchronize these signals with the kinematic data recorded by ALEx: this channel received a
trigger signal generated by an Arduino UNO, connected to the exoskeleton, which indicates the
starting and ending of any movement, as well as the starting of the robotic assistance in case it
is required during the movement. Note that when the robot assists a movement, the end of the
movement coincides with the end of the assistance.
Figure 6.3: Example of a trigger signal (up), and a zoomed part of the signal (down). Different
pulse widths refer to different events: green dots indicate the beginning of a movement; yellow
dots refer to the beginning of the robotic assistance; and red dots correspond to the end of a
movement.
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The starting of a movement is registered when the target to be reached by the subject appears
in the screen. The instant at which the robot begins assisting one subject (which happens when
he/she stops moving for 3s) is registered. The ending of a movement is registered when the target
is reached.
This trigger signal is a train of pulses: each pulse represents one of the events explained above,
and each event corresponds to a different pulse width (see the illustration in Figure 6.3).
EMG data was, then, partitioned into segments/epochs, each segment regarding one movement
(i.e. a task towards/backwards one target), considering the respective initial and final instants iden-
tified in the trigger signal by the width of each pulse. The movement corresponding to each EMG
segment was also identified by matching it with the corresponding kinematics data.
6.4.2 EMG signals pre-processing
Combinations of methods previously described in the literature, presented in 5.1, were tested
to pre-process the raw EMG signals, and the final implementation was chosen so to retain the
maximum information accounting for physiologic behavior and to include the minimum of unin-
formative inter/intra-subject variability. The normalization was done with respect to the complete
set of EMG segments (i.e. with all recorded movements), so that movements concerning different
targets/directions could be comparable.
Then, the raw EMG signals were:
1. detrended (to remove any linear trend of the signal mean),
2. band-pass filtered (20-400Hz) using a Butterworth filter response of 4th order (to exclude
movement artifacts and the motor units firing rate, frequencies usually under 20Hz, and to
remove additional high-frequency noise, over 400Hz),
3. full-wave rectified (to obtain the EMGs envelope and, thus, highlight the information re-
garding the level of muscle activation),
4. low-pass filtered (10Hz) using a Butterworth filter response of 4th order (to remove high-
frequency components introduced by the previous rectification),
5. and each EMG channel normalized by its maximum activity during a complete recording
session (i.e., including all movements).
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6.5 Scientific analysis plan to formulate the thesis
As explained in Chapter 1, to define the neurobiomechanical state of post-stroke patients during
the robot-aided upper limb motor rehabilitation, the present work estimates and quantifies the
motor improvement during the treatment using kinematic performance and muscle activity.
To achieve the first goal of this thesis and define the framework for the analysis of patients’
data (kinematics and muscle activity), a scientific analysis (see Figure 6.4) was designed to study
the variability in movement execution and, mainly, in muscle activity when performing 3D point-
to-point reaching movements in different directions. It includes:
I the quantification of effects of the movement condition (reaching point, i.e. targets, and
direction, i.e. forward or backward) on single muscle activity, muscle coordination and
movement execution, by performing, on datasets related to healthy subjects, an analysis of:
i spinal maps and electromyographic envelopes (representing single muscle activity),
ii muscle synergies (a representation of muscle coordination),
iii smoothness, accuracy, efficiency, and easiness, on the movements’ trajectory (a kine-
matic analysis on movement execution).
II the application of the same methods from i. to iii. to post-stroke patients’ data, to quantify
effects of the movement condition in this group of subjects.
Finally, to identify which metrics related to kinematics, spinal maps and muscle synergies can
be used as biomarkers to quantify motor impairment and recovery, the two groups of subjects are
compared, and the correlation between such metrics and FMUE (Fugl-Meyer Scale for the Upper
Extremity) is determined.
6.5
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Figure 6.4: Scientific plan designed to analyze the 3D point-to-point reaching movements in different directions, executed by healthy subjects and
post-stroke patients, to formulate the thesis on the neurobiomechanical state of stroke patients during the robotic treatment.
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6.6 Analysis of the control group (healthy subjects)
6.6.1 Datasets formation
Datasets containing forward/backward movements regarding all targets, and datasets contain-
ing movements forward/backward movements regarding one same target (see Table 6.2) were
built, for each subject, with the respective epochs of the pre-processed, not resampled EMG sig-
nals. Data was organized in this way, because it allows the comparison of the effects of the reach-
ing point (target) and direction (forward/backward) of the movement on single muscle activity,
muscle coordination and movement execution. To extract synergies and estimate the spinal cord
activity with higher accuracy 5, more than one repetition of each movement was included in the
datasets.
Table 6.2: Datasets of EMG signals (identified as D1 to D38) that were built to assess the influence
of the reaching point (target) and direction (forward/backward) of the movement on single muscle
activity, muscle coordination and movement execution. The column indicates the target(s) of the
movements included in the dataset (eg. T1 denotes target 1), the row indicates the direction.
[All targets] T1 T2 T... T17 T18
F D1 D3 D5 D... D35 D37
B D2 D4 D6 D... D36 D38
6.6.1.1 Exclusion of Movements’ Outliers
Each subject executed the movement towards each of the 18 targets (forward and backward),
repeating the cycle of those 36 movements for 5 times. However, not all the 5 repetitions of each
movement could be used, because:
1. For some subjects, for some targets, the EMG of one of the 5 repetitions was unavailable
(i.e., the EMG signals’ recording failed) – thus, there were only 4 repetitions in common
among all subjects and all targets;
2. The movement execution of each subject was found variable to some extent from one rep-
etition to another of a same movement (i.e., a movement towards a same target) – see the
examples in Section 7.1.1 of the Results. This intra-subject (and inter-subject) variability
in the movement kinematics (especially the speed and path), mainly due to factors difficult
5An accurate extraction of muscle synergies means the EMG signals of each subject could be accurately recon-
structed from a set of synergies obtained by averaging, across subjects, the extracted synergies of each subject. The
same reasoning can be applied to explicit an accurate estimation of the spinal cord activity.
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to control in the experiment 6 , were previously shown to affect at least some synergies un-
derlying the respective muscle activity (Cappellini et al., 2006; Sadaka-Stephan et al., 2015;
d’Avella et al., 2008), and, thus, influence the next steps of the analysis.
Therefore, for each subject and each task (i.e. a forward/backward movement in respect to a
single target), only 3 repetitions of the movement were used for the analysis of muscle activity and
kinematic data. The 3 repetitions were chosen based on the following reasoning:
I Since some features of the movement kinematics influence the extraction of synergies (Cap-
pellini et al., 2006; Sadaka-Stephan et al., 2015; d’Avella et al., 2008), kinematic metrics
(path length and movement duration – computed on the movement trajectory recorded by
ALEx) were used to compare multiple repetitions of a movement towards the same target.
II The first repetition of a movement executed by some subjects usually reflects the subject
adaptation to the task (see Section 7.1.1), and this learning phenomenon is undesirable to
be accounted for when defining a set of control synergies (which must represent the healthy
human motor coordination).
a
Considering this reasoning for each subject, the procedure to choose 3 of 4 repetitions was the
following:
1. The kinematic metrics (path length and movement duration) were computed for all move-
ments (all repetitions towards all targets).
2. Each repetition of a movement was labeled as outlier, considering separately the path length
and the movement duration, if the following two conditions were matched:
• The metric value corresponding to that given repetition was higher than 75%, or lower
than 25% of the percentiles of all repetitions (i.e. all values computed in 1. for the
metric)7 ;
• The previous condition was also true for a maximum of one additional repetition of
the same movement8.
3. The 2 labels attributed to each repetition (step 2), by using the path length or the movement
duration, were combined to decide whether to discard or not a given repetition. This step
6These include the residual stiffness of the robot and the unconstrained speed (such as the time to complete the
movement) during the experiment. Note that time was not constrained to prevent unrealistic data, because the subjects’
behavior was not natural when forced to finish within a time interval.
7 The 75% and 25% thresholds were empirically selected to balance the inclusion of very different movements with
the exclusion of a maximum of one repetition per target, per subject. The selected thresholds were, then, applied to all
subjects.
8It was considered that, if at least three repetitions of a same movement are outliers among all repetitions of all
movements, then, it is possible that such movement is significantly different from the others (i.e., the variability is not
due to the experiment), so, the given repetition should not be discarded.
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was performed differently to build datasets containing movements towards a single target
(a.) and to build datasets containing movements towards all targets (b.) (see examples in
Figure 6.5):
a) “Individual targets” datasets
Each repetition labeled as outlier in both metrics was automatically discarded. This
resulted in one or zero repetitions of any movement being considered outlier by both
metrics simultaneously, and being discarded this way. In the latter case (i.e. zero
outliers and, thus, no repetition automatically discarded), repetition 1 was discarded,
following the reasoning in II, thus, remaining always 3 repetitions for each movement.
b) “All targets” datasets
For these datasets, one complete cycle of movements towards the 18 targets was con-
sidered equivalent to “one repetition”. Therefore, discarding a repetition here means
to discard all the 18 movements.
The decision to discard or not one complete cycle of movements was based on the
number of movements, inside that cycle, which was considered outlier (by both met-
rics): the 3 cycles containing the less number of outliers were used.
4. The procedure in 3), a. and b., was repeated with forward and backward movements sepa-
rately
Finally, the EMG signals corresponding to the 3 chosen repetitions for each subject were
concatenated to build the datasets of muscle activity. In specific, datasets with All targets (D1 and
D2, in Table 6.2) included the 3 repetitions of all the 18 targets.
For direct analysis of EMG signals (amplitude analysis) and estimation of the motoneural
activity in the spinal cord (spinal maps extraction), it is necessary to have the signals of all subjects
with an equal number of time points, so that signals can be averaged and represented in the same
relative time (i.e. respect to the movement cycle – beginning to end). Therefore, for those two
analyses, EMG signals of each movement repetition included in each dataset were resampled on
the minimum number of samples (time points) across all movements executed by all subjects.
For the EMG factorization analysis (muscle synergies extraction), the non-resampled EMGs
were used.
To perform the kinematic assessment, movement trajectories of the respective 3 repetitions
selected by the exclusion of outliers were associated in datasets for each target and direction.
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Figure 6.5: Procedure to exclude outliers exemplified with forward (F), i.e. center-to-target, move-
ments of three healthy subjects (H03, H05, H08). The values of path length and movement du-
ration are plotted for each target, for repetitions 1 (purple), 2 (blue), 3 (red) and 4 (green). The
* correspond to the outliers identified across the 4 repetitions, independently for each of the two
metrics (path length; movement duration). Only repetitions considered an outlier for both metrics
(arrows) are discarded, in case of “individual targets” datasets, or counted, in case of “all targets”
datasets. In the latter case, the 3 repetitions for which a less number of targets was considered out-
lier (with both metrics) are chosen to include in the datasets (for example, for H05, repetitions 2,
3 and 4 are chosen, because repetition 1 is considered outlier in movements towards 2 targets, 10
and 15, while the other repetitions are never considered outliers or they are only in the movement
towards 1 target).
a
6.6.2 Task execution – Kinematic Analysis of the Movement
The position and velocity of the robot end-effector were considered to describe the movement
of the subject’ hand towards any target.
Once the exoskeleton automatically segments and identifies the kinematic data per movement,
these datasets did not need any setup or pre-processing, apart from selection of the movements
corresponding to the 3 repetitions chosen for each condition (from the exclusion of movement
outliers, explained in Section 6.6.1.1).
The execution of 3D reaching movements by healthy subjects was analyzed in terms of kine-
matic performance. To examine several features of the movement execution, kinematic metrics
were computed on the end-effector position and velocity matrices. The selected metrics to analyze
each feature are presented in Table 6.3.
In the literature, measures of accuracy are conventionally computed with respect to a straight
path, as it happens with metrics like trajectory straightness (Cirstea and Levin, 2000; Kahn et al.,
2006) or mean distance from theoretical path (Panarese et al., 2012; Pirondini et al., 2016; Colombo
et al., 2005). Oppositely, in this work, the trajectory performed by each healthy subject was ver-
ified to have a curvilinear path.Therefore, to measure movement accuracy, it was used a more
realistic path: the healthy path (averaged across healthy subjects). Then, mean distance from this
path was computed the same way as explained in Chapter 4.
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Table 6.3: Selected metrics to examine each feature of the healthy movement execution.
Movement feature Kinematic metrics
Temporal efficiency Movement Duration
Spatial efficiency Path Length
Accuracy Mean Distance from average-Healthy path (MDH)
Smoothness
Spectral Arc-Length (SAL),
Ratio of Mean acceleration with Peak acceleration (RMP)
Easiness Mean velocity
It must be noted that, for this biomechanical analysis, the kinematic metrics can be computed
for every single repetition of a movement without any problem of convergence (as it happens with
muscle synergies extraction algorithms). Therefore, any target reached by a patient during the
assessments can be compared with the respective one of the healthy group and, thus, with kine-
matics, movements were not organized in groups of targets.
6.6.3 Muscle activity – Amplitude analysis
Pre-processed and resampled EMG signals of all subjects were averaged across subjects to
obtain a global representation of the level of muscle activation of the healthy group for each target
and direction.
The RMS value of each EMG was computed, as a preliminary analysis, to provide a measure
of the signal amplitude and highlight possible differences between movements in the temporal
activation of each muscle. Given that EMG for all muscles were previously normalized by the
maximum, having the same amplitude range, then, the RMS values were averaged across muscles
to provide a global measure of the arm effort while executing the movements.
6.6.4 Muscle coordination – Extraction of muscle synergies
The muscle coordination of the healthy group while executing 3D point-to-point reaching
movements was described using muscle synergies.
Synergies were extracted for each dataset and their structure (muscle weight coefficients), as well
as the number of synergies, was compared across datasets to quantify the effects of movement
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conditions (different targets, and forward/backward movements) on muscle coordination.
6.6.4.1 The Extraction Algorithm
Synergies were extracted for each dataset of each subject, applying the Non-Negative Matrix
Factorization (NNMF) method to the EMG signals matrix. The nnmf MatLab function was used.
This method was selected because it is one of the most used methods to extract muscle synergies in
the literature (Pirondini et al., 2016; Coscia et al., 2014; Cheung et al., 2009; Santuz et al., 2017;
Steele et al., 2015b; Cheung et al., 2005) and it is the one providing easier interpretable results
given its constrain of non-negativity.
The Mult (Multiplicative Update Rules) and ALS (Alternating Least-Squares) algorithms,
variations of the NNMF detailed in Appendix A, were combined to improve the synergies ex-
traction. The Mult algorithm was only used to start the convergence (because it is more sensitive
to initial values, (Berry et al., 2007)), followed by the ALS algorithm to find the solution:
1. The weight (w) and time (h) coefficients were randomly initialized, and the EMG matrix
was given as input to the Mult algorithm, constraining the number of maximum iterations
to a very low value (5). The replicates (i.e., the number of times that the nnmf function
repeats the extraction, for outputting w and h for the lower-error repetition) was set to 50.9
2. Then, the computation of weight and time coefficients was repeated cyclically during 100
times, using the ALS algorithm, and the number of maximum iterations was set to a value
large enough to allow convergence (500). After each repetition, the output coefficients were
used as initial values to the following repetition, except for the first computation, in which
the initial values were the output of 1.
This algorithms combination increases the extraction accuracy (about 2%), and reduces the
computation time, especially when computing over large datasets (like D1 and D2).
6.6.4.2 Estimation of the Number of Synergies
After studying some of the methods detailed in 5.2., a searching procedure was exploited to
estimate the correct number of synergies, using the VAF (variance accounted for) as accuracy
metric, as in Pirondini et al. (2016); Cheung et al. (2012); Coscia et al. (2014); Clark et al. (2010).
The threshold for a good accuracy was defined as 95%, as in previous investigation (Pirondini
et al., 2016; Sadaka-Stephan et al., 2015). This method was selected by its good balance between
simplicity and reliability: it is very easy to compute and the results obtained were in fair agreement
with the related literature. 10
9This replication is necessary because w and h extracted each time may represent a local extremum of the error
surface. (Cheung et al., 2012)
10As mentioned in 5.2, the number of muscle synergies during point-to-point reaching movements has been estimated
before to range from 4 to 7 in healthy individuals. By using the VAF, the estimated number of synergies (see Chapter
7) is between this range. However, tests on the recorded data using, for example, the cumulative variance instead of the
VAF, resulted in a number of synergies ranging from 5 to 8.
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The searching procedure was done by extracting 3 to 7 synergies, using the algorithm de-
scribed in 6.6.4.1, and calculating, for each extraction, the VAF – see Equation 6.1. The number
of synergies retained was the minimum leading to a VAF higher than the threshold.
VAF = 1− ∑
M
n=1∑Tt=1(Doriginal(n, t)−Dreconstr(n, t))2
∑Mn=1∑Tt=1(Doriginal(n, t))2
(6.1)
where M=number of muscles,T=number of time-points, Doriginal is the original matrix of EMG
signals,and Dreconstr is the reconstructed matrix of EMG signals, by multiplcation of the muscle
weights and time activation coefficients of each synergy, and sum for all synergies.
6.6.4.3 Quantification of effects of movement conditions on the number of
synergies
To quantify the effects of the target and the movement direction on the number of synergies,
only the datasets D3 to D38 (i.e. datasets with movements regarding a single target and a single
direction) were compared.
As so, for each dataset, the estimated number of synergies of the 8 healthy subjects in that con-
dition were pooled together. This resulted in 36 distributions (corresponding to the 36 conditions),
each with 8 values. Then, the statistical difference across conditions was assessed as explained in
Section 6.6.4.7.
The results of this and the previous section were considered to determine the number of syn-
ergies to be used in the next steps.
6.6.4.4 Synergies Clustering
Muscle synergies extracted from all datasets of all subjects were ordered by their vector of
weigh coefficients, maximizing their similarity with a set of reference synergies.
Similarity was assessed by the normalized dot product (DOT) (Pirondini et al., 2016; Che-
ung et al., 2009; Tropea et al., 2013). The procedure of ordering based on the maximization of
similarity was achieved by:
1. computing the DOT between the set of synergies to be ordered and the synergies of the
reference set (resulting in a n-by-n matrix of DOT values, being n the number of synergies
previously estimated – see Section 7.1.4);
2. matching a pair of synergies having the maximum DOT of all DOTs in the matrix computed
in 1.;
3. eliminating from the matrix the matched synergies with the highest DOTs;
4. repeating the steps 2. and 3. until all synergies are matched with one of the reference
synergies.
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The set of reference synergies was generated with the set of 4 synergies extracted from dataset
D1 of all subjects. First, the synergies of all subjects were categorized into 4 clusters and, then,
the synergies of each cluster were averaged.
The chosen clustering method was a hierarchical procedure to minimize the Minkowski dis-
tance between the weight coefficient vectors of the synergies within each cluster (Pirondini et al.,
2016; Cheung et al., 2009). For that, MatLab statistics-toolbox functions were used: pdist (to
compute all the Minkowski distances, using the exponent P equal to 3), linkage (to compute a tree
of hierarchical clusters, based on the matrix of distances, and using the Ward method), and cluster
(to construct the clusters from the agglomerative hierarchical cluster tree).
6.6.4.5 Quantification of effects of movement conditions on the synergies’
structure
To quantify the effects of the reaching point and the movement direction on the synergies’
structure, only the datasets D3 to D38 (i.e. datasets with movements regarding a single target and
a single direction) were compared.
Thus, for each synergy (S1, S2, S3, S4) and each muscle, the corresponding weight coefficients
obtained for the 8 healthy subjects were pooled together, separately for each dataset. These 36
distributions were tested to determine if they were significantly different (see Section 6.6.4.7).
Nevertheless, the conclusion for each synergy is derived from the 15 statistical tests (15 weight
coefficients), i.e., one can only conclude the synergy’ structure is the same across conditions if,
for all the 15 muscle weights, no differences are found across conditions. Therefore, the multi-
comparison was done with the Bonferroni correction, to compensate the fact that, with multiple
tests (multiple muscle weights), the likelihood of incorrectly rejecting a null hypothesis (equal
synergy structure across conditions) increases (i.e. the probability of making a Type I error in-
creases).
6.6.4.6 Quantification of effects of movement conditions on inter-subject
similarity of the synergies’ structure
The normalized dot product (DOT) between the synergies’ vector of weight coefficients was
adopted as measure of similarity of the synergies structure. Thus, it was used to assess the robust-
ness of the synergies’ structure for each condition and to verify if the movement condition affected
this robustness.
As so, for each synergy (S1, S2, S3, S4), the DOT was computed between subjects in the same
movement condition, resulting in a distribution of 28 values (combinations of 8 subjects in pairs).
Then, the 36 distributions for each synergy were assessed concerning their statistical difference.
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6.6.4.7 Statistics
To determine the statistical significance of any difference across movement conditions (targets
and directions), the respective data from all subjects (being it the synergies weight coefficients, or
the number of synergies, etc.) was pooled together (resulting in a distribution of values for any
condition), and the hypothesis that data of all the conditions belong to the same population was
tested. A p-value of 0.05 was considered as confidence level.
Therefore, to decide whether to use the 2-Way ANOVA (ANalysis Of Variance) test or the
nonparametric Friedman test with 2 factors (being them target and direction), first, two hypothesis
were assessed (Rinaldi and Monaco, 2013):
1. The hypothesis of normal distribution for all the conditions was tested by the One-sample
Kolmogorov-Smirnov test (using the MatLab function kstest).
2. The homogeneity of variance across all the distributions was assessed by the Levene’s test
(using the MatLab function vartestn 11 ).
ANOVA is relatively robust with respect to violations of the normality assumption, but it is
more sensitive to variance inequality (Kirk, 1982). Thus, even if the conditions were determined
not Gaussian distributed, the possibility to assess them using the 2-Way ANOVA was considered,
depending on the results of variance homogeneity. This was done because, unlike two-way anal-
ysis of variance, Friedman’s test does not treat the two factors symmetrically and it does not test
for an interaction between them. So, to have the information concerning the interaction between
targets and directions, results of the 2-way ANOVA were obtained and, for the above-mentioned
situation, they were confirmed by performing also the Friedman test. (Rinaldi and Monaco, 2013)
In addition, a post-doc analysis was performed, using the MatLab multcompare function, to
determine which pairs of targets and directions were significantly different.
6.6.5 Estimation of Motoneural Activity in the Spinal Cord
For the upper limb muscles considered in the thesis, the reported location of the innervating
motoneurons (MN) is in the C2 to T1 segments of the spinal cord. (Kandel et al., 2000; Kendall
et al., 1993) Accordingly, the motoneural activity of these spinal segments was estimated by a
weighted summation of the EMG signals of all muscles innervated by the respective segment,
using the Equation 5.2 introduced in Chapter 5.
Such estimation was computed for each movement condition (target and direction) using the
pre-processed, resampled EMG signals averaged across the 3 repetitions included in the respective
dataset.
Weight coefficients reported in Kendall chart (Kendall et al., 1993) were assumed for each
muscle, as in previous studies with the upper limb (Pirondini et al., 2016; MacLellan et al., 2012).
Muscles innervated by spinal segments C2 to T1 are indicated in Table 6.4
11The Levene’s test is available in 3 options (‘LeveneQuadratic’, ‘LeveneAbsolute’ and ‘OBrien’ for the ‘TestType’
parameter). The results with the 3 options were considered for the next steps.
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Table 6.4: Upper limb muscles innervated by each spinal cord segment. X indicates the spinal cord
segment (row) contributing to the activity of the muscle (column). TRAPS – trapezius superior
(upper fibers); TRAPM – trapezius medialis (middle fibers); DANT – deltoid anterior; DMED
– deltoid medialis; DPOS – deltoid posterior; PEC – pectoralis major; LAT – latissimus dorsi;
INFRA – infraspinatus; RHO – rhomboid; BICS –bicep short head; BICL – bicep long head;
BRA – brachialis; BRAD – brachioradialis; TRILAT – triceps lateralis; TRILONG – triceps long
head; PRO – pronator; C2-C8 - cervical segments 2 to 8 of the spinal cord; T1 - thoracic segment
1 of the spinal cord.
TRAPS TRAPM DANT DMED DPOS PEC LAT INFRA RHO BICS BICL BRAD TRILAT TRILONG PRO
C2 X X
C3 X X
C4 X X X X
C5 X X X X X X X X X
C6 X X X X X X X X X X X X
C7 X X X X X
C8 X X X
T1 X X
The spatiotemporal distribution of the activity in the spinal cord while executing forward/
backward movements towards each target was represented for each subject and for the average
across subjects. To obtain a continuous and smoothed map (illustrating the spatial continuity
in the spinal cord), a filled contour plot was used (MatLab function contourf ), which computes
isolines from the matrix of spinal activity in the 8 segments and fills the area between the isolines
using a map of constant colors.(Ivanenko et al., 2008)
6.6.5.1 Quantification of effects of movement condition on inter-subject sim-
ilarity of the spinal maps
To verify the spinal maps similarity across subjects, the two-dimensional (2D) correlation
coefficient (see Equation 6.2) was computed (MatLab function corr2) between the averaged spinal
map and each subject’s spinal map, for every movement condition. This measure is the 2D-
equivalent of Pearson’s correlation coefficient, being adequate to compare two images, like the
spinal maps, in which the color is a representation of the signal scale. R ranges from -1 to 1, as
the Pearson’s coefficient: it is 1 when images are completely identical; 0 if images are completely
uncorrelated; and -1 if one image is the negative of the other. (Monaco et al., 2010)
R=
∑ni=1(xi− x¯).(yi− y¯)√
∑ni=1(xi− x¯)2.
√
∑ni=1(yi− y¯)2
=
cov(x,y)
σx.σy
(6.2)
where xi is the intensity of the ith pixel of the first image, yi is the intensity of the ith pixel of
the second image, and x¯ and y¯ are the mean intensities of the first and second images, respectively.
cov(x,y) is the covariance between image x and y, σx is the standard deviation of image x and σy is
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the standard deviation of image y.
The statistical significance of the effects of movement condition on the spinal maps similarity
across subjects was tested. The same reasoning explained in Section 6.6.4.1 of the synergies
analysis was followed: before any assessment with 2-Way ANOVA or Friedman test, the normality
assumption and variance homogeneity were verified.
6.6.5.2 Quantification of effects of movement condition on the shape and
magnitude of the spinal maps
To compare the spinal maps across movement conditions, two measures were considered:
1. The covariance between spinal maps of two conditions: this is a measure of the joint vari-
ability of two variables (in these case, 2D variables, the spinal maps). Two spinal maps
covariate if the increases/decreases of the motoneural activity occur for both maps, in the
same spinal zones, with a same magnitude. (Rice, 2006)
2. The 2D correlation coefficient between spinal maps of two conditions: this is a measure of
dependence of two variables; explicit in 6.2, it is equivalent to the covariance between maps
normalized by the standard deviation of both maps; two spinal maps are correlated if the
increases/decreases of the spinal activity occur for both maps, in the same spinal zones, but
not necessarily with a same magnitude. (Rice, 2006)
Therefore, covariance was used to assess the similarity of the shape of the spinal maps, and
covariance was used to assess the similarity of the level of activity.
To search for trends in the variation of the magnitude and shape of the spinal maps as a function
of the reaching point, each target was associated with its distance to 3 references (target 1, T1;
target 7, T7; target 13, T13), independently, and the covariance and correlation were computed
between the spinal map for that target and the spinal map of each reference. Two distance-metrics
were tested: the Euclidean distance and the “one-axis” distance. The former considers the relative
position of the target in 3 axes, while the latter one considers the position in 1 axis (the up-down
axis, when comparing with reference T1; the left-right axis, with reference T7; the distant-close
axis, with reference T13). See the example with target 16 in Figure 6.6 . This procedure was
repeated with forward and backward movements, to analyze trends in both directions.
Targets 1, 7 and 13 were taken as references because they are corners in the 3 main axes of the
sphere, relative to the subjects position.
The relative shape (correlation) and magnitude (covariance) of the spinal maps as a linear func-
tion of the relative position of the target (Euclidean/one-axis distance) was tested: the hypothesis
that these variables are not linearly correlated (linear correlation, ρ = 0) was assessed (MatLab
function corr, [ρ , p-value] = corr).
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Figure 6.6: Targets 1, 7 and 13 were taken as reference to quantify the variation of the shape and
magnitude of the spinal maps as a function of the target position. The Euclidean distance (in pink)
and the distance in one axis (in gold) is exemplified with target 16, for the up-down axis (left), the
left-right axis (middle), and the distant-close axis (right).
6.6.6 Grouping Targets
Targets were arranged in 4 groups, as shown in Figure 6.7.: group 1 includes targets 1, 2, 8,
9 and 14; group 2 includes targets 4, 5, 6, 11 and 12; group 3 includes targets 7, 18, 13 and 17;
and group 4 includes targets 3, 16, 10 and 15. Then, EMG signals of each target dataset were
concatenated by group, resulting in new, larger datasets.
Figure 6.7: Targets arranged in 4 groups: targets included in group 1 are marked in orange; group
2, in pink; group 3, in grey; group 4, in yellow.
Muscle synergies were extracted from the new 4 datasets of each subject and the number of
synergies was estimated, following the same methods of Section 6.6.4.
Spinal maps were computed as well for each subject and averaged across subjects for each
group of targets. Since spinal maps are linear functions of the EMG signals, basically, the spinal
map of the group is the average between the spinal maps corresponding to the targets included in
the group.
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6.7 Analysis of the stroke group
6.7.1 Datasets formation
Post-stroke patients easily get tired and are not able to repeat the movements as many times
as healthy subjects, due to their disability. As so, not as many movement repetitions as in the
case of healthy subjects are available to factorize the muscle activity of each individual movement
condition.
Therefore, EMG datasets were built in agreement with the latter conclusions of the healthy
group, organizing targets in the same way, for every recording session (assessment sessions) of
each patient: pre-processed EMGs corresponding to forward movements towards targets 1, 2, 8,
9 and 14 were concatenated in group 1; the ones towards targets 7, 13, 17 and 18 in group 2; the
ones towards targets 3, 10, 15 and 16 in group 3; and, finally, targets 4, 5, 6, 11 and 12 in group 4.
This was repeated with backward movements.
Although, theoretically, groups are not balanced in number of targets included, in practical,
they were balanced, because not all the targets are trained by the patient, especially in the first
assessments (being this the reason for the need to define a methodology and data organization to
analyze patients’ muscular data).
6.7.1.1 Exclusion of bad recordings
During the experiments, the uncoordinated behavior of some patients made it impossible to
use some of the EMG recordings. In these acquisitions, the electromyographic signals could not
measure the muscle activity due to the superimposition of high voltage noise impossible to be
filtered (see Appendix B). These corrupted signals were manually detected and excluded from the
analysis, before concatenating the EMGs in datasets.
When, for exceptional cases, more than three repetitions were available for some movement,
the first three were selected to proceed with the analysis.
kinematic data corresponding to the selected movement repetitions was organized in separate
datasets for each target and direction.
6.7.2 Task execution – Kinematic Analysis of the Movement
The position and velocity of the robot end-effector were considered to describe the movement
of the patient’s hand towards any target.
Once the exoskeleton automatically segments and identifies the kinematic data per movement,
these datasets did not need any setup or pre-processing, apart from exclusion of movements with-
out a correct EMG recording, as explained in the previous section.
The motor ability of post-stroke patients while performing 3D point-to-point reaching move-
ments was assessed by examination of several features of the movement execution similar to
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(Panarese et al., 2012). For each of these features, kinematic metrics were computed on the end-
effector position and velocity matrices. One metric (in addition to the same computed for healthy
subjects) was computed to evaluate the patient’s ability to accomplish the task by himself (i.e.
his/her independence on the robotic assistance). All of them are presented in Table 6.5.
Table 6.5: Selected metrics to examine each feature of the stroke patients’ movement execution.
Movement feature Kinematic metrics
Temporal efficiency Movement Duration
Spatial efficiency Path Length
Accuracy Mean distance to the average-Healthy path (MDH)
Smoothness
Spectral Arc-Length (SAL),
Ratio of Mean acceleration with Peak acceleration (RMP)
Easiness Mean velocity
Task accomplishment Assisted-distance
The measure of accuracy was computed by taking the mean value of the Euclidean distance to
the healthy path (average path across healthy subjects to reach a given target).
The assisted-distance corresponds to the length of the path robotically assisted, if there is
robotic assistance.
The other metrics were computed for assisted and non-assisted movements, but considering
only the trajectory performed by the patient.
6.7.3 Muscle coordination – Extraction of muscle synergies
Following the same methods as with the healthy group (see Sections 6.6.4.1. and 6.6.4.2),
muscle synergies were extracted from EMG datasets.
All patients’ synergies were ordered by their vector of weigh coefficients, maximizing their
similarity (normalized dot product) with a set of synergies obtained from the healthy subjects: for
each group of targets of the patient’s datasets, the synergies extracted from all healthy subjects for
that same group were averaged across subjects and used as reference.
This procedure was considered even if the estimated number of synergies for the patient was
lower or higher than the healthy number (i.e. 4 muscle synergies).
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6.7.3.1 Quantification of post-stroke modifications on the synergies struc-
ture and number for different movement conditions
The contribution of each synergy to the original EMG data was quantified using a “modified-
VAF” (modified version of the Variance Accounted For), i.e. the fraction of the integral of the data
reconstructed by that synergy over the integral of the original data (see Equation 6.3).
vn = modi f ied_VAFSn =
∑Mm=1∑Tt=1(datareconstructed)
∑Mm=1∑Tt=1(dataoriginal)
=
∑Mm=1∑Tt=1(HSn×WSn)
∑Mm=1∑Tt=1(dataoriginal)
(6.3)
where Sn is the synergy n, M is the number of muscles, T is the number of time points of
the original EMG signals (matrix dataoriginal), HSn) and WSn) are the time coefficients and the
muscle weight coefficients vectors of Sn, respectively; n is the synergy number (1,2,3 or 4).
To compare the contribution of each extracted synergy to the patient’s EMG signals with the
contribution of the corresponding synergy to the healthy subjects’ signals, this measure was ob-
tained for all subjects of both groups and a metric of similarity was defined as presented in Equa-
tion 6.4. This metric (vnsimilarity) represents the absolute similarity between the contribution of the
synergy n for the patient (vnpatient) and for healthy subjects (vnhealthy) and is inherently dependent
on the number of synergies12. It was computed between the patient and each healthy subject, and
averaged across healthy subjects, for every patient’s synergy matched with one of the 4 healthy
synergies.
vnsimilarity = 1−|vnhealthy− vnpatient | (6.4)
To compare the structure of each synergy extracted for the patient with the structure of the
corresponding synergy extracted for healthy subjects, the Pearson’s correlation coefficient (cn)
was used as measure of structure similarity. It was also computed between the patient and each
healthy subject, and averaged across subjects, for every patient’s synergy matched with one of the
4 healthy synergies.
These measures were obtained for all the EMG datasets (group 1 to 4, forward and backward
movements), to verify the modifications on the muscle synergies following stroke for different
movement conditions.
12For example, if 5 synergies are necessary to account for the patient’s dataoriginal variability, then, the modi f iedVAF
of the patient’s 4 synergies corresponding to the 4 healthy synergies will be lower than for healthy subjects, because
part of the dataoriginal results from the contribution of the 5th synergy.
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6.7.4 Estimation of Motoneural Activity in the Spinal Cord
The patients motoneural activity in the C2 to T1 segments of the spinal cord (the reported
location for the upper limb innervation (Kandel et al., 2000; Kendall et al., 1993)) was estimated
by a weighted summation of the EMGs of the respective innervated muscles (see Table 6.4 in
Section 6.6.5). This was done for the 4 groups of targets in both directions of the movement, using
the pre-processed, resampled EMGs.
The resulting spinal maps were plotted using the MatLab function contour, as explained in
Section 6.6.5.
6.7.4.1 Quantification of post-stroke modifications on the shape and mag-
nitude of the spinal maps for different movement conditions
To compare the spinal maps of the patient with the healthy ones, and verify the post-stroke
modifications for different movement conditions, the same measures used with the healthy group
were adopted: correlation and covariance between the subjects’ spinal maps (read the explanation
in Section 6.6.5.2).
6.8 The Neurobiomechanical State and Motor Performance of Stroke
patients during robot-aided rehabilitation
To assess the progress of the patient neuromuscular state (throughout the treatment) and compare
it with the respective evolution of the motor performance, in a more concise way, the two mea-
sures of modifications induced by stroke in muscle synergies, were combined in one metric (see
Equation 6.5). Basically, for each dataset (each group of targets), the measures of similarity (with
healthy persons) in number (vn) and structure (cn) of each synergy n (as defined in Section 6.7.3.1)
were summed and divided by n (the number of healthy synergies, i.e. 4). This was possible to do
because vn and cn are in the same order of magnitude (absolute values range from 0 to 1) and, thus,
the minimum possible value for their average is -0.5 13 (complete dissimilarity with the healthy
state) and the maximum is 1 (complete similarity with the healthy state).
metricsynergies =
1
n
.avg(c1,v1)+ ...+
1
n
.avg(cn,vn) (6.5)
13 The minimum value occurs with a correlation of -1 and a modified-VAF of 0, being equal to (-1+0)/2=-0.5
Note that it is an assymptote of the metric, because the minimum of the modified-VAF, zero, is never reached (i.e.,
zero is an assymptote of the modified-VAF), otherwise the respective synergy would not exist.
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It was not possible to join the two metrics related to spinal maps because of their very different
ranges. Thus, the 2D-correlation and covariance were evaluated separately.
Concerning biomechanics, each kinematic metric was evaluated individually regarding its abil-
ity to capture changes in the motor performance of the patient.
The FMUE (Fugl-Meyer for the Upper Extremity) score obtained by the patient in each ses-
sion of assessment was used to generally indicate his/her motor ability. All metrics were, then,
compared with that clinical score, computing the correlation between the two variables.
Additionally, to verify if the improvement trend reflected by the metrics was similar to the
improvement trend reported by the FMUE, the correlation between the kinematic metrics variation
and the FMUE variation was calculated for the kinematic metrics more correlated with that clinical
scale. This variation was taken from one assessment to the following one. The reasoning behind
this is based on the estimation of motor improvement by the personalization algorithm: parameters
of this algorithm (i.e. the included metrics) must have a clear trend of improvement to allow the
convergence of the algorithm to a plateau.
Finally, bootstrap method was applied to measure the uncertainty of the estimated correlation
between the metrics and FMUE. This was done due to the reduced number of data representing
the stroke population available for the thesis work.
Bootstrapping is a resampling technique which repeatedly chooses random samples from the
input data (in this case, the set of metric values and respective FMUE scores) with replacement,
and estimates the parameter of interest (the correlation). From these calculation, the confidence
interval for the parameter is estimated.
The method was used to resample the patients’ data in 1000 different data sets, for which the
correlation was estimated. Then, the histogram of the correlation across all bootstrap samples was
obtained to verify the distribution of the correlation coefficient, and the standard deviation of the
estimated correlation was computed.
The correlation with the FMUE scores and results of bootstrapping were used to validate
metrics as good candidates for parameters of the personalization algorithm.
Chapter 7
Results
7.1 Analysis of the control group (healthy subjects)
7.1.1 Movements’ outliers
For each subject and each target, from the first to the last repetition, the movement duration
tends to decrease; this decrease is higher from the first to the second repetition (-1.8s±6.0s, av-
erage across subjects and targets) than between the other repetitions (-0.18±1.9s, from the 2nd
to the 3rd repetition, -0.53±1.5s, from the 3rd to the 4th repetition). This seems to indicate that,
during repetition 1, the subjects are adapting to the experiment. However, to define a set of control
synergies (able to generally represent the healthy motor coordination), this learning phenomenon
is undesirable and, thus, should not be included in the datasets. Figure 7.1 reports examples of
trajectories performed by two healthy subjects towards target 1, where it is possible to see that, in
case of H01, all the repetitions of that movement follow a similar path, while, in case of H02, the
first repetition was executed with a very complex path and took much longer to reach the target
(40s) than the other repetitions (between 2 and 3s).
7.1.2 Task execution – Kinematic Analysis of the Movement
The time taken by healthy subjects to execute the reaching movements is dependent on the
target and, in general, they need more time in the forward than in the backward movement. The
same can be observed with the length of the path they follow. This indicates that both temporal and
spatial efficiency are influenced by the movement condition. Find in Appendix D the illustration
of results obtained for the kinematic metrics in healthy subjects.
Concerning the easiness in reaching (mean velocity), it is more consistent across targets and
directions, as well as the movement accuracy (mean distance to healthy path), apart from some
exceptions like targets 12 and 13.
Moreover, the average path across subjects was found more curvilinear than the typically as-
sumed straight path – see Figure 7.2.
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Figure 7.1: Trajectories of the forward movement executed by healthy subjects H01 (left) and
H02 (right) towards target 1, during the repetitions 1 (purple), 2 (blue), 3 (red) and 4 (green) of
that movement. The path of the 4 repetitions are similar in case of subject H01 (also with similar
movement durations: 2s, 3s, 1s, and 1s, respectively), but are very different in case of subject H02
(with movement durations of 40s, 2s, 3s, and 2s, respectively). Note that the axes limits of the
3D plots were selected differently for H01 and H02 to show the best perspective to observe the
movement path.
Figure 7.2: Example of the path followed by healthy subjects (in average) to reach targets 5, 8,
4 and 18, forward (in blue) and backward (in red). The sphere is represented in yellow and it is
rotated so that a better perspective of the path is observed. (“O” identifies the center of the sphere)
a
Movement smoothness of the upper limb has been characterized by several different measures
in the literature (Nordin et al., 2014). In this work, the Spectral Arc-Length (SAL) and the Ratio
between the Mean Acceleration and the Peak Acceleration (RMP) were adopted. Surprisingly, the
first (SAL) is more dependent on the target than the RMP. A higher SAL (i.e. a value closer to zero)
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corresponds to an increased smoothness, thus, forward movements seem to be less smooth than
backward movements, according to this measure. Indeed, a higher RMP also indicates increased
smoothness and, generally, this metric is higher for backward movements, nevertheless it does not
happen with all targets.
7.1.3 Muscular activity– Amplitude analysis
The averaged muscular activity across healthy subjects is presented in Figure 7.3, for each tar-
get and muscle, considering the forward and backward movements separately. The corresponding
RMS values for each target is presented in Figure 7.4, for all muscles and averaged across muscles.
The average RMS across muscles can be considered a measure of the muscular effort yielded by
the subjects to execute the movement towards each target.
Note that x-axis of graphs in Figure 7.3 indicates a relative time (0% to 100%) because the
signal of each subject was resampled by the minimum number of samples across subjects (see
section 6.4.2 of Chapter Methods) to have signals of all subjects with the same length.
From the EMG envelopes (Figure 7.3), it is visible that muscle activity is more similar across
targets and more monotone while executing the backward movement than while executing the
forward movement.
In general, in forward direction, the most active muscles for each target show an increasing
activity with the proximity to the target. Oppositely, although muscle activity is generally more
monotone in backward direction, there is a peak of activity at the beginning of the movement for
most targets and muscles, in this direction.
Additionally, activity of all muscles is generally higher during forward movements towards
targets at the top of the sphere, like 1, 2, 8, 9, and 14. More specifically, the shoulder elevators
(TRAPS, TRAPM) and abductors/rotators (DANT, DMED), as well as the LAT muscle (postural
back muscle and rotator of the shoulder) are preferentially recruited in these upper movements.
Moreover, the activity of Latissimus muscle and the anterior and medial heads of the Deltoid
muscle is also increasing when reaching targets 13, 17, and 18, which are targets more distant
from the subject. Another interesting result is the prevalent activity of the PEC (adductor and
rotator of the shoulder/arm) in forward movements toward targets in the most-left side of the
sphere (6, 7, 8).
Concerning the signals amplitude, no other relevant pattern seems to be highlighted. However,
a more objective information can be taken from the RMS values, specially from the average values
across muscles (a general representation of the muscular effort yielded by the subjects to execute
the movement for each target – in black, Figure 7.4): a patterned variation of the RMS occurs
across targets in forward movements – from the bottom to the top of the sphere, as well as from
near to distant targets, the RMS value tends to increase.
As expected from the EMG envelopes, in backward movements the RMS does not reveal any
particular trend.
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Figure 7.3: EMG envelopes averaged across healthy subjects (in black) while reaching targets 1 to
18, in forward direction (upper graph) and backward direction (lower graph). The envelopes for
each subject are represented in grey. The y-axis of each EMG indicates the normalized amplitude
of the signal (so, from 0 to 1). In the x-axis, the relative movement time (0% to 100% - beginning
to end) is indicated for each movement (i.e. for each target), and the target corresponding to the
movement is also indicated (1 to 18).
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Figure 7.4: Averaged (across subjects) RMS values of the EMG envelope of each muscle (in grey)
and averaged across muscles (in black) – global RMS, for targets 1 to 18, in forward (left) and
backward direction (right). Given the patterned variation of the RMS across targets, mainly in
forward direction, the targets associated to higher RMS values are highlighted in red, and the ones
associated to lower RMS values are marked in blue.
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7.1.4 Muscle coordination – Extraction of muscle synergies
7.1.4.1 Four Muscle Synergies explain Movements towards/backwards Dif-
ferent Targets
Using a searching procedure to estimate the correct number of synergies explaining the in-
formative variance of each dataset, 4 synergies were found to account for, at least, 95% of the
variability of any movement (forward/backward, target 1 to 18) – see Table 7.1. Exceptionally,
for target 2, backwards, the average is slightly higher, 4.6 synergies. Nevertheless, in datasets
containing all the targets, a higher number of synergies (approximately 6) is necessary to account
for the variability included in such data. This last result is a preliminary indication that, although
a movement in any condition can be explained by 4 modules of muscle coordination (4 muscle
synergies), their structure seems to differ across targets, being shared (or very similar) between
some targets.
Note that synergies were extracted for each healthy subject, from 3 to 7, and the number of
synergies was estimated for each subject independently (using the VAF ≥ 0.95 criterion, as ex-
plained in section 6.6.4.2). Therefore, results in Table 7.1 are the average (and standard deviation)
across healthy subjects. From the low standard deviation values, these results can be considered a
good representation of the behavior of the healthy group.
Table 7.1: Estimated number of synergies for datasets D1 to D38: average ± standard-deviation,
across healthy subjects. Estimation criterion: VAF ≥ 0.95. Tn stands for target n; F stands for
forward movement; B stands for backward movement.
[All targets] T1 T2 T3 T4 T5 T6
F 5.5 ± 0.9 3.3 ± 0.5 3.6 ± 0.7 3.9 ± 0.8 4.4 ± 0.7 4.3 ± 0.7 4.1 ± 0.8
B 5.5 ± 1.3 4.3 ± 1.0 4.6 ± 1.1 4.4 ± 0.7 4.0 ± 1.1 3.9 ± 0.8 3.9 ± 0.8
T7 T8 T9 T10 T11 T12
F 3.8 ± 1.0 3.5 ± 0.5 3.5 ± 0.8 4.3 ± 1.4 4.4 ± 1.1 4.1 ± 0.6
B 4.0 ± 0.5 4.3 ± 1.0 4.5 ± 1.1 4.1 ± 0.8 4.3 ± 0.9 3.5 ± 0.8
aaaaaa
T13 T14 T15 T16 T17 T18
F 3.8 ± 0.9 3.5 ± 0.5 4.4 ± 0.9 4.3 ± 0.9 3.8 ± 0.7 3.9 ± 1.0
B 3.9 ± 0.8 4.1 ± 1.0 4.1 ± 0.8 4.0 ± 0.8 4.1 ± 0.8 4.3 ± 0.9
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Although the number of synergies is not Gaussian distributed for any movement condition
(p<1e− 7, One-sample Kolmogorov-Smirnov test), we cannot reject the hypothesis of variance
homogeneity (p= 0.103, Levene’s test). Therefore, distributions of the number of synergies were
assessed by the 2-Way ANOVA and results were confirmed by the Friedman test with 2 factors.
See results in Table 7.2.
In fact, the two tests agree that we cannot reject the null hypothesis, both for targets and
directions, and, thus, differences on the number of synergies across movement conditions are not
significant (p>0.05). Moreover, we cannot reject the hypothesis that targets and directions are
independent factors (i.e. there is no significant interaction between them, p= 0.102). This means
that, for example, we can consider forward or backward movements and the above-mentioned
result is the same (targets do not affect the number of synergies significantly), and vice-versa.
This confirms that 4 synergies explain well any individual condition of the movement (i.e. one
target, one direction), so it was decided to use the set of 4 synergies extracted for each dataset in
the next steps of the analysis.
Table 7.2: Statistical difference across movement conditions – results of the 2-Way ANOVA and
Friedman test.
direction p-value, ANOVA2 0.050
p-value, Friedman 0.062
target p-value, ANOVA2 0.887
p-value, Friedman 0.894
factors interaction p-value, ANOVA2 0.102
a
7.1.4.2 Muscle Synergies Structure
The Reference Synergies
As explained in Section 6.6.4.4 of Chapter Methods, muscle synergies extracted from all
datasets of all subjects were ordered by their vector of weigh coefficients, maximizing their sim-
ilarity with a set of reference synergies obtained with dataset D1. The weights profile of these
synergies is shown in Figure 7.5.
The choice to use as reference the set of 4 synergies extracted from dataset D1 instead of 6
was done in accordance with the results presented in the previous section (4 synergies explain a
movement of any individual condition) and considering that D1 contains the variability of all the
other datasets. This means that, although 4 synergies do not explain all the variability of D1, they
represent the shared organization across all conditions to be compared..
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Figure 7.5: Structure of the reference synergies used to order the synergies extracted from all
subjects. Each bar represents the weight coefficient of a muscle. S1, S2, S3 and S4 denote synergy
1, 2, 3 and 4, respectively. In the x-axis, the name of the muscles is indicated: TRAPS – trapezius
superior; TRAPM – trapezius medialis; DANT – deltoid anterior; DMED – deltoid medialis;
DPOS – deltoid posterior; PEC – pectoralis major; LAT – latissimus dorsi; INFRA – infraspinatus;
RHO – rhomboid; BICS –bicep short head; BICL – bicep long head; BRA – brachialis; BRAD –
brachioradialis; TRILAT – triceps lateralis; TRILONG – triceps long head; PRO – pronator.
a
Muscles Synergies Structure by Target and Direction
The weights profile of muscle synergies is exemplified in Figure 7.6 using the results regarding
Target 1, 5, 10 and 13, forward and backward movements. These targets are reported as example,
because they are corners of the main directions (close-distant, and up-down, with respect to the
subject) highlighted by results of Section 7.1.3 and of the next sections.
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Figure 7.6: Weight coefficients of synergies extracted for forward (left) and backward (right)
movements, for targets 1, 5, 10 and 13, respectively from the top to the bottom of the figure. Each
blue bar represents the weight coefficient of one muscle, for one of the 8 healthy subjects. Thus,
8 bars are shown for each muscle. The average value across subjects is represented in yellow for
each weight coefficient.
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Synergies underlying Forward and Backward Movements have a Similar Structure, but
it is Modified from Target to target
For all muscles of all synergies, the normality test showed that coefficients are not Gaussian
distributed (p<0.05). The Levene’s test revealed that, for a major part of the weight coefficients
of all synergies (38 in 96 – see Figure 7.7), the distributions are not characterized by equal vari-
ance. Thus, Friedman test with 2 factors should be used, at least for those cases, to determine
if the weight coefficients are significantly different across movement conditions. However, only
ANOVA assesses the interaction between factors. Thus, both tests were performed and compared.
Figure 7.7: Illustration of the results obtained in Levene’s test: each cell indicates the result of the
test for each weight coefficient (representing one muscle, in the x-axis) of each synergy (1 to 4,
indicated in the y-axis). Yellow cells correspond to distributions of weight coefficient values with
unequal variance. Blue cells correspond to distributions of weight coefficient values characterized
by equal variance.
a
Results of the 2-Way ANOVA and Friedman tests agreed for all muscle weights. In Figures 7.8
and 7.9, the weight coefficients significantly different (p<0.05) are shown for the 2 factors, targets
and directions. More specifically, results of the multi-comparison across 18 targets are detailed
inside the cell concerning each weight coefficient.
Figure 7.8: Results of the statistical test to determine the effects of movement direction on the
synergies structure. Muscle weight coefficients (columns) of synergies S1 to S4 (rows) which
significantly differ (p<0.05) between forward and backward movements are highlighted in yellow.
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Figure 7.9: Results of the statistical test to determine the effects of the target on the synergies
structure. Muscle weight coefficients (columns) of synergies S1 to S4 (rows) which significantly
differ (p<0.05) across targets are highlighted in yellow. Results of the multi-comparison are spec-
ified for each weight coefficient, indicating the pairs of targets which have a significantly different
weight coefficient.
Results in Figure 7.8 indicate that synergies’ structure is not identical, in case of S1, S2 and
S3, but it is very similar, because only one weight coefficient is significantly different between
forward and backward movements. Therefore, the movement direction seems to have almost no
effects on the profile of muscle weights.
Oppositely, results in Figure 7.9 demonstrate that synergies structure is considerably affected
by the target location. Indeed, several weight coefficients (most of them for synergies 1 to 3)
are significantly different for a large number of pairs of targets.Moreover, such differences seem
to agree with results of Section 7.1.3, occurring in a patterned way in the up-down and close-
distant axes. In fact, Figure 7.9 reveals 4 groups of targets for which there are no differences
for any weight coefficient between targets within a same group, but, oppositely, there are sig-
nificantly different weight coefficients between targets of different groups: {T1,T2,T8,T9,T14};
{T4,T5,T6,T11,T12}; {T7,T18,T13,T17}; and {T3,T16,T10,T15}. Exceptionally, in the last group,
target 10 is different from one target of its group, but only in four weight coefficients (in red, in
Figure 7.9).
Inter-subject similarity of the synergies’ structure is affected by the movement condition
(target, direction)
The average DOT (normalized dot product) across pairs of subjects is presented for all syn-
ergies, targets and directions in Figure 7.10 They reflect the inter-subject variability in muscle
coordination in healthy subjects to perform a same task. As one can observe in the figure, the
similarity across subjects is lower for S1 and S4.
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Figure 7.10: Normalized dot product (DOT) between the synergies’ structure of pairs of subjects,
for synergy 1 (S1), 2 (S2), 3 (S3) and 4 (S4), for each movement condition. The x-axis indicates
the target (1 to 18) and the y-axis indicates the average DOT. Blue and orange bars regard forward
and backward movements, respectively.
a
Distributions of DOT values are not Gaussian (p<1e− 7, One-sample Kolmogorov-Smirnov
test), and do not have equal variances (p<1e−6, Levene’s test). As with weight coefficients, both
ANOVA and Friedman tests were performed and compared. Table 7.3 presents the resulting p-
values.
Table 7.3: Results of the statistical test to determine the effects of the movement condition on the
similarity of the synergies’ structure across subjects.
S1 S2 S3 S4
direction p-value Friedman 0.153 9.03 e -12 2.44 e -06 0.244
p-value ANOVA2 0.083 7.39 e -19 1.27 e -11 0.503
Target p-value Friedman 5.88 e -12 4.11 e -28 7.93 e -13 9.19 e -07
p-value ANOVA2 2.31 e -1 4.46 e -3 3.30 e -24 1.10 e -07
factors* interaction p-value ANOVA2 0.190 1.66 e -42 1.94 e -33 0.703
The similarity of S1 across subjects, as well as of S4, is not affected by the direction, but it
is significantly affected (p<0.05) by the target. The similarity of S2 across subjects, as well as
of S3, is significantly affected (p<0.05) by both the target and the direction. However, the very
low p-value, for S2 and S3, in respect to the interaction between targets and directions indicates
that targets and directions are not independent, i.e., the effect of the target on the inter-subject
similarity differs if the forward or the backward direction is considered. This means the results of
a multi-comparison could not be fairly interpreted and, thus, this step was not considered here.
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7.1.4.3 Four Muscle Synergies explain Movements Grouped by Target
The number of synergies estimated for each group of targets is presented in Table 7.4 synergies
explain at least 95% of the variability in any of the 4 groups of movements. Given the preservation
of the number of synergies when movements are strategically grouped as when they are individ-
ually factorized, this result indicates that muscle coordination is similar enough between targets
within a same group, supporting the use of these groups of targets to compare healthy subjects’
with patients’ synergies.
Exceptionally, for group 1, backward direction, the average is slightly higher, 4.6. synergies.
In fact, this group includes target 2 and the number of synergies estimated for this target, individ-
ually, was also higher (4.6), as reported in Section 7.1.4.1.
Table 7.4: Estimated number of synergies for Groups 1 to 4: average ± standard-deviation, across
healthy subjects. Estimation criterion: VAF ≥ 0.95. Gn stands for group n; F stands for forward
movement; B stands for backward movement.
F B
G1 3.6 ± 0.7 4.6 ± 1.1
G2 3.8 ± 1.0 3.9 ± 0.4
G3 3.9 ± 0.8 4.4 ± 0.7
G4 4.4 ± 0.7 4.4 ± 0.7
a
The 4 muscle synergies’ structure for groups is shown in Figures 7.11 and 7.12., averaged
across healthy subjects.
Forward and backward movements are explained by synergies with a very similar structure.
However, S4 of group 4 loses, in backward, the contribution of the deltoid posterior highlighted in
forward.
One can observe the most important muscles of the first 3 synergies are the same for all groups
of targets, apart from slight differences in their coefficients (foreseen by the previous statistical
tests): DANT and DMED, in S1; BICS, BICL, BRAD and PRO, in S2; LAT, INFRA and RHO, in
S3. The last synergy (S4) is group-specific: TRAPS, TRAPM and DANT are the most important
muscles, in group 1; PEC, in group 2; TRILAT and TRILONG (and DPOS, in forwards), in group
4. In particular, for group 3, S4 seems to include the coordinated work of trapezius fibers as in S4
of group 1, but with the contribution of more muscles (deltoid heads, and back muscles).
Note that, after ordering the synergies of all subjects and averaging them across subjects, the 4
synergies were reordered to be represented in figures 7.11 and 7.12 with the 3 most similar in the
top, and s4 as last synergy. So, the order is not the same as in figure 7.6, for individual targets.
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Figure 7.11: Structure of muscles synergies underlying the movements included in group 1 (top-
left), 2 (top-right), 3 (bottom-left), and 4 (bottom-right), in forward direction. Weight coefficients
are averaged across subjects (standard deviation is also indicated in red). The first three synergies
have a similar profile across groups. The last synergy is group-specific (main group of muscles is
highlighted in orange, pink and yellow for groups 1, 2 and 4 respectively). In S4 of group 3, a set
of several muscles works together (trapezius, deltoid, and back muscles).
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Figure 7.12: Structure of muscles synergies underlying the movements included in group 1 (top-
left), 2 (top-right), 3 (bottom-left), and 4 (bottom-right), in backward direction. Weight coeffi-
cients are averaged across subjects (standard deviation is also indicated in red). The first three
synergies have a similar profile across groups. The last synergy is group-specific (main group of
muscles is highlighted in orange, pink and yellow for groups 1, 2 and 4 respectively). In S4 of
group 3, a set of several muscles works together (trapezius, deltoid, and back muscles). In S4 of
group 4, DPOS is not coordinatively recruited with triceps, as in forward.
7.1.5 Motoneural Activity in the Spinal Cord
Estimated activity in the spinal cord of healthy subjects, between segments C2 to T1 (the
ones innervating the upper limb), is represented in Figure 7.13. In forward movements, one can
observe how the distribution of this activity is organized along space and time, generally increasing
in intensity as subjects go from reaching targets placed at the bottom of the sphere to reaching the
ones at the top of the sphere. In the same axis (bottom-top), higher segments of the spinal cord
tend to be more active than the lower ones, and the spinal activity increases, in general, from the
beginning to the end of the movement.
In backward movements, the spatiotemporal distribution of the motoneural activity seems
more regular across almost all targets, being the higher cervical segments more active. Oppositely
to forward direction, this activity tends to be more intense in the beginning of the movements.
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Figure 7.13: Spinal maps (averaged across healthy subjects) obtained for each movement condition: forward (left maps); backward (right maps); targets
from 1 to 18. The spinal maps are ordered according to the spatial distribution of the respective targets in the sphere. The color map associated with the
value of motoneural activity is presented in the colorbar on the left.
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7.1.5.1 Inter-subject Similarity of the Spinal Maps is not affected by the
target and movement direction
The 2D correlation coefficient (2-dimensional equivalent of the Pearson’s correlation), r, be-
tween the spinal map averaged across subjects and the spinal map of each subject is presented, for
each target and direction, is presented in Table 7.5. The inter-subject similarity of the spinal maps
is not significantly affected by the target (p=0.62) nor by the movement direction (p=0.85).
Table 7.5: 2D-Correlation coefficient between the spinal map averaged across subjects and the
spinal map of each subject.
T1 T2 T3 T4 T5 T6
F 0.70 ± 0.20 0.56 ± 0.18 0.52 ± 0.22 0.46 ± 0.19 0.50 ± 0.17 0.47 ± 0.18
B 0.65 ± 0.25 0.49 ± 0.27 0.52 ± 0.24 0.47 ± 0.21 0.54 ± 0.15 0.43 ± 0.28
T7 T8 T9 T10 T11 T12
F 0.46 ± 0.23 0.61 ± 0.15 0.64 ± 0.18 0.60 ± 0.21 0.62 ± 0.30 0.49 ± 0.26
B 0.45 ± 0.23 0.51 ± 0.18 0.57 ± 0.24 0.56 ± 0.31 0.63 ± 0.29 0.49 ± 0.28
T13 T14 T15 T16 T17 T18
F 0.51 ± 0.29 0.65 ± 0.17 0.58 ± 0.29 0.59 ± 0.19 0.48 ± 0.27 0.60 ± 0.26
B 0.54 ± 0.24 0.68 ± 0.22 0.53 ± 0.30 0.53 ± 0.18 0.58 ± 0.25 0.54 ± 0.29
a
7.1.5.2 Estimated spinal cord activity as a linear function of the target dis-
tance from the top of the sphere
Both 2D-correlation and covariance (i.e. the similarity in shape and level of activity, respec-
tively) of the spinal map related to each single target with the spinal map of Target 1 (the top of the
sphere) linearly decrease with the distance of the target to the top of the sphere. This result was ob-
tained in both movement directions and with both metrics of distance. However, the coefficient of
determination (r) is higher for forward movements (Figure 7.14) than for backwards movements
(Figure 7.15), and the best determined relations are between correlation and the z-axis distance
(Figure 7.14, left), and between covariance and the Euclidean distance (Figure 7.14, right).
In the right-left and close-distant axes, the correlation and covariance are also linearly related
with the distance of the target to Target 7 and 13, respectively, but the r is not as high as for the
above-mentioned results in forward direction (and some results are not statistical significant) – see
Appendix C.
96 Results
Figure 7.14: Relation between the 2D-correlation and the distance in the z-axis (left), and be-
tween covariance and the Euclidean distance (right), for forward movements. In the x-axis
is the indicated the distance from the target to Target 1. In the y-axis is indicated the 2D-
correlation/covariance between the spinal map for the target and the one for Target 1. r is the
coefficient of determination, p is the statistical significance.
Figure 7.15: Relation between the 2D-correlation and the distance in the z-axis (left), and be-
tween covariance and the Euclidean distance (right), for backward movements. In the x-axis
is the indicated the distance from the target to Target 1. In the y-axis is indicated the 2D-
correlation/covariance between the spinal map for the target and the one for Target 1. r is the
coefficient of determination, p is the statistical significance.
7.2 Analysis of the stroke group 97
7.1.5.3 Spinal Maps for Movements Grouped by Targets
The healthy spinal maps obtained for group 1, 2, 3 and 4 and represented in Figure 7.16. These
spinal maps were later used to compare with the ones of patients.
Figure 7.16: Spinal maps obtained after grouping the movements by target, in forward (top) and
backward (bottom).
a
7.2 Analysis of the stroke group
7.2.1 Task execution – Kinematic Analysis of the Movement
Movement features were assessed for every condition (target and direction) by averaging the
kinematic metrics’ values across repetitions of the same movement. These results are described
here for all targets and directions together, to analyze the global performance of the patient, and
they are detailed for specific targets/directions when the patient behaves differently to execute
movements in that condition. For a matter of concision, given the extension of the results, only
global values (i.e. the average across targets and directions) for each metric are presented in the
thesis (see Figures H.1 and H.2, in Appendix).
The most remarkable results were obtained when assessing accuracy (with the mean distance
to the healthy path, MDH), smoothness (both with the Spectral Arc-Length, SAL, and the Ratio of
Mean Acceleration with Peak Acceleration, RMP) and task accomplishment (using the Assisted-
Distance).
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Patients ALEx-HUG-001, 003 and 004 were able to improve these movement features from
the beginning of the experiments until 1 month after the end of the treatment, demonstrating, not
only that therapy helped to increase the motor performance of these patients in different aspects
(at least in reaching movements), but patients also retained the abilities re-learned.
Patient ALEx-HUG-006 spontaneously recovered these skills (although in a very short range)
from assessment 1 to assessment 2. But, when assessed at the end of the treatment (A3), she was
assisted by the exoskeleton for several times (more than in A1 and A2) and her kinematic results
had worsened in respect to the ones obtained in A1. It must not be forgotten that she was not
feeling completely well, during A3, and sometimes the acquisitions were stopped and restarted.
Movements towards targets in the left side of the sphere or more distant from the body, like
target 18, 13 and 17, usually do not follow the same trend of improvement as the others. See
the example of patient ALEx-HUG-001, in Figure 7.17, with these targets, for which the absolute
values of MDH and SAL are not systematically reducing, as with other targets.
Figure 7.17: Example of results obtained by patient ALEx-HUG-001 in movements towards tar-
gets 18, 13 and 17, which do not follow the same trend of improvement as the other targets.
Patients’ accuracy is also repeatedly lower in backward than forward movements, at any time
of the experiments. This was somehow expected, since one could observe that, typically, patients
pay more attention and try harder to execute well the forward movements. And, in addition, all pa-
tients have shown to execute backward movements more easily than forward ones, according to the
results of mean velocity (slightly higher values in backwards). Thus, it is not the case of a reduced
ability when executing backward movements, but more the consequence of a choice/preference.
This result must, however, be considered because it influences the global measure of motor per-
formance to be compared with the FMUE.
Patients ALEx-HUG-001, 003 and 004 were able to execute movements in a faster way in
assessments 3 and 4 than in assessments 1 and 2 for all targets, demonstrating an increased easiness
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in reaching movements after receiving the motor therapy. Oppositely, patient ALEx-HUG-006
could not improve this feature from the beginning to the end of the treatment, always moving
more slowly than healthy subjects and the other patients.
Concerning efficiency, patient ALEx-HUG-003 improved both temporal and spatial features
(there is a progressive decrease in the movement duration and path length), and her efficiency is
consistent across targets. In fact, after the treatment, her mean velocity in reaching movements
surpassed the average healthy one and, recalling that her smoothness also progressively increased,
these results suggest that training with the exoskeleton had a benefic effect on the patient’s motor
skills. Also, patients 001 and 004 improved their temporal efficiency, but the path length did
not decrease so much as patient 003 after the treatment. However, the behavior of patient 004 is
more consistent across targets than patient 001: possibly, patient 001 needed to practice more the
movements towards some of the targets in specific, to learn a shorter path.
Finally, the assisted-distance (i.e. the length of the path where the patient required robotic
assistance) decreased over the experiments course (even with patient 006, from A1 to A2), sup-
porting the fact that, over the rehabilitation, patients become more skilled in reaching movements
and rely less on the assistance of the exoskeleton.
7.2.2 Muscle coordination – Muscle Synergies
The number of muscle synergies estimated for each patient is presented in Table 7.6. Globally,
it increases from the beginning (A1) to the end of the experiments (A4) and the patients’ motor
ability also increases (see the FMUE, Fugl-Meyer for the Upper Extremity, in the table).
Remarkably, in assessment 2 (A2), patient ALEx-HUG-001 spontaneously recovered the 4
synergies for almost all groups of targets. However, her motor ability reported by the FMUE
barely changed. In fact, despite the general increase of both FMUE and number of synergies,
the trend of this number, during the experiment, is not consistent with the trend of the FMUE
score. See other example, patient ALEx-HUG-003, which improved her motor ability from one
assessment to the following one, but the number of synergies only increases from A2 to A3.
Interestingly, patient ALEx-HUG-004, which has received the personalized treatment, recov-
ered the 4 muscle synergies for all groups at the third assessment, however, 1 month later (A4), the
number of synergies was higher in respect to the healthy one (5 muscle synergies). This was not
due to a simple fractionation of synergies (as reported in another study (Cheung et al., 2012)), but
due to a new muscular reorganization (as with the chronic patients studied in (Roh et al., 2013))
– see the example with group 2, in Figure 7.18: S2, in assessment 3, was fractionated in S2 and
S5, in assessment 4; the contribution of trapezius was considerably reduced, too; and the work of
back muscles (LAT, INFRA, RHO) was split in 2 synergies (S3 and S4), being coordinated with
the PEC in S3.
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Table 7.6: Number of synergies estimated for each patient, group of targets and each assessment.
A1, A2, A3 and A4 indicates the assessment session. F denotes forward movements, and B
backward movements. G1, G2, G3 and G4 indicates the group of targets. The average number
across groups and the FMUE score of the patient is also indicated for each assessment.
ALEx-HUG-001 ALEx-HUG-003
G1 2 3 3 3 F 2 2 3 3
2 3 2 4 B 2 2 3 3
G2 3 3 3 4 F 3 2 2 3
3 4 3 4 B 3 2 3 3
G3 2 4 3 4 F 2 2 3 3
2 4 3 4 B 3 2 3 3
G4 3 3 3 4 F 2 2 4 3
2 4 4 3 B 2 2 4 4
average 2.4 3.5 3.0 3.8 2.4 2.0 3.1 3.1
FMUE 47 49 56 55 17 34 46 52
A1 A2 A3 A4 A1 A2 A3 A4
ALEx-HUG-004 ALEx-HUG-006
G1 3 – 5 5 F 3 3 3 –
3 – 4 4 B 3 3 3 –
G2 3 – 4 5 F 3 4 3 –
3 – 4 5 B 2 4 3 –
G3 3 – 4 5 F 3 3 3 –
3 – 3 5 B 2 3 3 –
G4 3 – 4 4 F 3 2 2 –
3 – 5 4 B 3 3 3 –
average 3.0 – 4.1 4.6 2.8 3.1 2.9 –
FMUE 17 – 30 34 24 27 29 –
A1 A2 A3 A4 A1 A2 A3 A4
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Figure 7.18: Modifications of the synergies structure from assessment 3 (left) to assessment 4
(right), in patient ALEx-HUG-004.
Concerning the similarity of the synergies’ structure between the patients and the healthy
subjects, the average correlation across the 4 synergies (the 4 most similar to the healthy) is shown
for each assessment, group of targets and each patient in Figure E.1 of Appendix E. One can
observe that, for all patients, the similarity with healthy is very low (less than 0.5) and, although it
generally increases spontaneously from the first to the second assessment, this behavior is not the
same for all groups of targets and patients after the treatment (A3 and A4):
• For patients 001 and 003, which received the conventional robotic treatment, the evolution of
similarity varies: the correlation between synergies of 001 and healthy synergies generally
reduces from A2 to A3, and increases in A4; with 003, it decreases from A2 to A3, but it
does not increase in A4;
• For patient 004, which received the personalized treatment, apart from group 2, the similar-
ity increases, but not as much as patient 001;
• The structure of all synergies of patient 006 (which received the standard therapy) is very
different from the healthy ones (correlation is less than 0.2).
• Among groups of targets, the similarity with the healthy structure is very poor for group 2,
for all patients (see the example with ALEx-HUG-003, in Figure 7.19).
Regarding the importance of each synergy for the patients’ data (i.e. the contribution of the
synergy to the integral of muscle activity, vn), it is very similar to the importance of the equivalent
synergy for the healthy data (see Appendix E, Figure E.2). For all patients and groups of targets,
the vnsimilarity was higher than 0.7. Variations of this value do not have a clear trend with the patient
motor improvement.
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Figure 7.19: Synergies profile of ALEx-HUG-003 in assessment 3, obtained for group 2 (left) and
the correlation between all synergies of these patient and the respective healthy ones (right), in
backwards. Notice the modified structure of synergies concerning group 2 justifying the negative
correlation with the healthy one.
a
7.2.3 Estimation of Motoneural Activity in the Spinal Cord
Oppositely to healthy subjects, stroke patients did not show any trend in the spatiotemporal
distribution of motoneural activity across groups of targets, before the treatment (A1 and A2)
and in the follow-up (A4) – See Figure F.1 as example. However, with patients ALEx-HUG-001
and 003, after the treatment (A3), their spinal maps resemble more the healthy ones: there is a
progressive reduction of the magnitude of the motoneural activity from group 1 to group 4 (Figure
7.20).
Another interesting result is that motor therapy seems to promote the activity of upper cervical
segments of the spinal cord (C2 to C4): in patients treated with the robotic-assisted therapy (001,
003 and 004), activity in these spinal segments increases from A1 to A3; the patient treated with
the standard therapy (ALExHUG-006) shows a more intense activity in the lower segments (C7 to
T1), even after the treatment (A3), but in A3 cervical segments are also active.
In the follow-up, however, the level of activity of patients 001, 003 and 004 was reduced. See
the examples of evolution of spinal maps of patient ALEx-HUG-001 and 006 in Appendix F.
Correlation and covariance between patient and healthy spinal maps of the same group of
targets increase from A1 to A3 for patients ALEx-HUG-001 and ALEx-HUG-003, and decrease
in A4. For patient 004, the covariance and correlation do not change considerably from A1 to A3
and decrease in A4.
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Figure 7.20: Spinal maps of patient Alex-HUG-003 in assessment 3, for groups 1 to 4 (from left
to right), forwards. Notice the similar trend as the healthy spinal maps across groups.
Although these measures do not variate according to the trend of the patients’ FMUE score
(see Table 7.6), it must be highlighted that by the end of the treatment (A3), the spinal maps of
these patients are highly correlated with the healthy ones (0.80 ± 0.08, ALEx-HUG-001; 0.85 ±
0.07, ALEx-HUG-003; 0.76 ± 0.11, ALEx-HUG-004).
However, they were not able to retain that similarity one month later, in A4 (0.16 ± 0.30,
ALEx-HUG-001; 0.37 ± 0.14, ALEx-HUG-003; 0.12 ± 0.31, ALEx-HUG-004). See details for
each group of targets in Appendix G.
As expected from the visual inspection of the spinal maps, the shape and magnitude of the
spinal maps of patient 006, before the treatment (A1 and A2), are inversely correlated with the
healthy ones, but in A3 the similarity increases due to the activity in the upper segments of the
spinal cord. However, no information is available to verify if this patient retains, later, such in-
crease in similarity with healthy.
7.3 The Neurobiomechanical State and Motor Performance of Stroke
patients during robot-aided rehabilitation
The neurobiomechanical state of post-stroke patients during the rehabilitation course was defined
using the patients’ muscular activity and movement kinematics. Measures of similarity between
the patient’s neuromuscular state and the healthy one were defined based on the muscular coor-
dination (structure of muscle synergies) and the estimated motoneural activity in the spinal cord.
In addition, the movement execution was quantified in terms of efficiency, smoothness, accuracy,
easiness and dependence on robotic assistance.
In Section 7.2, one could observe that synergies’ structure and spinal maps of patients did not
progress towards the healthy patterns in the same trend of improvement of their motor skills. This
was quantitatively confirmed by the correlation between muscle activity metrics and the FMUE
scale.
The synergies’ metric, as defined in Section 6.8, poorly correlated with the FMUE scores of
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patients: 0.32 ± 0.21. The shape-similarity and magnitude-similarity of the spinal maps also re-
sulted in just 0.25 ± 0.24 and 0.021 ± 0.29 of correlation with this clinical scale, respectively.
Given the very low estimated values, bootstrap method was applied to these metrics only to deter-
mine the standard error of the correlation when data sets are resampled.
On the other hand, in Section 7.2.1, the kinematic of movement execution reflected the mo-
tor improvement of patients in various features of the movement. Patients receiving the robotic
treatment improved all features, in general, from the beginning to the end of the treatment, but the
best correlated metrics with their clinical scores were the MDH (quantifying accuracy), the RMP
(a measure of smoothness), and the assisted-distance (a measure of dependence on the robotic
assistance). See the correlation for each metric, and the respective standard deviation obtained
by resampling the patients’ data (bootstrap method), in Figure 7.21 (left side), together with the
histogram (number of occurrences) of correlation obtained in the resampled data.
In addition, the correlation between the variation of the FMUE, over the rehabilitation course,
and the variation of these kinematic metrics is higher (graphs on the right side of Figure 7.21).
This supports the fact that, more than their absolute value, the variation of these metrics quantifies
the progress of the patients’ performance.
Results for other kinematic metrics are presented in Appendix I. These metrics did not achieve
so good results; thus, graphical representations are provided only for the correlation between these
variables and the FMUE, not for the variation of these variables.
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Figure 7.21: Correlation between the clinical scale (FMUE) and metrics of the kinematic assess-
ment (on the left), and between the variation of FMUE and the variation of those metrics (on the
right), over the rehabilitation course. The average and standard deviation of the correlation are
indicated below the respective histogram of the bootstrap method results. Histograms show the
number of occurrences (bootstrap resamples / data sets) which resulted in a value of the correlation
indicated in the x-axis. MDH, RMP and Assisted-distance achieved the best results of correlation
and the lowest values of standard deviations.
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Chapter 8
Discussion
8.1 Analysis of the control group (healthy subjects)
Despite being a narrow sample of the non-disabled human population, the group of healthy sub-
jects was selected to match the range of ages of the stroke patients, and studying these subjects
was fundamental to organize the patients’ data.
The variation of level of activity of EMG envelops (RMS values) started to provide clues on the
main effects of the movement condition in muscular organization, revealing that muscular effort
in healthy subjects is particularly intense when reaching more distant targets and near the top of
the sphere (i.e. when executing distal and upper movements). These results evidence the effect of
gravity on 3D reaching movements.
Then, as expected, the factorization of electromyographic signals confirmed that the activity
of 15 muscles can be reduced to a smaller set of variables, the muscle synergies, which describe
the coordinated recruitment of a group of muscles. Four muscle synergies were found to account
for the variability of muscle activity for every movement condition (every target, in forwards, or
backwards). These results agree with other studies of upper limb movements that found 2 to 8
synergies in healthy subjects (Sabatini, 2002; d’Avella et al., 2006; Flanders, 1991).
Indeed, the protocol adopted to record data of healthy subjects did not constrain the movements
in terms of speed and motion, thus, subjects presented some differences in movement trajectories.
This was mainly verified during the first times that subjects executed the movements, indicating
that it is likely due to an adaptation (and learning mechanism) of the subject to use the robot. This
could be surpassed in future acquisitions by adding a simple step in the protocol: subjects should
be given the opportunity to get familiarized with the exoskeleton and execute one or two times the
reaching movements. Only after, the acquisitions should be performed.
Even though, using the available data (acquired without the additional step suggested above),
the intra- and inter-subject variability was successfully reduced with the algorithm to exclude
movements’ outliers, allowing, then, the extraction of similar muscles synergies across subjects
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from comparable movements (Figures 7.6 and 7.10).
Therefore, this corroborates the general theory, addressed in Chapter 3, that motor control
is modular and movement planning basically consists in organizing these modules to achieve a
desired trajectory. In the specific context of 3D point-to-point reaching movements, these modules
functionally and generally represent:
1 the shoulder abduction and flexion – synergy S3 (with the weighted coordination of DANT
and DMED, and other muscles, depending on the target);
2 the elbow flexion – S4 (essentially with BICS, BICL, BRAD and PRO, but also with TRI-
LAT or PEC, depending on the target);
3 the retraction and medial rotation of the shoulder (to straight the posture) – S2 (with LAT,
INFRA and RHO, also with the contribution of TRAPS and TRAPM in several targets).
4 a not very clear function, since the coordinated muscles in S1 are more variable across
targets and subjects than with the other synergies.
Particularly concerning S1, the function associated to this muscle synergy was better under-
stood for each target, when they were associated in groups, as discussed later.
Moreover, a very similar muscular organization was found for movements in both directions
(forward or backward), when reaching the same target. First, S4 is not affect by this condition
(direction), having an identical profile for both movements. Second, only one weight coefficient
over 15 muscles was found significantly different (p<0.05) between forward and backward move-
ments, for each of the synergies S1, S2 and S3: referring to TRILONG in S1, TRAPS in S2, and
DANT in S3. Finally, only the contribution of DANT in S3 is high (a weight coefficient superior
to 0.5) for most of the targets and subjects (Figure 7.6). Therefore, one can conclude that effects
of movement direction in the synergies’ structure may be neglected.
Nevertheless, the same cannot be assumed when comparing movements regarding different
targets. Muscle profile of all synergies is affected in several weight coefficients corresponding to
muscles with the main function represented by the synergy (for example, LAT, INFRA, and RHO,
in S2; DANT and DMED in S3; TRILAT in S4).
Moreover, multi-comparison revealed that such differences in the weight coefficients seem to
agree with results of the amplitude analysis (Section 7.1.3), occurring in a patterned way in the
up-down and close-distant axes. In fact, results detailed in Figure 7.9 revealed 4 groups of targets
for which there are no differences for any weight coefficient between targets within a same group,
but, oppositely, there are significantly different weight coefficients between targets of different
groups: {T1,T2,T8,T9,T14}; {T4,T5,T6,T11,T12}; {T7,T18,T13,T17}; and {T3,T16,T10,T15}.
Exceptionally, in the last group, target 10 is different from one target of its group, but only in four
weight coefficients (in red, in Figure 7.9).
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This finding suggests that muscle activity is mainly preserved in targets close to 4 main di-
rections. This opens the possibility to consider just 4 main directions for muscle activity analysis
with a consequent simplification of the analysis of stroke patients. Having just 4 main directions
would allow to increase the number of repetitions for each direction by grouping the repetitions
of each target and it would solve the problem of having different movement conditions in each
session of assessment and each patient.
In addition to muscle coordination, motoneural activity of the spinal cord was estimated in
healthy subjects, between segments C2 and T1 (the ones innervating the upper limb).
As far as it was possible to know, spinal maps of healthy subjects have not been character-
ized in depth while executing reaching movements in 3-dimensions (Pirondini et al., 2016). This
method has been used mainly to study movements with the lower limb (Ivanenko et al., 2008;
Monaco et al., 2010). For the thesis, this method was selected because it was expected to be
a valuable tool to study muscle organization in the upper limb, as it happened, simplifying the
analysis in case of complex movements that require the recording of many muscles.
In fact, spatiotemporal distribution of motoneural activity in the spinal cord demonstrated to
be sensitive to the movement condition, like with muscle synergies. Estimated activity in forward
movements generally increases from the bottom to the top of the sphere, i.e. the global magnitude
of the spinal map increases with the height of the target.
Moreover, a linear relation was found between the distance of the target to the top of the sphere
and the respective level of magnitude relatively to the magnitude of the spinal map for Target 1 (the
top of the sphere). This relation is very significant (p <1 e -11; r = -0.98) if the Euclidean distance
is considered to locate the target in respect to Target 1, and the covariance is used to measure the
relative magnitude of the spinal map in respect to the one of Target 1.
The same occurred with the shape of the spinal maps (i.e. the relative distribution of motoneu-
ral activity along space and time). This shape becomes more similar to the one of spinal map for
Target 1 as the distance to that target diminishes. Again, a very significant (p <1 e -6) linear rela-
tion (r = -0.90) was found between the distance in the z-axis (i.e. top-bottom) and the correlation
with the spinal map for Target 1.
In the y-axis (i.e. close-distant axis in respect to the subject), significant variations of the
magnitude (r = -0.63; p = 0.005) and shape (r = -0.84; p = 1.68 e -5) of the spinal maps were
found.
As expected from the visual inspection of the spinal maps, in backward movements, magnitude
and shape variate with the location of the target but these results were not as remarkable as with
forward movements.
Furthermore, targets 2, 8, 9, and 14 are at the same (Euclidean or z-axis) distance to target 1, as
well as targets 3, 7, 10, 15, 16, 17, and 18, and, moreover, targets 4, 6, 11 and 12. Given the results
of linear relations with the location and magnitude/shape of the spinal maps, and disregarding the
effects of location of target 1 and target 5, the hypothesis to group targets as suggested by the
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analysis of muscle synergies was also supported by the analysis of spinal maps.
Therefore, to further test the hypothesis that targets could be grouped, muscle activity of each
healthy subject was arranged in new datasets including more than one target (according to the
statistical results of synergies’ structure and spinal maps): group 1 – {T1, T2, T8, T9, T14}; group
2 – {T4, T5, T6, T11, T12}; group 3 – {T7, T18, T13, T17}; group 4 – {T3, T16, T10, T15}.
EMG signals were factorized to extract muscle synergies and weighted-summed to extract spinal
maps.
Once again, four muscle synergies were estimated for all groups of targets, both in forward
and backward directions. The only exception occurred with group 1, backwards, for which 4.6
synergies (in average across healthy subjects) were estimated. This may be justified by the fact
that group 1 includes target 2 and the number of synergies estimated for this target, individually,
was also higher, as reported in Section 7.1.4.1.
Given the preservation of the number of synergies when movements are strategically grouped
as when they are individually factorized, this result indicates that muscle coordination is similar
enough between targets within a same group, supporting the use of these groups of targets to
compare with patients’ synergies.
Concerning synergies’ structure for groups of targets, there are 3 muscle synergies in common
among groups (or, at least, with a very similar muscle weights profile), and other 3 synergies dif-
fering (S4 of group 1, 2 and 4). The synergy S4 of group 3, however, seems to represent the same
function as S4 of group 1, but merged with the contribution of additional muscles. This may be
explained by the fact that group 3 is not so homogeneous (concerning the muscular organization)
as the others, which was partially foreseen by the statistical differences found for some muscle
weights between Target 10 and Targets 3, 15 and 16.
Thus, in total, 6 to 7 different synergies are necessary to reach all the targets of the sphere,
which also fairly agrees with the estimated number of synergies when movements regarding all
targets are pooled together (Section 7.1.4.1).
More in detail, the profile of S4 (the equivalent of S1 obtained for individual targets) for
groups 1, 2 and 4 seems to highlight the necessary muscle functions to move towards the main
direction of the movements included in these groups: movements of group 1 are executed in the
upper part of the sphere, demanding a coordinated work of trapezius and deltoids to lift the arm to
reach higher positions; most targets of group 2 are positioned at the left, distant side of the sphere,
demanding medial rotation of the arm/shoulder, function of pectoralis muscle; group 4 is located
in the bottom of the sphere, requiring mainly extension of elbow (triceps) and shoulder (posterior
deltoid). Profiles of S1, S2 and S3 are equivalent to S3, S4 and S2, respectively, obtained for
movements regarding individual targets.
Concerning spinal maps for groups of targets, one could observe that they are a good approx-
imation of the spatiotemporal distribution represented by the spinal map for each target within
a same group and, more important, the trend in magnitude and shape along the top-bottom and
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close-distant axes, in forwards, was retained by this organization of the targets.
Therefore, it was considered that muscle activity of stroke patients could be organized in the
same way (grouping targets) to extract muscle synergies and spinal maps, to compare them with
the healthy ones and evaluate the progress of the patients’ neuromuscular state.
Regarding the kinematic analysis, it was possible to verify the motor ability of healthy subjects
in terms of efficiency, accuracy, smoothness, and easiness.
As expected from the exclusion of movements outliers, time and path length are not uniform
across targets and directions. In particular, subjects are more efficient when executing backward
movements, which is quite expected because, despite starting in different targets, all backward
movements are executed towards the same point, the center of the sphere, and, thus, subjects have
the opportunity to practice more times a similar movement (at least when it is closer to the center).
In addition, the smoothness measured by SAL (Spectral Arc-Length) also varied across tar-
gets, similarly to the duration and path length. Nevertheless, RMP (Ratio of Mean Acceleration
with Peak Acceleration), another measure of smoothness, was not so sensitive as SAL to sudden
changes in the movement of healthy subjects and the standard errors are lower. The reduced sen-
sitivity of RMP relative to SAL may imply one of two cases: RMP is less susceptible to noise (i.e.
sudden changes in the movement which do not reflect motor ability of the subject but characterize
natural movements with the upper limb) than SAL; or SAL provides a wider range to measure
smoothness and, consequently, motor performance. The real case was evaluated with the stroke
group, since with those subjects it was possible to compare results of both metrics with a clinical
scale (FMUE) which characterizes motor performance.
Regarding easiness and movement accuracy, healthy subjects performed similarly across tar-
gets. Once more, from the increased speed, one could verify they were capable to execute back-
ward movements more easily than forward ones.
Finally, as hypothesized, the average path across subjects is not a straight line, as theoretically
suggested before (Flash and Hogan, 1985; Amirabdollahian et al., 2002), and this correction in a
widely used measure of accuracy was expected to obtain good results in capturing motor perfor-
mance of stroke patients.
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8.2 Analysis of the stroke group
Patients who received the robotic-assisted treatment (ALEx-HUG-001, 003 and 004) clearly im-
proved their motor performance, according to their FMUE score, the general increase of the num-
ber of synergies from the beginning to the end of the experiments, and their progressively better
results in the kinematic assessment.
Nevertheless, the motor improvement of these patients was not clearly reflected by their muscle
coordination (the structure of their muscle synergies) nor by the estimated motoneural activity of
the spinal cord (spinal maps).
In fact, although the number of synergies tends to 4, as in nondisabled subjects, it seems
the muscular organization is highly modified in respect to the healthy one (correlation values are
always less than 0.5). These modifications are not systematic, but dependent on the group of
targets and the patient.
In specific, the progress of the synergies’ structure obtained for group 2 is very distinct from
the other groups: these synergies are uncorrelated or inversely correlated with the healthy ones, for
all patients. This seems to indicate that patients are not able to use the same muscle coordination
as healthy subjects (specially with PEC) to reach targets in the left side of the sphere. In fact,
some features of movement execution (like smoothness and accuracy) were found less improved
for some of the targets included in these group. Therefore, these results can be used by clinicians
to pay specific attention to the posture of future patients enrolled in the study while reaching this
group of targets.
From the results with other groups of targets, it is difficult to compare the effects of the two
types of robotic-assisted therapy in the neuromuscular state of the patient, because data of few
patients is available at the moment, and, for example, the effects of conventional robotic treatment
in the synergies’ structure was different for patients 001 and 003, indicating that, possibly, more
factors (rather than just the type of treatment) influence these results.
The most consistent observation obtained from muscle activity assessment was found in spinal
maps: motoneural activity in upper cervical segments of the spinal cord is commonly increased
for all patients (inclusively ALEx-HUG-006) after the treatment (A3). However, patients 001, 003
and 004 were not able to retain the same level of activity 1 month later.
Even though, at the follow-up, these patients have maintained or improved their motor skills
(such as their accuracy, smoothness and efficiency) and obtained good FMUE scores, which shows
that deviations from healthy patterns of muscle activity still allow stroke survivors to re-learn
movements of the upper limb.
Patient ALEx-HUG-006, which received the standard therapy, did not improve considerably,
according to her FMUE score and the poor results in both the muscle and kinematic assessment.
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Particularly concerning the structure of synergies, this is the most different patient from the healthy
group. Notwithstanding, in what respects to her motoneural activity, it started with an inverse
spatial distribution with respect to the healthy one, but, in assessment 3, upper cervical segments
were more active, like other patients and healthy subjects.
Moreover, the fact that data from assessment 4 is missing and, during assessment 3, acqui-
sitions and movement execution by the subject have been constrained by the patient’s condition,
make it difficult to take reliable conclusions about this patient and, moreover, to fairly compare
the conventional therapy with the robotic-assisted one, for now.
Another issue is the fact that all patients to be included in group 1 (like 006) have contact
with the exoskeleton only during the assessment sessions. As observed with healthy subjects, it
is necessary to execute movements more than one time to be used to the robot and, in addition,
patients usually fatigue faster than healthy. Therefore, this may bias the comparison between stan-
dard and robotic therapies using muscle and kinematic results obtained from assessment sessions
which require the use of the exoskeleton.
A possible solution was to adopt an assessment method that is independent of the rehabilitation
therapy: each patient (of any group of treatment) could perform free 3D reaching movements, i.e.
without wearing the exoskeleton, and kinematics could be recorded with a motion capture system
- mocap (using a set of cameras, and markers placed over the necessary anatomical places in the
arm). This method would still allow to compute the same kinematic metrics studied in this thesis,
but it would be necessary to determine the 3D position of the target and also to present that target
to the patient differently from the current protocol (because this is currently determined by the
robot): using virtual reality. The sphere could be presented to the patient wearing virtual reality
glasses. This way, the location of the sphere is known relatively to the patient. Matching this data
with kinematics recorded by the mocap system, the 3D position of the sphere would be known.
In fact, using virtual reality to present the sphere, instead of the current 2D screen, could
also solve another important aspect of the rehabilitation protocol with ALEx: while the reaching
movements are three-dimensional, the sphere is two-dimensionally projected; therefore, patients
(and also healthy subjects) need to adapt their perception of depth. On the other hand, virtual
reality provides a better environment to train arm movements with the normal connection between
the human visual and motor systems.
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8.3 The Neurobiomechanical State and Motor Performance of Stroke
patients during robot-aided rehabilitation
As explained in Section 6.8, the FMUE (Fugl-Meyer for the Upper Extremity) was considered
to reflect the global motor ability of the patient in each session of assessment. Therefore, the
correlation between this clinical scale and all metrics of kinematics, synergies and spinal maps was
determined, to verify which of these could significantly quantify the patient’s motor performance.
The significance of the estimated correlation was assessed by resampling the patients’ data, using
the bootstrap method.
Moreover, the motor improvement algorithm of the personalization treatment continuously
estimates the patient motor performance and replaces a task by another one more difficult, based
on its progress: when the motor performance of the patient in executing the movement towards
some target converges to a plateau, this movement is replaced by another one which demands
more training. Thus, it is important that the trend of improvement quantified by any metric is
correlated with the trend of improvement reported by the FMUE. Therefore, this correlation was
also computed to check the ability of each metric to capture changes in motor improvement.
In Section 7.2, one could observe that synergies’ structure and spinal maps of patients did
not progress towards the healthy patterns in the same trend of improvement of their motor skills.
Then, when assessing the synergies’ and spinal maps’ metrics concerning their ability to capture
the patients’ level of motor performance, it was expected to obtain a low correlation with the
FMUE scale, as it happened.
Indeed, in the literature, a deterministic relation between neuromuscular state following stroke
and motor performance has not been validated yet, because different studies have achieved distinct
results (Cheung et al., 2009; Coscia et al., 2014; Roh et al., 2013). Thus, the work developed in this
thesis with stroke patients was a preliminary study, but imperative to verify the existence of any
relation as the above-mentioned, for 3D point-to-point reaching movements, so that parameters of
such relation could be included in the personalized treatment.
For the moment, muscle coordination and single muscle activity can only be used as an ad-
ditional information about the patient condition in respect to healthy subjects. If provided to
clinicians that supervise the robotic treatment, the result of these measures can alert them to verify
if the patient is executing the tasks with compensatory or more natural movements, if he/she is
positioned in the best way and is distributing the effort correctly in the arm and back, to avoid in-
juries in muscles and joints. Additional data from the remaining 44 patients that will be included
in the study will be necessary to establish if and which muscular features as muscle synergies
and spinal maps will reflect the patient’s motor improvement in order to incorporate them in the
personalization algorithm.
On the other hand, from the kinematic assessment of the stroke group, it was possible to
demonstrate that metrics of movement smoothness, accuracy and dependence on robotic assis-
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tance are able to quantify the motor performance of patients following their FMUE scores. In
specific, MDH, RMP and the assisted-distance are good candidates to be parameters of the motor
impairment algorithm.
The correlation between MDH and FMUE, as well as between the Assisted-distance and the
same scale is negative, because motor performance implies a decrease of these parameters (i.e., a
lower distance to the healthy path, and a reduced dependence on the assistance of the exoskeleton).
On the contrary, the correlation between the RMP and FMUE is positive, because an increase of
RMP means a decrease of peak acceleration in respect to the mean acceleration, i.e. a higher
smoothness.
Despite the fact that absolute values of correlation were not higher than 0.75, these results
are significative, because, first, standard errors obtained with bootstrap method were not higher
than 0.21, and, second, in other similar studies with kinematic robot-based evaluations (Bosecker
et al., 2010; Ellis et al., 2008; Yang et al., 2017), reported correlation between assessed metrics and
clinical scales are similar or lower than the ones obtained here. Additionally, it must be accounted
that clinical scales are always affected by subjectivity to some extent. In particular, FMUE is
widely used and highly recommend (Fugl-Meyer et al., 1975) and, during the experiments, the
same clinician assessed patients, but intra-rater assessments may change up to 5.2 on 66 points
(Singer and Garcia-Vega, 2017).
Moreover, results obtained with the mean distance to the average-healthy path (MDH) show
that, in fact, this metric is more realistic than the typically adopted distance to a theoretical, straight
path (nMD). Actually, nMD had been previously tested in the context of Neuroprobes’ project, but
no significant trend of improvement had been observed, in opposition to other studies of planar
movements (Cirstea and Levin, 2000; Panarese et al., 2012). The reason for that may rely on
a wrong assumption that 3D movements are straight, when, truly, they are more complex, more
curvilinear, as verified with the healthy group.
In addition, although both RMP and SAL quantify smoothness, RMP was somewhat more
able to follow the motor improvement trend of stroke patients. In fact, also when assessing the
healthy group, SAL has shown a higher sensibility to any difference across healthy subjects (ex-
plicit in higher standard deviations) and higher variability across targets than RMP. Thus, from the
results with stroke patients, this suggests that such increased sensibility may not account for true
differences of motor ability, but natural variability across subjects.
Finally, other metrics have been tested, but results were not better than those already described.
In particular, this happened with mean velocity. This metric can be used to assess easiness in
executing some movement, by observing deviations from healthy values and their evolution along
the treatment. For this reason, it was included in the kinematic assessment of stroke patients, so
that a more complete evaluation was done. However, it must be noted that, during the experiments,
patients were usually encouraged to pay more attention to the trajectory they should follow to reach
the target, and not to be too concerned with reaching it quickly. Thus, it was likely that mean
velocity would not show a high correlation with the patient FMUE score, as it actually happened.
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Chapter 9
Conclusions and Future Perspectives
This thesis contributed to define the neurobiomechanical state of acute/subacute stroke patients
during robot-aided motor rehabilitation of the upper limb, with a novel exoskeleton, ALEx Rehab
Station.
The work developed towards such definition relied on data collected from 8 healthy subjects
and 4 stroke patients, recorded while these persons executed 3D point-to-point reaching move-
ments in different conditions (directions and reaching points).
The first challenge addressed in this work was the fact that each patient only trains some
movements in each session of treatment and these are different from session to session and from
patient to patient making data analysis among sessions and between patients and healthy group
complex.
Muscle synergies and spinal maps allowed to define the structure of muscle activity and high-
lighted the possibility to organize targets in four groups in both directions (forward and backward),
simplifying the analysis of stroke patients’ data.
Muscle synergies and spinal maps are representations of a subject’s neuromuscular state.
Stroke patients were assessed concerning the evolution of their activity towards the healthy state.
Results show that even if motor skills are recovered, patients not always reacquire the natural
patterns of nondisabled persons (patterns of muscular coordination and motoneural activity in the
spinal cord). Notwithstanding, the benefits of recovering such patterns is still an open question
concerning their utility for patients to regain their independence and life quality. Additionally,
some deviations from healthy patterns may suggest that attention is required to correct maladap-
tive patients’ posture and movement execution during motor rehabilitation, making this a useful
information for clinicians. In this thesis, it was possible to detect a consistent case of such useful-
ness (with targets of group 2), which leads to the conclusion that information provided by muscle
synergies and spinal maps can be used as feedback for clinicians, improving the personalization of
robotic therapy. To provide a more specific information to clinicians, about the patient’s posture
when executing some movement, it is necessary, in future work, to identify a relation between
the patients’ abnormal neural patterns (like the abnormal synergies’ profiles) and his/her posture.
This would allow, for example, to detect if the patient is using compensatory movements, such
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as the exaggerated shoulder protraction (and/or forward rotation of the trunk), during reaching
movements, typically observed in stroke patients having a reduced ability to extend the elbow.
Results about kinematics showed a different and more defined trend. Rehabilitation and, in
particular the robotic-assisted one, showed benefic effects for stroke patients in more than one
feature of movement execution. The patients were able to improve all parameters evaluated: ac-
curacy, smoothness, efficiency, easiness and dependence on robotic assistance (i.e. their ability to
accomplish some task with the arm). Thanks to their correlation with the FMUE scores, a widely
used clinical scale and reference for the level of motor ability, three kinematic metrics, among
those tested, seem significantly able to capture changes of motor performance:
1 The Mean Distance to the average-Healthy path (MDH), which measures movement accu-
racy;
2 Ratio of Mean Acceleration with Peak Acceleration (RMP), which quantifies smoothness;
3 and the Assisted-Distance, which is a quantity of the patient’s dependence on the robotic
assistance.
As so, they could contribute to estimate the patient motor impairment in the personalization
algorithm. The robustness of these conclusions was estimated using a resampling method (boot-
strapping) on the data of the few available patients.
While kinematics describes aspects of the biomechanical state of stroke subjects and it can
be used for the personalized algorithm, muscle activity still requires further investigations. To
this concern, the framework analysis developed in this work can be applied to the remaining 40
healthy participants and 44 stroke patients planned in Neuroprobes project. It is expected that
these additional data will provide evidences for the inclusion of muscle activity features in the
personalization algorithm.
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Appendix A
Non-Negative Matrix Factorization
(NNMF)
Non-Negative Matrix Factorization (NNMF) is a method of linear algebra to decompose multi-
variate data. Thus, the problem is the following: given a matrix V (being a set of m multivariate
t-dimensional data vectors, in the case of muscle activity, being m EMG signals with t time points),
find two matrices C and S in which matrix V can be factorized. This is equivalent to Equation A
(* ≡ matrix multiplication), because usually the problem has not an exact solution, being only
approximated numerically. (Steele et al., 2015a; Shourijeh et al., 2016; Lee and Seung, 2001)
V ≈C ∗S (A.1)
In this problem, V, C and S have the particularity of having only non-negative elements, which
facilitates the process of discovering. This property (non-negativity) is, on the other hand, inher-
ent to the envelope of muscular activity data, so this method is adequate to analyze EMG signals,
during the arm movements, in order to find the combination of activated synergies. In this context,
C represents the matrix of m x Ns scaling coefficients (relative activation of synergies) and S rep-
resents the Ns x t matrix of muscle synergies, being Ns the number of synergies to be determined.
EMG signals are assumed to be possible to reconstruct from more than one synergy. (Steele et al.,
2015a; Shourijeh et al., 2016; Lee and Seung, 2001)
Several algorithms have been proposed to find C and S matrices by minimization of the error
between matrix V (the original EMG signals) and the approximated reconstructed matrix (signals
resulting from the matrices C and S multiplication). Currently, available algorithms can only reach
a local optimal solution, not a global one.
The most used, because of their easy implementation and for converging fast enough, are
the two numerical algorithms analyzed by Lee and Seung (2001) which allow a locally optimal
matrix factorization by multiplicative update rules. Another algorithm was later developed, the
ALS (alternating least-squares) algorithm, which converges faster and more consistently (the mul-
tiplicative update rules have been shown more sensitive to initial values). (Berry et al., 2007)
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So, this subsection describes only these three algorithms.
The two algorithms of Lee and Seung (2001) iteratively update matrices C and S until a cost
function is minimized. Thus, they differ in the cost function considered to evaluate the approx-
imation of Equation A. Algorithm 1 aims to minimize the Euclidean distance (Equation A), the
algorithm 2 aims to minimize a measure called, by the authors, “divergence” of V from the matrix
resulting from C*S (Equation A). (Lee and Seung, 2001)
‖V −C ∗S‖2 =∑
i j
[Vi j− (C ∗S)i j]2 (A.2)
D(V‖(C ∗S)) =∑
i j
(Vi j ∗ log Vi j
(C ∗S)i j −Vi j+(C ∗S)i j) (A.3)
Matrices C and S are determined, at each iteration, from the multiplication of their current
values by a factor, different for algorithms 1 and 2 (Equations A and Equation A, respectively).
These factors are the ones which guarantee that the cost does not increase with increasing iterations
(but converge to a local minimum). When C and S reach a stationary point of those cost functions,
the cost function value becomes invariant. (Lee and Seung, 2001)
Sαµ ← Sαµ (C
T ∗V )αµ
(CT ∗C ∗S)αµ (A.4)
Ciα ←Ciα (V ∗S
T )iα
(C ∗S∗ST )iα (A.5)
Sαµ ← Sαµ ∑iCiα ∗Viµ/(C ∗S)iµ∑kCkα
(A.6)
Ciα ←Ciα ∑µ
Sαµ ∗Viµ/(C ∗S)iµ
∑ν Sαν
(A.7)
Concerning the ALS algorithm (Berry et al., 2007), it is based on the fact that, given one
matrix, C or S, the other matrix can be found computing the least squares error and minimizing it.
As so, as the name itself indicates, a least square computation is followed by another least square
computation to alternatively determine the matrices C and S, like in the following pseudocode:
for i = 1:maxiter
(LS) Solve for H in matrix equation W T ∗W ∗H =W T ∗A.
Set all negative elements in H to 0.
(LS) Solve for W in matrix equation H ∗HT ∗W T = H ∗AT .
Set all negative elements in W to 0.
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end
The multiplicative update rules have the disadvantage of restricting the path followed by the
algorithm: once an element of C or S becomes 0, it must remain 0. So, even if that path for a
given zero element is a poor path, the algorithm will continue following it. On the contrary, ALS
algorithm is more flexible, thus leading to more consistent results. (Berry et al., 2007)
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Appendix B
Example of a corrupted EMG signal
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138 Example of a corrupted EMG signal
Figure B.1: Example of a bad recording where Brachioradialis EMG is severely corrupted. (A)
Raw EMG signals. (B) Pre-processed EMG signals.
Appendix C
Spinal maps and the location of the
target - linear relations
Table C.1: Linear relation between the 2D-correlation/covariance and the distance from one target
to the respective reference (Target 13 in close-distant axis; Target 7 in left-right axis). r is the
coefficient of determination and p is the respective statistical significance.
Forward Backward
Close-distant axis
(y-axis)
Left-right axis
(x-axis)
Close-distant axis
(y-axis)
Left-right axis
(x-axis)
2D-correlation vs.
y-distance:
r =−0.84
p= 1.68e−5
2D-correlation vs.
Euclidean distance:
r =−0.79
p= 9.96e−5
2D-correlation vs.
y-distance:
r =−0.72
p= 7.10e−4
2D-correlation vs.
x-distance:
r =−0.49
p= 0.039
Covariance vs. Eu-
clidean distance:
r =−0.63
p= 0.005
Covariance vs. x-
distance:
r =−0.40
p= 0.096
Covariance vs. Eu-
clidean distance:
r =−0.68
p= 0.002
Covariance vs. x-
distance:
r =−0.07
p= 0.096
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Appendix D
Kinematic results of healthy subjects
Figure D.1: Kinematic metric results obtained in healthy subjects. Average and standard deviation
is indicated across subjects.
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Appendix E
Muscle synergies’ measures - results of
stroke patients
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144 Muscle synergies’ measures - results of stroke patients
Figure E.1: Correlation between the structure of the patients’ synergies and the healthy synergies
(average across 4 synergies), for each group of targets (group 1, 2, 3 and 4), assessment and patient.
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Figure E.2: “Modified-VAF” similarity (vnsimilarity, see Section 6.7.3.1) for each group of targets
in each assessment session of patients 001, 003, 004 and 006.
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Appendix F
Spinal maps of stroke patients -
examples
Figure F.1: Spinal maps of patient ALEx-HUG-001, for forward movements. Each row corre-
sponds to one group of targets (G1, G2, G3 and G4). Each column corresponds to one assessment
(A1 to A4, from left to right).
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Figure F.2: Spinal maps of patient ALEx-HUG-006, for forward movements. Each row corre-
sponds to one group of targets (G1, G2, G3 and G4). Each column corresponds to one assessment
(A1 to A3, from left to right).
Appendix G
Spinal maps’ measures - results of
stroke patients
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150 Spinal maps’ measures - results of stroke patients
Figure G.1: 2-Dimensional correlation between the patients’ spinal maps and the respective
healthy ones.
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Figure G.2: Covariance between the patients’ spinal maps and the respective healthy ones.
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Appendix H
Kinematic metrics - results of stroke
patients
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154 Kinematic metrics - results of stroke patients
Figure H.1: Results of all patients (ALEx-HUG-001, 003, 004 and 006) in the Kinematic as-
sessment, from assessment 1 (A1) to assessment 4 (A4). Represented values (in green) are the
average across all targets (forward and backward movements). Healthy results (averaged across
the 8 subjects, and across targets and directions) are presented in black. (continues in the next
page)
Kinematic metrics - results of stroke patients 155
Figure H.2: Results of all patients (ALEx-HUG-001, 003, 004 and 006) in the Kinematic as-
sessment, from assessment 1 (A1) to assessment 4 (A4). Represented values (in green) are the
average across all targets (forward and backward movements). Healthy results (averaged across
the 8 subjects, and across targets and directions) are presented in black.
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Appendix I
Kinematics and motor performance
Figure I.1: Correlation between the clinical scale (FMUE) and metrics of the kinematic assess-
ment. The average and standard deviation of the correlation are indicated below the respective
histogram of the bootstrap method results. Histograms indicate the number of occurrences (boot-
strap resamples / data sets) which resulted in a value of the correlation indicated in the x-axis.
SAL is the spectral Arc-Length. This metric, the path length, the movement duration and the
mean velocity did not achieve representative results, since their correlation with the respective
FMUE score is very low.
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